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PART I SUMMARY 
1. Summary 
As the leading cause for protozoal diarrhea worldwide, the small intestinal parasite Giardia lamblia (syn. 
G. intestinalis, G. duodenalis) is an important pathogen of humans and animals and bears responsibility 
for considerable morbidity and large economic losses for the livestock industry. The flagellated, motile 
trophozoites attach to epithelial cells in the small intestine of the host. Antigenic variation of surface 
coat proteins permits the parasite to outwit the host immune system, leading to persistent infection 
associated with watery diarrhea, abdominal pain, resorption disorders, and weight loss. Aside from its 
medical importance, Giardia has become a valuable model for both cell and evolutionary biologists. In 
course of a perfect adaptation to its ecological niche, this unicellular eukaryote has undergone massive 
reductive evolution which resulted in an even lower cellular complexity than that of the predicted last 
eukaryotic common ancestor (LECA). Consistently, most cellular processes in Giardia are simplified, and 
organelles are present in a highly reduced form, if not lost altogether. The minimized cellular 
environment in Giardia permits both the study of basic cell biological questions in minimal context as 
well as exploring eukaryotic diversity.  
 
Parasite transmission of Giardia via the fecal-oral route requires the formation of an extracellular matrix, 
the cyst wall, conferring resistance to harsh environmental conditions. Considering its efficiency as a 
protective barrier, the structural composition of the unique Giardia cyst wall is surprisingly minimal 
consisting of but three paralogous cyst wall proteins (CWP1-3) and a β-(1,3)-N-Acetyl-galactosamine 
(GalNAc) homopolymer. To mediate secretion of the cyst wall material (CWM) in the absence of a 
steady-state Golgi, Giardia generates specialized organelles termed encystation-specific vesicles (ESVs) 
de novo at ER exit sites during encystation. As post-ER compartments dedicated to accumulation, 
modification, sorting, and regulated secretion of the newly synthesized CWM, ESVs feature striking 
parallels to the eukaryotic Golgi on a functional level. Being of critical importance for transmission to a 
new host and thus representing potential drug targets, ESVs and the CWM have been under 
investigation for many years. However, a detailed characterization of their structure, composition, 
neogenesis and functionality has been difficult due to the paucity of ESV-specific factors and the 
challenges posed by the highly reduced and diverged parasite genome.  
In order to identify novel ESV-associated factors that may help characterize the nature of these 
specialized secretory organelles, we developed a novel approach combining flow cytometry-based 
organelle sorting (FAOS), shotgun proteomics and in silico data filtration to define the ESV proteome. 
Analysis and validation of the ESV organelle proteomic dataset provide strong evidence that CWP1-3 are 
the only highly abundant and stage-specifically expressed protein components of the cyst wall. Our data 
suggest that ESV neogenesis and maturation are primarily driven by the cargo proteins (CWP1-3) 
themselves with the assistance of only few, as yet unknown minor factors, if any, similar to the 
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formation of dense-core secretory granules (DCSG) in mammalian cells. Moreover, a strong physical 
connection between the ER and ESVs seems to be maintained until sorting and secretion of the CWM 
begins. Based on our findings and the known inherent properties of CWPs for self-aggregation, disulfide- 
based and isopeptide cross-linking, as well as carbohydrate (GalNAc) binding, we established three 
testable models for cargo-driven ESV neogenesis and maturation with CWP1-3 as the key driving-factors 
of the process.  
 
The molecular underpinnings of these models require a detailed analysis of each CWP’s function and 
contribution to the organelle neogenesis and maturation process. A straightforward approach to address 
this question comprise gene knock-out studies which are performed relatively easily in many other 
eukaryotic model organisms, but are currently not possible in Giardia due also to the parasite’s 
tetraploid genome and the minimal repertoire of suitable drug resistance markers. Alternative strategies 
geared towards gene knock-down have been applied in Giardia but provide, at best, information on the 
biological effects of reduced cellular protein concentrations. However, this might be insufficient for the 
detailed functional analysis of highly abundant proteins such as CWP1-3 during encystation.  
To overcome these limitations and to be able to manipulate the G. lamblia genome in a more effective 
manner we implemented the E. coli phage P1-derived Cre/loxP system in Giardia. The simple two-
component system is based on the recombinase Cre (causes recombination) which recognizes specific, 
short DNA target sites termed loxP (locus of crossing over (x) in P1) and mediates recombination 
between them, resulting in excision, insertion, translocation or inversion of the interjacent DNA 
sequence. The system is already applied to manipulate the genome of other protozoa, and we were able 
to demonstrate the functional expression of the Cre recombinase in G. lamblia in this work. The 
application of the Cre/loxP system in Giardia allowed the removal of a previously inserted puromycin 
drug-resistance cassette from the Giardia genome and its recycling by using it in a subsequent, additional 
round of genetic manipulation in the same cell line.  
Using this key concept for serial removal of all four alleles of a target gene in both nuclei, the Cre/loxP 
system paves the way towards the first bona fide gene-knock out in G. lamblia. We now propose a 
detailed model for the Cre/loxP-based generation of cwp1-3 gene knock-outs. The elimination of these 
key components will hopefully provide insight into neogenesis and functionality of ESVs as well as 
secretory transport assembly of the protective surface composite biopolymer, and help to unravel the 
nature of these specialized and unique secretory organelles.  
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2. Zusammenfassung  
Als Hauptverursacher von Protozoen-verursachter Durchfallerkrankungen weltweit ist der einzellige 
Darmparasit Giardia lamblia (syn. G. intestinalis, G. duodenalis) ein nicht zu unterschätzendes Pathogen 
von Mensch und Tier und trägt die Verantwortung für eine beträchtliche Krankheitsziffer und grossen 
Schaden in der landwirtschaftlichen Tierhaltung. Der begeisselte und motile Trophozoit heftet sich an 
das Dünndarmepithel seines Wirtes an, wobei eine kontinuierliche Variation der Oberflächenantigene es 
ihm erlaubt, das Immunsystem des Wirtes zu überlisten. Dies führt zu persistierenden Infektionen, 
welche mit wässrigem Durchfall, Unterleibsschmerzen, Resorptionsstörungen und Gewichtsverlust 
einhergehen. Neben seiner medizinischen Relevanz ist Giardia zu einem einzigartigen Modellparasiten 
für Forschung in der Zell- und Evolutionsbiologie geworden. Aufgrund der evolutionsbedingen, perfekten 
Anpassung an seine ökologische Nische mittels massiver zellulärer Reduktion weist Giardia eine noch 
einfachere zelluläre Komplexität auf als der letzte gemeinsame eukaryotische Vorgänger (LECA). Die 
Konsequenz dieser reduktiven Evolution manifestiert sich in einer vereinfachten Version der meisten 
zellulären Prozesse und Organellen, falls diese überhaupt vorhanden sind. Diese minimale zelluläre 
Ausstattung in Giardia ermöglicht das Studium von grundlegenden zellbiologischen Fragestellungen 
innerhalb eines stark vereinfachten zellulären Kontextes, aber auch die Erforschung eukaryotischer 
Diversität.  
  
Um auf dem fäkal-oralen Weg auf einen neuen Wirt übertragen und den harschen Umweltbedingungen 
standhalten zu können, benötigt Giardia eine protektive extrazelluläre Matrix, die Zystenwand. Letztere 
ist angesichts ihrer effektiven Schutzfunktion überraschend einfach aufgebaut, besteht sie doch nur aus 
drei verwandten Zystenwand-Proteinen (cyst wall proteins 1-3, CWPs 1-3) und einem β-(1,3)-N-Acetyl-
Galactosamin (GalNAc) Zucker. Da Giardia keinen permanenten Golgi-Apparat mehr besitzt, wird das 
Material für die Zystenwand (cyst wall material, CWM) während des Enzystierungsprozesses mittels 
spezialisierten Organellen, den Enzystierungs-Spezifischen Vesikeln (encystation-specific vesicles, ESVs) 
gereift und sekretiert. Letztere gehen aus spezialisierten Regionen des Endoplasmatischen Retikulums 
hervor (ER exit sites) und sind verantwortlich für die Akkumulierung, Modifikation, das Sortieren und die 
sequentielle Sekretion des neu synthetisierten CWM. In einem funktionellen Sinne erkennt man bei ESVs 
klare Parallelen zum klassischen eukaryotischen Golgi.  Aufgrund ihrer Relevanz in der 
Parasitenübertragung von Wirt zu Wirt sind ESV Organellen potentielle Angriffspunkte für Therapeutika 
und werden deshalb seit vielen Jahren intensiv erforscht. Eine detaillierte Charakterisierung der 
Zusammensetzung, Entstehung und Selbstregulation der Organellen war bisher jedoch nicht möglich, da 
erst wenige ESV-spezifischen Faktoren bekannt sind und letztere aufgrund des stark reduzierten und 
divergierten Parasitengenoms nur schwer zu identifizieren sind.  
Um unbekannte ESV-assoziierte Proteine zu identifizieren und die Eigenschaften dieser  spezialisierten 
Sekretionsorganellen besser charakterisieren zu können, haben wir einen neuen experimentellen Ansatz 
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entwickelt. Eine Kombination aus Fluoreszenz-basiertem Organellen Sortieren (FAOS), 
massenspektrometrischer Proteinbestimmung (shotgun mass spectrometry), gefolgt von 
computergestützter Filtration der generierten Daten erlaubte es uns,  die Proteinzusammensetzung von 
ESV Organellen zu definieren.  
Die Analyse und Validierung der erhaltenen Daten weist stark darauf hin, dass CWP1-3 die einzigen 
hochabundanten und enzystierungs-spezifisch exprimierten Komponenten der Zystenwand sind. Unsere 
Daten deuten auf eine Entstehung und Reifung von ESVs primär durch die Eigenschaften der 
akkumulierten Proteine (CWPs) selber hin, die mit Hilfe von nur wenigen oder keinen zusätzlichen 
Faktoren gesteuert wird, ähnlich der Entstehung von Sekretions-Granula in Säugetierzellen. Zudem 
scheint eine direkte Verbindung zwischen dem ER und ESVs über die gesamte Zeit der Organellen-
Reifung zu bestehen. Basierend auf unseren Resultaten und den bekannten Eigenschaften von CWP1-3 
mit sich selbst zu aggregieren, kovalente Disulfid- und Isopeptidverbindungen zu bilden, sowie den 
Zystenwand-spezifischen GalNAc Zucker zu binden, haben wir drei testbare Modell-Szenarien für die 
Bildung und Reifung von ESV Organellen entwickelt, wobei CWP1-3 die Schlüsselfaktoren darstellen.  
 
Ein experimenteller Test dieser Modelle beansprucht eine detaillierte Analyse der Funktion jedes CWPs, 
um dessen individuellen Beitrag zur Entstehung und Reifung der ESV Organellen zu bestimmen. Im 
Idealfall würde man diese Fragestellung mit der Entfernung der jeweiligen Gene (knock-out) vom Giardia 
Genom angehen. Obschon dieser Ansatz in vielen anderen eukaryotischen Modellorganismen zu 
realisieren ist, stellt er in Giardia aufgrund des tetraploiden Genoms in zwei Zellkernen und der wenigen 
geeigneten Selektionsmarkern ein vorläufig unüberwindbares Problem dar. Alternative Strategien mit 
dem Ziel der Unterdrückung der Proteinexpression (knock-down) wurden in Giardia zwar angewandt, 
resultieren aber bestenfalls in der Reduktion der zellulären Proteinkonzentration. Dies ist für eine 
funktionelle Analyse von stark exprimierten Proteinen, wie CWP1-3 während der Enzystierung, mit 
grosser Wahrscheinlichkeit nicht ausreichend.  
Um dieses Hindernis zu überwinden und das Genom von Giardia effektiver manipulieren zu können, 
haben wir das Cre/loxP System des E. coli Phagen P1 in Giardia implementiert. Das einfache zwei-
Komponenten System basiert auf der Cre (causes recombination) Rekombinase, welche bestimmte kurze 
DNA Sequenzen, die loxP (locus of crossing over (x) in P1) Sequenzen, erkennt und rekombiniert. Dies 
resultiert im Ausschneiden, Inserieren, in der Verlagerung oder im Umdrehen der dazwischenliegenden 
DNA Sequenz. Das Cre/loxP System findet bereits Anwendung in der Genommanipulation von anderen 
Protozoen, und wir haben nun zeigen können, dass die Cre-Rekombinase auch in G. lamblia funktionell 
exprimiert wird.  
Die Anwendung des Cre/loxP Systems in Giardia ermöglichte uns, eine zuvor eingesetzte Puromycin-
Resistenzkassette aus dem Giardia Genom zu entfernen, und diese in einer darauffolgenden weiteren 
Genommanipulation derselben Zelllinie nochmals als Selektionsmarker zu verwenden. Dieses System 
birgt den Schlüssel zur seriellen Entfernung ausgewählter Zielgene aus dem Giardia Genom und bringt 
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uns dem ersten Gen knock-out in diesem Parasiten einen entscheidenden Schritt näher. Basierend auf 
dem Cre/loxP System haben wir eine detaillierte Strategie für die Realisierung von cwp1-3 Gen knock-
outs in G. lamblia entwickelt. Die Eliminierung dieser Schlüsselkomponenten wird Einblick in die 
Entstehung und Funktionsweise von ESVs gewähren und helfen, die natürliche Beschaffenheit dieser 
spezialisierten und einzigartigen Sekretionsorganellen zu enthüllen.  
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PART II AIM OF THE THESIS  
For transmission to a new host, G. lamblia depends on the synthesis and deposition of a protective 
extracellular composite biopolymer, the cyst wall. Three Giardia cyst wall proteins (CWPs 1-3) constitute 
the major protein components of this extracellular matrix and are, in the absence of a conventional Golgi 
apparatus in Giardia, secreted to the cell surface by stage-specifically induced organelles termed 
encystation-specific vesicles (ESVs). The correct modification and sorting of CWPs in ESVs and their 
regulated secretory trafficking are essential for the functional integrity of the protective wall and thus 
plays a critical factor in parasite transmission.  
Although subject of investigation for many years, information on CWPs and their secretory organelles is 
sparse. A detailed systematic analysis has been prevented not only by the parasites tetraploid genome 
and the paucity of drug resistance markers which have disallowed the application of forward genetic 
approaches to study gene and protein function, but also by the parasites diverged and highly reduced 
genome that makes the identification of organelle-associated factors a considerable challenge.  
 
The aim of my thesis was to investigate the protein composition of ESVs to detect novel factors 
associated with these organelles and thereby lay the groundwork to gaining insight into ESV neogenesis, 
functionality and stage-specific regulation. In an approach with a similar goal but using a different angle, 
I aimed to implement the E. coli phage P1-derived Cre/loxP system in G. lamblia to significantly enhance 
the spectrum of genome manipulations in Giardia and provide the key for future gene knock-out studies 
of CWP1-3, the ESV cargo proteins.  
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PART III INTRODUCTION 
1. Giardia lamblia 
1.1. Giardiasis and the Giardia life cycle 
It was in his own watery stool, where the pioneering Dutch microscopist Antony Van Leeuwenhoek 
discovered Giardia, and he entered the history books in 1681 with the following description of G. lamblia 
trophozoites: “I have at times seen very prettily moving animalcules ….. Their bodies were somewhat 
longer than broad, and their belly, which was flattened, provided with several feet, with which they made 
such a movement …” (documented by 1). Not until 26 years ago, experimental infection studies on 
human volunteers lead to the proof of human pathogenicity of this small intestinal parasite by fulfilling 
the Koch postulates 2. In the meantime, Giardia was recognized as one of the leading causes for 
protozoal diarrhea worldwide, bearing responsibility for substantial morbidity and economic loss 3. The 
flagellated parasite causes acute or chronic diarrhea associated with abdominal pain, nausea, 
malabsorption, and weight loss. The prevalence ranges from 2-7% in developed countries to 20-30% in 
most developing countries worldwide 4; Giardiasis was included in the “WHO neglected disease 
initiative” in 2004 5.  
 
 
 
Figure 1: The two stages of the 
G. lamblia life cycle. A) Giardia 
trophozoite. The ventral disk 
structure and the flagella are 
indicated. B) Giardia cyst. 
Images: reference 
6
.  
 
 
G. lamblia has a simple life cycle consisting of mobile, flagellated trophozoites (figure 1A) and 
environmentally resistant cysts (figure 1B) which are transmitted from host to host on the fecal-oral 
route. After ingestion by a new host and exposure to the acidic environment of the stomach, the Giardia 
cysts are triggered to initiate excystation 3. The resulting trophozoites actively attach to the epithelium of 
the small intestine by a disk-like structure on their ventral side (figure 1A), and multiply asexually by 
binary fission. To evade the host immune system, trophozoites mediate antigenic variation in their 
protein surface coat 7. Upon distinct environmental triggers, such as a change in bile concentration, 
bioavailability of lipids, or an increase in pH, trophozoites undergo a complex stage-differentiation 
process and transform to resistant cysts with low metabolic activity which are shed with the feces of the 
host. The G. lamblia life cycle, including encystation and excystation, can be reproduced axenically in 
vitro 8.  
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1.2. Evolutionary background  
Until recently, Giardia was considered one of the earliest branching eukaryotes, together with other 
cytological simple parasitic lineages including Trichomonas, Trypanosoma and Leishmania (figure 2). 
Based on phylogenetic ribosomal RNA (rRNA) analysis and the apparent absence of several organelles, 
introns, and mitotic machinery, it was proposed that these lineages are primitively simple and branch at 
the very basis of the eukaryotic tree 9, 10.  
During the last decade, more powerful algorithms and the increasing amount of available data for 
phylogenomic analysis has revolutionized the understanding of eukaryotic evolution. Previous 
phylogenetic trees, based on small subunit (16S-like) rRNA analysis which predicted eukaryotic evolution 
as a “progression” from the simple to the complex 9, 11, were recently replaced by an alternative model 
which predicts the existence of six major eukaryotic groups and removes the root of eukaryotes 
including the amitochondrial protists (figure 2) 10, 12-14. The novel, egalitarian tree distributes protozoan 
parasites into three different eukaryotic major groups that are separated by several non-parasitic taxa. 
This entails that the parasitic lifestyle was “invented” independently on many separate occasions 11. 
Hence, similar phenotypic variants of parasite life styles belonging to different taxa are the result of 
convergent evolution rather than inherited from an early eukaryotic ancestor. An example is provided by 
the antigenic variation of surface coat proteins, which is used by several protozoa as a strategy to evade 
the host immune system 15. The phenomenon is well described in Giardia and Trypanosoma from the 
Excavata supergroup, as well as for Plasmodium belonging to the Chromalveolata 15. Another example 
for convergent evolution is the synthesis of specialized organelles for the secretion of protective 
extracellular matrices 16, as observed in Entamoeba invadens, the social amoeba Dictyostelium 
discoideum, the ciliate Tetrahymena termophila,  and Giardia lamblia, which belong to three different 
eukaryotic supergroups.  
 
Figure 2: Different models for the 
evolution of eukaryotes 
10
. Left: 
Recently proposed egalitarian 
(unrooted) tree based on molecular 
phylogenetic data 
12-14
. The eukaryotes 
are categorized into six major groups. 
Parasitic protozoan lineages (bold) are 
dispersed in three groups. Right: 
Former elitist tree based on small 
subunit (16S-like) ribosomal RNA data 
only 
9
. The amitochondrial protists 
represent the earliest diverging 
eukaryotic lineages. Dd: Dictyostelium 
discoideum; Eh: Entamoeba histolytica, 
Gi: Giardia lamblia; Lm: Leishmania major; Pf: Plasmodium falciparum; Tg: Toxoplasma gondii; Tv: Trichomonas 
vaginalis; Tb: Trypanosoma brucei. 
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Based on the current knowledge, the predicted last eukaryotic common ancestor (LECA) was not 
primitively simple but instead a “complete” eukaryotic cell which had a nucleus, an ER and Golgi 
apparatus, mitochondria, a complex eukaryotic cytoskeleton including flagella, and underwent mitosis 
and meiosis 12. As a consequence, the apparent lack of mitochondria and other features, that originally 
characterized various eukaryotes as primitively simple, are now considered a result of minimization or 
secondary loss through reductive evolution. A case in point are the Giardia mitosomes 17, relic 
mitochondria that have lost many mitochondrial features such as the citric acid cycle, the respiration 
chain, and their genome (discussed below).  
 
1.3. The Giardia organelle system  
In course of perfect adaptation to its ecological niche, Giardia has undergone substantial reductive 
evolution. This resulted in a simplified version of most cellular processes, metabolic pathways, and 
minimization or even loss of cellular organelles such as mitochondria, peroxisomes, and a classical Golgi 
apparatus 11, 18, 19. On a morphological and molecular level, three clearly identifiable organelle systems 
have been specified in Giardia trophozoites (figure 3) 20: An extensive endoplasmic reticulum (ER), the 
peripheral vesicles (PVs), and relic mitochondrial organelles termed mitosomes. In encysting 
trophozoites, additional organelles termed encystation-specific vesicles (ESVs) are generated in a stage-
specific manner, which contain secretory material destined for regulated export to the cyst wall 21, 22.  
 
 
Figure 3: The three-dimensional model generated 
from confocal image stacks shows organelle systems 
in G. lamblia 
20
. In Giardia trophozoites, three 
organelle systems have been identified: the 
mitosomes (orange, A, C), the peripheral vesicles 
(PVs, green, B, C), and the ER including the 
perinuclear region and nuclear envelopes (light blue, 
A, C, D). In encysting cells, an additional set of 
organelles termed encystation-specific vesicles (ESVs) 
is established de novo (red, B, C). Nuclear DNA is 
stained with DAPI. Organelle-specific markers are 
IscU: Iron-sulfur-cluster assembly protein, CWP1: cyst 
wall protein 1, PDI2: protein disulfide isomerase 2.   
 
 
The endoplasmic reticulum (ER)  
The Giardia ER consists of cisternal and tubular elements and extends from the nuclear envelopes 
throughout the entire cell body 23 and touches but does not penetrate the cortical space occupied by PVs 
20. With respect to secretory protein trafficking, Giardia possesses a conventional ER: conserved 
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machinery for translocation mediates co-translational import of secreted proteins into the ER, and 
protein folding is assisted by a series of conserved chaperones such as protein disulfide isomerases 
(PDIs), the Hsp70 Binding Protein BiP, and peptidyl-prolyl cis-trans isomerases 11. Unlike in many 
eukaryotes, N-glycosylation of proteins is restricted to the addition of GlcNAc1-2 to asparagine 
24. 
Consistent with this, the parasite lacks the ER based (calnexin/calreticulin) quality control system for 
glycoprotein folding, and encodes neither enzymes required for synthesis of the conventional eukaryotic 
core oligosaccharide GlcNAc2Man9Glc3 nor factors for N-glycan or O-glycan processing in the ER or Golgi 
11.  
The ER is positioned at the crossroads of endocytic and exocytic protein trafficking in Giardia. Due to the 
absence of a conventional Golgi apparatus, the ER plays a major role in direct secretion of proteins to 
their target organelles or the plasma membrane 21. In addition, the organelle is involved in endocytic 
trafficking by uptake and catabolism of pre-sorted bulk endocytosed material from the Giardia 
peripheral vesicles 25.  
 
Peripheral vesicles (PVs) 
Peripheral vesicles (PVs) are small, 150 nm-sized organelles that underlie the plasma membrane of the 
entire dorsal side and a specialized region termed bare zone at the center of the ventral disk 26. PVs 
mediate endocytosis of soluble and membrane-bound factors and acidify 25-28. The organelles periodically 
open to the environment, presumably by direct fusion with the plasma membrane, and take up fluid 
phase material non-selectively 25, 26, 29. While most fluid phase markers remain in PVs until extruded upon 
the next cycle of fusion with the plasma membrane,  selected markers are transported rapidly inward to 
the proximal ER and the nuclear envelope 25, suggesting a discriminatory sorting function associated with 
PVs. Besides their endocytic and sorting characteristics 30-32, PVs have a lysosomal nature since they 
acidify and become digestive compartments 29. Containing cathepsins and acid hydrolases, PVs are likely 
involved in degradation of bulk endocytosed material before their trafficking to the ER 25. Further, PVs 
might play a role in secretory protein trafficking as indicated by various studies. The organelles were 
suggested to secrete distinct proteins including an acid phosphatase required for decomposition of the 
cyst wall during excystation 33, and also variant-specific surface proteins (VSPs) which have been 
detected in PVs in immuno-electron microscopy studies 32, 34.  
 
Mitosomes  
The Giardia mitosomes are less than 200 nm-sized, double-membrane bounded cytoplasmic 
compartments. The organelles come in two flavors: they are either distributed throughout the cell 
(peripheral mitosomes) or tightly clustered in the basal body region between the two nuclei (central 
mitosomes)35. While the Giardia mitosomes harbor a simple protein import and folding machinery 35-38 
and function in synthesis and assembly of iron-sulfur clusters 17, 38-40, they lack other classical 
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mitochondrial attributes such as cristae, the respiration chain, the citric acid cycle, or a mitochondrial 
genome.  
 
Encystation specific vesicles (ESVs) 
The process of encystation in Giardia includes synthesis and regulated secretion of a polymerizing 
extracellular matrix, the cyst wall (CW). Considering its high environmental resistance, the Giardial CW is 
a biopolymer of surprisingly low complexity. Three paralogous cyst wall proteins (CWP1-3) are the only 
known structural proteins of the extracellular wall 41-43. The CWPs are between 241 and 362 amino acids 
in length and share high sequence identity. They all contain predicted hydrophobic N-terminal secretory 
signal peptides, a central region consisting of 4 to 5 tandem arrayed leucine-rich repeats, followed by 
cysteine-rich regions (figure 4). CWP2 contains an additional C-terminal domain of 121 residues which is 
rich in basic amino acids and is not found in CWP1 or CWP3. This C-terminal part of this basic extension is 
proteolytically processed during ESV maturation 44 (discussed below). In addition to the three CWPs, the 
cyst wall contains a β-(1-3)-GalNAc polymer which is unique to Giardia and makes up about 60% of the 
wall material 45, 46. Where the sugar polymer is synthesized and how and when it is trafficked to the cell 
surface has not been resolved definitively.  
 
  
 
 
 
 
 
 
 
 
 
A very unusual aspect is that Giardia has no steady-state Golgi apparatus with which to organize 
secretory transport of proteins and regulated secretion of the cyst wall material (CWM) in particular. 
Instead, encystation-specific vesicles (ESV) are formed de novo from ER exit sites during encystation 21, 47, 
48. As post-ER compartments, these organelles accumulate and delay only the newly synthesized CWPs 
and no other secretory cargo for post-translational modification. In addition, ESVs play a key role in 
sorting and sequential secretion of the Giardia CWM to the cell surface where it polymerizes 44. Hence, 
ESV organelles closely resemble the eukaryotic Golgi on a functional level. In fact, the latest data strongly 
support the hypothesis that ESVs are inducible, transient Golgi cisterna-equivalents: COPII-dependent 
ESV neogenesis appears to be highly analogous to formation of cis-Golgi cisternae 47, 48, and maturing 
ESVs sort cargo in a manner that is very reminiscent of sorting at the trans-Golgi network 44. Further, 
Figure 4: Schematic depiction of CWP1 and CWP2 domain organization 
41
. 
Checkered boxes: signal peptides, cross-hatched boxes: leucine rich repeats, 
stippled boxes: cysteine-rich regions, black box: 121 residue C-terminal 
domain. CWP3 is very similar to CWP1 and is not shown.  
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ESVs are sensitive to Brefeldin A, a fungal metabolite that causes Golgi-disassembly in higher eukaryotes 
22, 49. ESVs were proposed to be transient (i.e. pulsed) single-stacked Golgi-analogs that undergo 
maturation from a cis- to a trans-stage, reminiscent of the cisternal maturation model for Golgi function 
in higher eukaryotes 21, 44. On the other hand, ESVs are not a permanent feature of trophozoites and 
clearly differ from a classical Golgi from a structural point of view, since neither conserved structural nor 
functional proteins of the Golgi have been identified in ESVs so far.  
 
1.4. Constitutive and regulated protein secretion in Giardia lamblia 
As a consequence of secondary reduction, Giardia trophozoites have no classical Golgi apparatus, and 
secreted proteins are trafficked from the ER straight to the target organelle or the plasma membrane 21, 
50, 51. A large part of the constitutive secretory activity of trophozoites includes the secretion of 
membrane-spanning variant-specific surface proteins (VSPs) 20. These proteins with cysteine-rich 
exodomains mediate antigenic variation on the trophozoite plasma membrane, helping the parasite to 
evade the host immune system 7. Of the predicted 235 to 275 VSPs 11, only one coats the parasite 
membrane at a time 52.  Antigenic switching, i.e. exchange of the VSP type currently expressed on the 
surface by a different one, occurs every 6 to 13 generations 53 and is dependent on RNA interference 
(RNAi) mediated silencing mechanisms as discussed below 54. The VSPs extracellular domains are cleaved 
and exodmaons are released as soluble antigens into the environment 55. This results in continuous 
secretion and turnover of the currently expressed VSP type on the plasma membrane. Surface targeting 
of trafficked VSPs from the ER requires an absolutely conserved C-terminal CRGKA motif 21. Trafficking 
likely occurs directly from the ER to the plasma membrane 21, 50, 51, and is sensitive to Brefeldin A 41, 49, a 
fungal metabolite interfering with the functions of the GTPase Arf1. This suggests involvement of COPI-
dependent membrane carriers in VSP export (figure 5).  
In addition to VSPs, a group of non-variable cysteine-rich proteins 56 are also targeted to the plasma 
membrane, as well as an unknown number of the roughly 500 proteins that are predicted to enter the 
secretory pathway 20 (http://Giardiadb.org/Giardiadb/showQuestion.do?questionFullName=Gene 
Questions.GenesWithSignalPeptide).  
 
In cells which differentiate to cysts, a regulated secretory pathway is generated by de novo formation of 
specialized organelles termed encystation-specific vesicles (ESVs)21, 22. ESVs secrete the CWM to the 
parasite surface (figure 5). Whether the GalNAc-sugar component of the cyst wall is trafficked via ESVs to 
the cell surface or takes an alternative route is currently unknown.  
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Figure 5: Basic model of secretory pathways in 
G. lamblia. Top: Regulated secretion of CWM in 
encysting trophozoites. The CWM is exported 
from transitional ER (tER) sites in a COPII-
dependent manner and accumulates in early 
ESV organelles (red) which are established de 
novo. ESVs grow in size by accumulation of CWM 
and undergo a maturation process. From mature 
ESVs (yellow), the CWM is secreted via unknown 
transport intermediates to the cell surface, 
where it polymerizes to from the cyst wall. 
Bottom: Constitutive secretion of variant-specific surface proteins (VSPs) in trophozoites and encysting cells. VSPs 
are directly trafficked from tER sites to the plasma membrane, likely in COPI-dependent transport intermediates. 
tER: transitional ER; N: nucleus; ESVs: encystation-specific vesicles; PM: plasma membrane; CW: cyst wall; VSPs: 
variant specific surface proteins.  
 
A frequently used laboratory protocol to induce stage-differentiation of G. lamblia trophozoites is a two-
step method based on bile deprivation and a subsequent increase in pH combined with addition of 
porcine bile 57. Expression of CWPs is induced stage-specifically from a zero level in trophozoites, and 
mRNA levels peak at 7 hours post induction (p.i.) 44, 57.  Additional modulation of CWP expression is 
dependent on a conserved motif in their promoter sequence which serves as binding region for a Myb1-
like transcription factor 57. In addition to CWP1-3, Giardia Myb1 positively regulates transcription of a set 
of key enzymes required for the cyst wall sugar synthesis 57, 58.  
Synthesis and co-translational import of CWPs into the ER lumen occurs during the first 7 hours of 
encystation (figure 6). The CWPs are selectively sorted out from constitutively secreted material at ER 
exit sites and leave the ER in a COPII dependent manner 21, 47, 48, 59. Accumulation of CWPs in emerging 
ESVs is observed by fluorescence microscopy from 2 hours post induction (p.i.) of encystation and is 
completed after 8 to 10 hours p.i. 49. The material is delayed in ESVs for several hours, allowing post-
translational maturation; the highly homologous CWPs are partitioned into two fractions which are then 
secreted sequentially 44. In a first step (8 to 12 hours p.i.), CWP3 and the proteolytically cleaved C-
terminal fragment of CWP2 (ΔC) undergo selective condensation, resulting in the formation of two 
biophysically distinct CWM fractions inside ESVs. The remaining two components, CWP1 and the N-
terminal part of processed CWP2 (ΔN), remain fluid and circulate between ESVs within a dynamic, 
tubular membrane possibly via the ER 47. In a second phase (16 to 20 hours p.i.), the fluid components 
are sorted away from the condensed material and appear in small compartments near the cell periphery, 
before they are secreted rapidly and form a structurally resistant matrix on the cell surface. The 
condensed material remains in internal compartments, is decondensed and secreted slowly during 
several hours, and most likely forms an inner layer of the cyst wall 44.  
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Figure 6: Detailed model for the secretion of 
CWPs in G. lamblia 
44
. Top: Confocal image 
stacks (volume reconstructions) at different 
time points p.i. showing CWP1 (red) as a 
component of the fluid CWMfl fraction and 
CWP2-ΔC (green) in the condensed CWMco 
fraction. Bottom: Cartoon depicting the 
different steps of ESV formation and 
maturation. A) First appearance of CWM in 
the ER at 2 hours p.i.. B) Sorting of CWM from 
constitutively secreted material at tran-
sitional ER (tER) sites. C) ESVs accumulate 
CWM and increase in size. D) Proteolytic 
processing of CWP2 and partitioning of the 
CWM into a condensed (CWMco) and a fluid 
(CWMfl) fraction. E) Exchange of CWMfl 
between ESVs via dynamic membrane tubules. 
F) Sorting of CWMco and CWMfl into distinct 
compartments. G) Rapid secretion of CWMfl and establishment of an outer wall. H) Slow secretion of CWMco, 
likely involving decondensation. Maturation must be completed before cysts become water-resistant. CWM: cyst 
wall material; co: condensed; fl: fluid; p.i.: post induction of encystation; tER: transitional ER; h: hours post 
induction of encystation. 
 
 
Besides CWP1-3, constituting the only known stage-specifically expressed CW components, a number of 
constitutively expressed minor proteins appear to be trafficked via ESVs to the cell surface. They include 
the high cysteine non-variant cyst protein (HCNCp) 56 and six EGF-like cyst proteins (EGFCP1-6) 60. Whilst 
these proteins localized to the nuclear envelope and the peripheral ER in trophozoites, they were 
detected also in ESVs during encystation, and in the cell body and cyst wall of cysts 56, 60. A calcium-
binding protein termed granule specific protein (GSP) was detected in ESVs during encystation but not in 
the cyst wall 61. GSP was suggested to regulate calcium-dependent degranulation of ESVs during 
encystation 61.  
In total fewer than 20 proteins are known to re-localize stage-specifically from other cellular 
compartments and undergo a transient association with ESVs. Among these are several trafficking 
proteins either known or supposed to be involved in CWP transport from ER to ESVs during early 
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encystation (Giardial homologs of Sar1, Sec31, Yip1, Rab1a), or in secretion of the CWM to the cell 
surface at later encystation time points (dynamin-like protein DLP, Arf1, Rab11) 18, 29, 47, 62, 63. Proteasome 
complexes are recruited to ESV membranes during early encystation, perhaps as a result of post-ER 
quality control and associated degradation processes 62.  In addition, recruitment of COPI-coat 
components to ESVs and the KDEL-dependent retrieval of the ER chaperone Hsp70/BiP from ESVs 
suggested the presence of a COPI-based retrograde trafficking from ESVs to the ER 62.  
Several SNARE (soluble N-ethylmalemide–sensitive factor attachment protein receptor) proteins were 
detected at ESV organelles 63. Finally, two cysteine proteases are recruited to ESVs; a subtilisin-like 
proprotein convertase (SPC), localizing to the perinuclear ER in trophozoites 64, and a cathepsin-B like 
cysteine protease 2 (CP2) being one of several candidates discussed regarding the proteolytic processing 
of CWP2 65.  
 
While the CWPs reach the surface by trafficking through ESVs, it is still unclear when and where in the 
exocytic pathway the cyst wall sugar (CWS) component, a β-(1,3)-GalNAc homopolymer, is synthesized 
and how it is finally incorporated into the cyst wall 45, 46. The recent literature suggests synthesis of the 
cyst wall monomer, UDP-GalNAc, from glucose by a series of cytosolic enzymes that are upregulated 
after induction of encystation 58. The UDP-GalNAc monomer is polymerized into the β-(1‐3)‐GalNAc 
homopolymer by a putative cyst wall synthase 66. Whereas the activity of the enzyme has been 
demonstrated 66, its identity was never unraveled.  
 
1.5. Genetic organization in Giardia lamblia  
The Giardia genome 
The most widely used laboratory strain of G. lamblia (WB clone 6, ATCC 50803, human isolate 67) has a 
compact genome of 11.7 MB in size which is fully sequenced 11, 68. It codes for 6470 predicted open 
reading frames (ORFs) that frequently overlap and are distributed on 5 chromosomes 11. Although the 
Giardia genome is size-wise comparable to that of yeast, Giardia has significantly simplified variants of 
most cellular processes and machineries, including those for transcription and translation, compared to 
those of yeast and other eukaryotic organisms 11. The presence of many genes with bacterial or archaeal 
origins in Giardia suggests that lateral gene transfer has strongly influenced the shaping of the parasite’s 
genome 11.  
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Transcription, mRNA processing, and translation  
The promoter sequences in Giardia are unusually short with a length of 70 bp or less69. Although the 
Giardia transcription factors sometimes remarkably diverge from those of other eukaryotes 70, mRNA 
maturation in Giardia involves many features typical for eukaryotes including 5’ capping 71, 
polyadenylation 11, 69, and rarely also intron splicing 11.  
Transcripts in Giardia have short untranslated regions (UTRs), ranging from 0 to 14 nucleotides for 
5’UTRs, and 10 to 30 nucleotides for 3’UTRs 69. Based on the minimal 5’UTRs and some missing 
translation initiation factors it was proposed that initiation of translation in Giardia does not include 
ribosome scanning as observed in eukaryotic cells, but instead proceeds similar to prokaryotes 11. It was 
found that each of the Giardia ORFs contains a so-called downstream box (DB) consisting of 13 
nucleotides which is also found in E. coli. Due to a complementary region in the 16S ribosomal RNA, this 
conserved sequence promotes efficient initiation of protein synthesis even in the absence of a Shine 
Dalgarno sequence 11.  
Only 5 genes containing introns were detected so far, and cis-splicing has been experimentally 
demonstrated for 4 of them 11, 72-74. Giardia encodes a complete eukaryotic splicing machinery 11. Since 
the number of introns in the parasite is very low, the question comes up why mRNA splicing is actually 
maintained in Giardia. A recent study reported the trans-splicing of two parts of the cytosolic chaperone 
Hsp90 mRNA in Giardia which is encoded by separate genes 75-77. Involvement of the spliceosome as a 
key factor in the expression of essential housekeeping genes might explain the maintenance of the 
spliceosome.  
 
RNA interference in Giardia  
The eukaryotic RNA interference pathway plays a key role in gene silencing and consists of the three key 
factors Dicer, Argonaute, and an RNA-dependent RNA polymerase (RdRP). In contrast to higher 
eukaryotes, Giardia encodes only for a single copy of each factor 78-80. The Giardia genes for Dicer and 
Argonaute were initially not identified due to the high divergence or even absence of normally 
conserved protein domains. Proof for the existence of a functional RNAi machinery in Giardia was 
provided by a recent study demonstrating that antigenic switching of Giardia VSP surface proteins is 
controlled by RNAi-based silencing 54. Besides involvement in antigenic variation, the RNAi pathway 
seems to play an important role in the parasite since down-regulation of Giardial Argonaute leads to 
inhibition of cell growth 81.  
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The Giardia nuclei 
As a member of the Diplomonads, Giardia has two diploid nuclei which make the cell effectively 
tetraploid 82, 83. Both nuclei are transcriptionally active, and nuclear inheritance to daughter cells during 
semi-open mitosis occurs via equatorial segregation (figure 7)82-84.  
 
 
 
 
 
 
 
Figure 7: Nuclear inheritance in the Giardia life cycle 
84
. Left: Trophozoite dividing by binary fission. The nuclei are 
inherited equatorially, so that each daughter cell receives one copy of each parental nucleus. Right: Trophozoite 
undergoing encystation. An incomplete mitosis results in a cyst with four daughter nuclei containing four genome 
complements each. During excystation, the emerged exyzoite undergoes two rounds of cytokinesis and one round 
of karyokinesis, resulting in four daughter trophozoites. Each of them receives one copy of the initial parental 
nuclei.  
 
 
Until recently, Giardia has been considered a strictly asexual organism replicating only by binary fission. 
However, the unexpectedly low level of heterozygosity raised the question how homozygosity between 
the separated nuclei as well as on the population level is maintained 11. Possible answers were found 
only recently through the detection of meiotic genes and evidence from population genetic studies 
which support the occurrence of sexual recombination in Giardia 85-87. In addition, it was observed that 
Giardia nuclei can exchange chromosomal material in cysts (figure 7) 84. These findings might explain 
both the genome homogenization on the population level and between to two nuclei.  
Giardia’s binuclear state raises interesting questions about the emergence and functionality of the two 
nuclei, as well as how orchestration of transcription is controlled. On the other hand, the tetraploid 
genome organization strongly limits the application of genetic and cell biological approaches to 
investigate this intestinal parasite. The situation is worsened by the limited repertoire of only two drug-
resistance markers suitable for selection of transgenic Giardia 88-91. Accordingly, genetic manipulations of 
relatively low complexity, such as gene knock outs, are easily realized in many other eukaryotic 
organisms but constitute a currently insuperable barrier in Giardia.  
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2. The Cre/loxP system  
In site-specific recombination (SSR), a DNA molecule is cut at two specific positions by a recombinase, 
and the cut ends are recombined differently 92. SSR systems are found in many organisms where they 
play diverse roles such as phage integration into and excision from host cell genomes, plasmid copy 
number regulation, or monomerization of multimeric bacterial plasmids and chromosomes 92. The best 
investigated SSR systems are the ones from bacteriophages, bacteria, and yeast. The DNA recombination 
sites of different systems vary considerably in size, ranging from 30 bp up to 240 bp. Many SSR systems 
require the help of accessory proteins in addition to the recombinase 92.  
The E. coli P1 phage-derived SSR system is a simple bipartite system and based on short recombination 
sites. The Cre-recombinase (causes recombination) mediates inter- and intramolecular recombination of 
short 34 bp-sized loxP sites (locus of crossing over (x) in P1) without the involvement of any co-factors 93, 
94. Depending on the relative orientation of two loxP sites with respect to one another, Cre-mediated 
recombination results in excision, insertion, inversion, or translocation of loxP-flanked (“floxed”) DNA 
sequences (figure 8) 95.  
 
 
 
 
 
 
 
 
 
 
Figure 8: Recombination reactions mediated by Cre 
95
. The outcome depends on the relative orientation of the loxP 
sites with respect to one another. A) Identical orientation of loxP sites: Cre excises a floxed sequence which results 
in a circular molecule (left) or integrates a circular molecule into a linear molecule each possessing a loxP site 
(right). B) Inverted orientation of loxP sites: Cre mediates inversion of floxed DNA sequence. C) LoxP sites present 
on different linear molecules: Cre exchanges sequences distal to loxP sites. This intermolecular recombination can 
occur between loxP sites on non-homologous chromosomes. Arrowheads: loxP sites; circle: Cre momoner; a-j: 
distinct DNA sequences.   
 
The 34 bp loxP site consists of an asymmetrical core which is flanked by two inverted repeats (figure 9). 
To catalyze the recombination reaction, 4 Cre recombinase monomers bind to the inverted repeats of 
two loxP sites (figure 9). Interestingly, the Cre-recombinase tolerates certain variations in the targeting 
site. The alternative lox sites are still recognized by Cre, but recombination occurs only between 
homotopic pairs of these variant sites 95.  
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Due to its simplicity, the system has become a powerful research tool and is used nowadays to tightly 
regulate the location and timing of genetic manipulations in a wide variety of organisms. Focusing on 
protozoan parasites, the system was successfully established in Toxoplamsa gondii, Trypanosoma brucei, 
and recently also Plasmodium falciparum 96-98.  
Specifically, the Cre/loxP system has been used for vector insertion into the T. gondii genome 96, and for 
the removal of drug resistance markers in T. brucei and P. falciparum 98-100. An interesting Cre/lox-based 
approach was applied in T. gondii by Koshy and colleagues  who developed a system for in vivo 
monitoring of parasite infection in mice 101. They generated a T. gondii cell line which injects a Cre-fusion 
protein into Cre-reporter mouse cells, resulting in expression of GFP upon parasite invasion. Another 
application of the Cre/loxP system was the generation of knock outs in T. brucei and T. gondii 99, 102.  
Figure 9: Schematic depiction of the Cre-mediated recombination mechanism. A) 34 bp loxP 
site consisting of an 8 bp asymmetrical core (arrowhead) flanked by two 13 bp inverted 
repeats 
94
 (arrows). B) Recombination between two loxP sites (black and white) is initiated 
by the formation of a synaptic complex of 4 Cre monomers (blue) each binding to one of 
two inverted repeats of a loxP site. C) The loxP asymmetrical core is the site of strand 
cleavage, strand exchange, and ligation. D) The recombination process results in the 
exchange of DNA sequences distal to loxP sites 
95
.    
 
PART III     INTRODUCTION 
23 
3. Goals of the Thesis 
3.1. Project 1: Proteomic analysis of Giardia lamblia encystation-specific vesicles (ESVs)  
For transmission to a new host, G. lamblia depends on the regulated secretion of a protective 
extracellular composite biopolymer, the cyst wall. In the absence of a conventional Golgi apparatus, 
specialized secretory organelles termed encystation-specific vesicles (ESVs) are synthesized de novo 
during encystation, dedicated to accumulation, maturation, sorting and regulated secretion of the cyst 
wall material (CWM). As absolutely essential factors for parasite transmission to a new host, ESVs 
represent potential drug targets and therefore have been subject of intense research for years. 
However, the molecular underpinning of ESVs, their neogenesis as well as their functionality is not well 
understood, and a detailed systematic analysis has been impeded by the scarcity of ESV-specific factors 
and the challenge to identify latter in the highly reduced and diverged parasite genome.  
 
The aim of this study was the identification of novel ESV-associated factors that may help to characterize 
the nature of these specialized secretory organelles in more detail.   
Using various experimental approaches, we addressed the following questions: i) Can we define the ESV 
organelle proteome by using a novel, flow-cytometry based approach, and identify additional factors 
that are associated with ESVs? ii) What can these data tell us about ESV neogenesis, composition, and 
functionality? iii) Based on the newly gained information, can we establish a more detailed model for 
ESV neogenesis and homeostasis?  
 
3.2. Project 2: Implementation of the Cre/loxP system in Giardia lamblia  
The three Giardia cyst wall proteins (CWPs 1-3) constitute, besides a β-(1,3)-N-Acetyl-Galactosamine 
(GalNAc) carbohydrate, the major components of the cyst wall, hence play a critical role for the 
parasite’s survival in the environment prior to infection of a new host. The functional integrity of the 
water-resistant cyst wall strongly depends on the CWP1-3 post-translational maturation, correct sorting 
and regulated secretion. A pivotal role in this process is attributed to encystation-specific vesicles (ESVs), 
specialized secretory organelles that are established exclusively in encysting cells for accumulation, 
maturation and secretion of the CWPs.  
The function of individual CWPs in ESV neogenesis and maturation as well as their respective 
contribution to the formation of the highly resistant cyst wall is of substantial interest not only due to 
their key roles in successful fecal-oral parasite transmission, but also for the investigation of minimal 
composite biopolymers conferring resistance to cells. However, detailed information on the CWP 
function is scarce, and the application of forward genetic approaches to study gene or protein function in 
G. lamblia is strongly limited by the parasite’s tetraploid genome and the paucity of suitable drug-
resistance markers to select for transgenic cells. As a consequence, relatively straightforward genetic 
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manipulations such as gene knock-outs have never been realized in Giardia so far. Several alternative 
techniques aiming for gene knock-down have been applied but only with limited success.  
To manipulate the G. lamblia genome in a more effective manner, we aimed to established the E. coli P1 
phage-derived Cre/loxP in this parasite. The simple system is based on the Cre-recombinase that 
mediates recombination between two identical DNA sequences termed loxP. When oriented in the same 
direction, this results in the excision of the interjacent DNA sequence.  
 
In a series of experiments we addressed the following questions: i) Is the phage P1-derived Cre-
recombinase expressed in Giardia functional? ii) Can we use the system to remove a stably integrated, 
floxed puromycin resistance cassette and other intervening gene sequences from the Giardia genome? 
iii) Going further, can we apply the Cre/loxP system for recycling of a puromycin resistance marker to 
perform serial transfections of the same cell line?  
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1. Proteomics of secretory and endocytic organelles in Giardia lamblia  
This study represents the main part of my PhD work. I started elaborating the strategy and the 
technological basis for this project in the first year of my PhD and worked 3.5 years intensely on it. The 
idea of simultaneous sorting of two organelle types and in silico filtration of mass spectrometry data was 
developed together with my direct supervisor Prof. Adrian B. Hehl, who supported me in all steps during 
this project including manuscript writing.  
 
The great majority of this work including the development of novel protocols, the experimental and 
bioinformatics work as well as analysis and interpretation of the results was performed by me (see 
figures 1-8 except for figure 3 left and figure 5), with the partial collaboration of Dr. Cornelia Spycher.  
 
The protocol for flow cytometry-based organelle sorting (FAOS) is at the very limits of technology and 
was established together with Vinko Tosevski from the Flow Cytometry Facility of University of Zurich. In 
course of this work I have become an independent power user at the Flow Cytometry Facility. Mass 
spectrometry analysis was performed in collaboration with Dr. Paolo Nanni from the Functional 
Genomics Center Zurich (FGCZ). All datasets will be made publicly accessible by incorporation onto the 
GiardiaDB (www.GiardiaDB.org) web platform.  
 
Manuscript draft writing as well as figure assembly was performed almost entirely by me. This 
manuscript was submitted to PLOSone on the 20th of December 2013 and is currently under review.  
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Abstract 
Giardia lamblia is a flagellated protozoan enteroparasite transmitted as an environmentally 
resistant cyst. Trophozoites attach to the small intestine of vertebrate hosts and proliferate by binary 
fission. They access nutrients directly via uptake of bulk fluid phase material into specialized endocytic 
organelles termed peripheral vesicles (PVs), mainly on the exposed dorsal side. When trophozoites reach 
the G2/M restriction point in the cell cycle they can begin another round of cell division or encyst if they 
encounter specific environmental cues. They induce neogenesis of Golgi-like organelles, encystation-
specific vesicles (ESVs), for regulated secretion of cyst wall material. PVs and ESVs are highly simplified 
and thus evolutionary diverged endocytic and exocytic organelle systems with key roles in proliferation 
and transmission to a new host, respectively. Both organelle systems physically and functionally intersect 
at the endoplasmic reticulum (ER) which has catabolic as well as anabolic functions. However, the 
unusually high degree of sequence divergence in Giardia rapidly exhausts phylogenomic strategies to 
identify and characterize the molecular underpinnings of these streamlined organelles. To define the 
first proteome of ESVs and PVs we used a novel strategy combining flow cytometry-based organelle 
sorting with in silico filtration of mass spectrometry data. From the limited size datasets we retrieved 
many hypothetical but also known organelle-specific factors. In contrast to PVs, ESVs appear to maintain 
a strong physical and functional link to the ER including recruitment of ribosomes to organelle 
membranes. Overall the data provide further evidence for the formation of a cyst extracellular matrix 
with minimal complexity.  
Introduction 
As the leading cause for protozoal diarrhea worldwide, the small intestinal parasite Giardia 
lamblia (syn. G. duodenalis, G. intestinalis) is an important pathogen of humans and animals causing 
significant morbidity and economic loss [1]. The Giardia life cycle is simple and consists of trophozoites, 
which multiply by binary fission in the gut of animal and human hosts, and an infectious cyst stage. 
Trophozoites attach actively to the epithelium of the small intestine and exhibit antigenic variation of 
variant surface proteins (VSPs) in their protein surface coat [2, 3]. Triggered by environmental cues (e.g. 
bile concentration, bioavailability of lipids, pH) trophozoites undergo a complex stage‐differentiation 
process and transform to environmentally resistant cyst forms. The complete life‐cycle, including cyst 
formation and excystation, can be reproduced in vitro.  
 
Giardia belongs to the phylum Diplomonadida, unicellular eukaryotes that have undergone 
considerable reductive evolution resulting in minimization or even loss of most cellular systems such as 
mitochondria, peroxisomes, a Golgi apparatus, and a classical endo-lysosomal system. Despite this 
unusual organization 3 giardial organelle systems are clearly discernible: the endplasmic reticulum (ER) 
which extends bilaterally through the cell body [4], relic mitochondria (mitosomes), localized at the cell 
center but also dispersed in the cytoplasm [5, 6], and peripheral vesicles (PVs). PVs  are ~150 nm 
compartments with a fixed localization underlying the plasma membrane on the dorsal side and are also 
present in a specialized region of the ventral disk [7, 8]. PVs have been dubbed endosomal‐lysosomal 
compartments based on localization of hydrolase activity [7, 9-11], their ability to acidify [10, 12, 13], and 
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to take up exogenous ferritin as well as fluid phase markers [12, 14-16]. While in classical eukaryotic 
systems endosomes undergo organelle maturation, a similar process is not observed for PVs in Giardia. A 
selective pathway sorting proteins from the plasma membrane to PVs has been demonstrated [13, 17-
19], and there is experimental evidence for a direct but selective connectivity between PVs and the ER 
[8]. PVs are thought to be the major route of nutrient uptake by the parasite, but the range of their 
functions, their morphogenesis and propagation remain unclear. Additional open questions concern the 
exact mechanism of bulk fluid uptake into the organelles and how endocytic cargo is sorted and 
trafficked to the ER.  
Constitutive secretion of giardial proteins does not require a Golgi apparatus. As a consequence, 
secreted proteins are exported directly from the ER to target organelles such as PVs or the plasma 
membrane [20]. Organelles with Golgi properties (encystation-specific vesicles, ESVs) are generated de 
novo exclusively for regulated export of the cyst wall biopolymer consisting of three paralogous cyst wall 
proteins (CWP1-3) [21-23], and a unique β(1-3)-GalNAc homopolymer glycan [24, 25]. ESV formation is 
induced by COPII-dependent export of cyst wall proteins from ER exit sites [26, 27]. CWPs partition into 
two biophysically distinct phases before being sorted and secreted sequentially to build the two layers of 
the composite cyst wall polymer as an extracellular matrix 20-24 h post induction (p.i.) in vitro [28]. 
Although current data strongly support the hypothesis that ESVs are Golgi-derived organelles, the 
molecular underpinnings of ESV neogenesis and their identity as post-ER organelles remain controversial.  
As with most systems and molecular machineries in diplomonads, PV and ESV organelles can be 
classified in terms of function but are highly divergent, i.e. there is some experimental evidence for their 
respective roles in the cell, but the paucity of molecular and morphological landmarks for organelle 
structure and function has prevented a systematic and detailed characterization. Nevertheless both 
organelle systems are essential and as such represent potentially vulnerable structures of this highly 
adapted parasite. The significant reductive evolution and sequence divergence in Giardia also means that 
strategies using homology-based identification and functional analysis of PV and ESV proteins [29-31] are 
biased towards few identifiable factors. The aim of this study was to identify novel factors that are 
specifically associated with these organelles and that may help characterize their nature, range of 
function, and evolutionary history in the context of the giardial ecological niche. To address these 
questions we developed a conceptually new approach to generate enriched organelle proteome datasets 
in two steps: (i) simultaneous flow cytometry-based sorting of a mixed microsome fraction containing 
green fluorescent ESV organelles with CWP3-GFP in condensed cores and red labeled peripheral vesicles 
(PV); (ii) mass spectrometry analysis and subtraction of overlapping hits to increase identification of 
organelle-specific candidates. Detailed analysis of the datasets and localization of selected candidate 
proteins suggests a close association of ESVs with the ER and no evidence for additional cargo or 
organelle-specific factors involved in their genesis and maturation. Conversely, although direct 
connections with the ER have been demonstrated, PVs appear to have a discrete compartment identity 
with a specific set of organelle proteins.  
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Results 
Giardia has an extensive ER [4] which stretches almost throughout the entire cytoplasm and to 
the cell periphery. Giardial organelle preparations for proteomic analysis are uniformly contaminated 
with membrane and membrane associated ER proteins [32, 33]. To overcome this we developed and 
implemented a new strategy to investigate the proteome of two organelle sets which are known to be in 
close proximity to and even in direct contact with the ER: ESV organelles [26, 27] and PV organelles [8]. 
After cell disruption we simultaneously enriched differentially labeled ESV and PV organelles by 
fluorescence-assisted organelle sorting (FAOS) from a mixed microsome fraction. We reasoned that the 
simultaneously sorted vesicle fractions would contain comparable amounts of mostly cytoplasmic and 
ER-derived unspecific proteins, and that this overlap could be subtracted from the respective mass 
spectrometry (MS) datasets in silico to reveal organelle-specific proteins.  
 
Enrichment and separation of fluorescently labeled organelles by flow cytometry 
We used flow cytometry to sort differentially labeled ESVs (with CWP3-GFP) and PVs (with 
Dextran-AlexaFluor647, AF647) simultaneously from a mixed microsome fraction prepared from 
trophozoites and transgenic encysting cells. Cell labeling, harvesting, and disruption were performed in 
three completely independent experiments (biological replicates). The sorts were performed on a BD 
FACS AriaIII flow cytometer using a sort precision mode of 0/32/0 to obtain maximal purity. Three gates 
were set: a very broad parent gate P3 in the SSC vs. FSC plot that excluded the readily apparent 
measurement noise, and gates P1 and P2 in a bivariate dot plot to define the GFP-positive and AF647-
positive events, respectively (figure 1A). The target events in the mixed microsome fraction were 4.3% 
GFP-positives and 4.7% AF647-positives, corresponding to ESV and PV organelles, respectively.  
Post-sort quality control by flow cytometry showed more than eight-fold increase of both, GFP-positive 
events (39.6%, figure 1B, top) and AF647-positive events (42%, figure 1B, bottom). In the post sort 
analysis 104 events of the AF647-enriched fraction contained no GFP-positive events, i.e. ESV organelles 
(figure 1B, bottom, gate P1). Likewise, analysis of 104 events of the GFP-enriched fraction contained no 
AF647-positive events, i.e. PV organelles (figure 1B, top, gate P2), with a scatter profile corresponding to 
that of the pre-sort sample. The cluster of events extending diagonally and between the GFP and AF647 
fraction was apparent in all samples analyzed, both pre- and post-sort. Comparisons of normal buffer 
preparations (used across all experiments) with more meticulously prepared sample buffers and sheath 
fluid (manually filtered through liquid filters with a pore size of 220 nm) led us to conclude that these 
events predominantly represent inorganic or similar particulates of very small size. Taken together, GFP- 
and AF647-positive events were completely separable, and we achieved a 100% relative enrichment 
using this approach.  
To confirm the separation of labeled organelles, we detected GFP in post-sort precipitates (figure 1C) 
using Western blot analysis. Using an anti-GFP antibody, a band between 40 and 55 kDa corresponding 
to the predicted CWP3-GFP fusion protein (53 kDa) was detected in the ESV-enriched fraction but not in 
the PV-enriched fraction. An additional GFP-signal was detected in the high molecular weight area in the 
ESV-enriched fraction, presumably corresponding to insoluble CWP3-GFP aggregates from condensed 
cores of ESVs or covalently linked homo-multimers. Taken together with the data obtained by post sort 
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flow cytometry, we concluded that the two organelles could be quantitatively separated which was a 
prerequisite for the subsequent subtractive analysis.  
Figure 1: Flow cytometry based organelle sorting. A) Pre-sort flow cytometry analysis: 10e5 events of a mixed 
microsome fraction containing 4.3% GFP-positive events (ESV organelles) and 4.7% AF647-positive events (PV 
organelles). SSC/FSC scatter plot:  P3, parent gate (organelle population); P1 (red) GFP-positive-, and P2 (blue) 
AF647-positive events. P4 and P5 (controls) were set to randomly collect additional material for later protein 
precipitation test runs. B) Post sort analysis shows enrichment of GFP-positive events (39.6 %; B, top) and AF647-
positive events (42.0%; B, bottom). C) Western blot analysis of enriched organelle fractions (post-sort precipitates) 
detecting GFP shows a distinct band for CWP3-GFP (53 kDA, arrow) in the ESV fraction, but not the PV post sort 
fraction. M: protein size ladder (kDa); pos, neg: Positive and negative controls from an ESV-fraction and a non-ESV-
fraction (control) of a sucrose density gradient centrifugation experiment performed with 13h encysting Giardia 
cells expressing CWP3-GFP [28].  
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Mass spectrometry analysis of organelle-enriched fractions 
Sorted organelle-enriched fractions were analyzed by mass spectrometry using a shotgun 
approach combining 1D-SDS-PAGE and LC ESI-MS/MS. With a Mascot ion cut-off score of 20 for peptide-
spectrum matches, a minimum of 2 unique peptides, and a protein probability of 80%, a total of 1281 
proteins were identified in the combined triplicate ESV and PV fractions. After subtraction of 
environmental contaminations, e.g. keratins, 1213 G. lamblia proteins remained. A false discovery rate 
(FDR) of 0.0% for peptides and 0.5% for proteins was calculated by Scaffold. In the unified ESV fractions 
(E1+E2+E3) a total of 1129 proteins were identified; 750 (66%) thereof were detected in all three 
samples and 933 (83%) in at least 2 of 3 samples (figure 2A, top). Comparable numbers were found for 
PV organelles: of 1140 proteins identified in total (P1+P2+P3), 708 (62%) were detected in all three 
samples and 923 (81%) in at least 2 of 3 samples (figure 2A, bottom). The large overlaps of the P and E 
datasets, respectively, demonstrated high reproducibility between replicate experiments. For a detailed 
compilation of identified proteins see table S1.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Subtractive analysis eliminates many predominantly translation-associated and ER-derived 
contaminants  
 Simultaneous sorting of two differentially labeled organelles (ESVs and PVs) from a mixed 
microsome fraction allows subtracting the unspecific background of unlabeled soluble proteins as well as 
small cell debris contained within the positively sorted  droplets which are generated by the vibrating 
nozzle of the cell sorter. The premise was that by eliminating all proteins common to the ESV and PV 
datasets (intersection) the organelle-specificity of each dataset would increase significantly. In particular, 
Figure 2: Reproducibility of biological 
triplicates and annotation clustering of 
intersection. A) VENN diagrams for ESV 
(E1, E2, E3) and PV (P1, P2, P3) mass 
spectrometry datasets (total n=1281). ESV 
datasets (A, top) n=1129 with overlaps. 
750 proteins (66%) were detected in all 
three datasets. PV datasets (A, bottom) 
n=1140 with overlaps. 708 proteins (62%) 
were detected in all three datasets. B) 
Clustering analysis of 1059 proteins 
defined by the E1-E3 and P1-P3 data 
intersection (see figure S3)  using the 
DAVID bioinformatics tool [34]. X-axis: 
functional clusters with an enrichment 
score above 3; y-axis: number of proteins; 
value in bold on top of column: 
enrichment score. A detailed summary of 
all 14 clusters can be found in the text S2A 
and S2B.  
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the occurrence of ER-derived contaminants, which have been a severe problem in all previous attempts 
to enrich Giardia organelles, should be strongly reduced.  
The total 1213 hits in all replicate mass spectrometry datasets contained 1059 putative contaminants, 
defined by the E1-E3 and P1-P3 data intersection, whilst 72 proteins were considered ESV-specific and 82 
PV-specific (figure 2B, top). A detailed description of the workflow and the in silico identification of the 
data intersect can be found in the figures S1 and S2. This relatively high ratio of contaminants to 
organelle-specific proteins was not surprising considering the results of previous cell fractionation 
experiments and the analysis of organelle fractions by SDS-PAGE in this study (not shown).  
 
Analysis of the eliminated ESV and PV dataset intersection  
A more detailed analysis of the two organelle-specific and the large intersecting datasets was 
performed using the DAVID bioinformatics tool [34]. From 1059 proteins in the dataset intersection we 
removed an additional 28 with obsolete gene models. Of the 1031 remaining proteins 903 could be 
assigned to 14 different DAVID clusters (enrichment score >1), while 128 proteins could not be clustered. 
4 of the 14 DAVID clusters showed an enrichment score of >3 (figure 2B, bottom). The top ranking 
clusters were “ribosomal proteins” (enrichment score 16.12, 701 proteins), “protein biosynthesis” 
(enrichment score 5.33, 305 proteins), “chaperones / protein folding” (enrichment score 3.38, 101 
proteins) and “carbohydrate metabolism” (enrichment score 3.02, 176 proteins). A corresponding 
genome-wide analysis as a reference using a total of 5150 validated genes yielded on average 79 clusters 
per 3’000 gene models, with the vast majority of enrichment scores <1 and none >2. See also 
supplementary data (texts S2A and S2B) for a detailed description of all DAVID analyses results. Taken 
together, this demonstrates the relative enrichment for translation-associated and ER-derived factors in 
the data intersection, supporting the idea that subtraction of these hits will increase the specificity of 
organelle datasets. Conversely no obvious clusters were detected in the control datasets representing a 
genome-wide sampling.  
 
Parsing and manual annotation of ESV and PV organelle specific proteins 
The large majority of gene models and protein annotations in the Giardia Genome Database 
(GiardiaDB) are based on automated predictions. For a manual annotation of organelle-specific datasets 
we used function and homology prediction programs (PSORTII, TMHMM, SMART, pBLAST and HHPred) 
to identify putative signal peptides, transmembrane domains, protein functional domains and 
homologies (table 1 and supplementary table S2). In total we suggest re-annotation of 28 genes (listed in 
supplementary table S2). For parsing, 17 categories were used (figure 3) based on predicted function or 
localization according to the criteria described in this study or in previous reports [30].  
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Table 1: ESV and PV candidate list  
ESV candidates (n=72) PV candidates (n=82) 
Cat. GeneID Product description Loc. Cat. GeneID Product description Loc. 
HGS Gl2014 Hypothetical protein  HGS Gl13651 Hypothetical protein  
HGS Gl7350 Hypothetical protein cy HGS Gl15918 Hypothetical protein  
HGS Gl9007 Hypothetical protein  HGS Gl16811* Hypothetical protein  
HGS Gl9157 Hypothetical protein cy HGS Gl17468 Hypothetical protein  
HGS Gl10221 Hypothetical protein er HGS Gl29119 Hypothetical protein  
HGS Gl10568 Hypothetical protein  HGS Gl6535 Hypothetical protein  
HGS Gl14235 Hypothetical protein  HGS Gl9573 Hypothetical protein  
HGS Gl14458 Hypothetical protein 
pe, 
ex, es 
HGS Gl13774 Hypothetical protein  
HGS Gl16522 Hypothetical protein  HGS Gl13783 Hypothetical protein  
HGS Gl22136 Hypothetical protein er HGS Gl16926 Hypothetical protein  
HGS Gl24453 Hypothetical protein  HGS Gl17330 Hypothetical protein  
HGS Gl25205 Hypothetical protein er, es HGS Gl17571* Hypothetical protein  
HGS Gl32419 Hypothetical protein 
er, 
ex, es 
HGS Gl24451 Hypothetical protein  
HGS Gl87926 Hypothetical protein vd HGS Gl3920 Hypothetical protein  
HGS Gl90434 Hypothetical protein  HGS Gl4852 Hypothetical protein  
HGS Gl113722 Hypothetical protein  HGS Gl5890 Hypothetical protein  
HGS Gl137705 Hypothetical protein  HGS Gl6334 Hypothetical protein  
HGS Gl137712 Hypothetical protein  HGS Gl10181 Hypothetical protein  
HNS Gl5568 Hypothetical protein  HGS Gl10524 Hypothetical protein  
HNS Gl8799 Hypothetical protein  HGS Gl10608 Hypothetical protein  
HNS Gl11246 Hypothetical protein  HGS Gl112893 Hypothetical protein  
HNS Gl13262 Hypothetical protein  HGS Gl14971 Hypothetical protein  
HNS Gl14345 Coiled-coil protein  HGS Gl16543 Hypothetical protein  
HNS Gl14877 Hypothetical protein  HGS Gl4018 Hypothetical protein  
HNS Gl15956 WD-40 repeat protein er HGS Gl4270 Hypothetical protein 
pm, 
cy, pv? 
HNS Gl22806 Hypothetical protein  HGS Gl17347 Hypothetical protein  
HNS Gl23357* hypothetical protein  HNS Gl91354* Hypothetical protein  
HNS Gl88581 Synaptic glycoprotein SC2 er HNS Gl10522 Hypothetical protein  
HNS Gl94654 Hypothetical protein  HNS Gl16237 Hypothetical protein  
MET Gl4059 MTA/SAH-nucleosidase  HNS Gl16367 Hypothetical protein  
MET Gl4507 
CTP synthase / UTP-ammonia 
lyase 
 HNS Gl16998 Hypothetical protein  
MET Gl6757* Isochorismatase  HNS Gl7778 Hypothetical protein  
PRO Gl7896 
26S proteasome non-ATPase 
regulatory subunit 7 
 R/T Gl11287 Ribosomal protein L7Ae  
PRO Gl16823 
Non ATPase subunit MPR1 of 26S 
proteasome 
 R/T Gl14869 Ribosomal protein L24  
NUC Gl7474 
DNA-directed RNA polymerase 
RPB3 
 SUG Gl104031 Glycogen synthase, putative  
R/T Gl9899* putative eIF2A  NUA Gl16328* pseudouridine synthase  
R/T Gl10341* putative 50S ribosomal protein L1  MOT Gl13825 Kinesin-1  
R/T Gl10780 Ribosomal protein S27  TPO Gl40224 MDR protein-like protein er, pe 
R/T Gl11319 U3 snRNP IMP3, putative  ER Gl14856 SRP receptor  
R/T Gl11755* 30S ribosomal protein S8E  MIS Gl3095* 
Cyclin_N domain containing 
protein 
 
R/T Gl15156 SRP GTPase 
cy, 
er, es 
MIS Gl8394* 
RdX-domain containing 
protein 
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Table 1: ESV and PV candidate list  
ESV candidates (n=72) PV candidates (n=82) 
Cat. GeneID Product description Loc. Cat. GeneID Product description Loc. 
R/T Gl15546* putative eIF3  MIS Gl32697* 
methyltransferase-domain 
containing protein 
 
R/T Gl40521* putative eIF2A  MIS Gl24979* 
thioredoxin domain containing 
protein 
 
SUG Gl8382* 
Putative UDP-GlcNAc-4’-
epimerase (GALE) 
er MIS Gl2013 Glutaredoxin-related protein  
SUG Gl10324 Ribulose-phosphate 3-epimerase  MIS Gl2933 
Programmed cell death 
protein-like protein 
 
SUG Gl11595* 
Glycosyl transferase family 8 
protein 
cy MIS Gl5871 
Developmentally regulated 
GTP-binding protein 1 
 
SUG Gl15483* UDP-GlcNAc transporter 
er, 
pe, es 
MIS Gl8559 
V-type ATPase, 16 kDa 
proteolipid subunit 
er, pe 
NUA Gl16887 
ATP-dependent RNA helicase 
HAS1, putative 
 TRA Gl16521 Alpha-SNAP pv 
NUA Gl113365 5'-3' exoribonuclease 2  TRA Gl15104 Sec1, putative pv 
MOT Gl101138 Dynein heavy chain  TRA Gl15339 
AP complex large chain 
subunit BetaA 
er 
MOT Gl111950 Dynein heavy chain  TRA Gl96994* Qa3-SNARE pv 
TPO Gl11299 Amino acid transporter, putative er TRA Gl15472* VPS46a 
cy, 
pm? 
pv? 
ER Gl101339 
FKBP-type peptidyl-prolyl cis-trans 
isomerase 
 P/K Gl11554 Kinase, NEK  
MIS Gl6185* NTPase  P/K Gl15935 Kinase, NEK  
MIS Gl7207* Calcium-binding pr. cy P/K Gl17231 Kinase, NEK  
MIS Gl8524* AAA ATPase  P/K Gl2661 CdK regulatory subunit  
MIS Gl9594 Hsp70 binding protein  P/K Gl17069 Kinase, NEK  
MIS Gl14277 N-acetyltransferase-like protein  P/K Gl2053 Ser/Thr protein phosphatase 4  
MIS Gl14604* 
cytosolic Fe-S cluster assembling 
factor NBP35 
 P/K Gl17556 Kinase, CAMK CAMKL  
MIS Gl32838* Nitrogen fixation protein NifU  P/K Gl9894 
Protein phosphatase 2A 
regulatory subunit putative 
 
MIS Gl113143 
Lipopolysaccharide-responsive 
and beige-like anchor protein 
 F/C Gl11164 Protein 21.1  
MIS Gl9058* Putative TAP42  F/C Gl11165 Protein 21.1  
TRA Gl8049* Putative importin alpha  F/C Gl113622 Protein 21.1  
TRA Gl15204 ERP3  F/C Gl16532 Protein 21.1  
TRA Gl17109 Vacuolar protein sorting 11  F/C Gl17046 Protein 21.1  
TRA Gl137698 Sec13  F/C Gl23492 Protein 21.1  
P/K Gl14545* 
putative Ser/Thr-protein 
phosphatase PP2A 
 F/C Gl6744 Centrin  
P/K Gl14661* Ser/Thr protein kinase  F/C Gl95192 Protein 21.1  
P/K Gl32312 Protein phosphatase 2C  F/C Gl9750 
Intraflagellar transport protein 
component IFT74/72 
 
F/C Gl4026 Alpha-19 giardin  F/C Gl10038 Alpha-18 giardin  
F/C Gl15587 Protein 21.1  F/C Gl10219 Protein 21.1  
F/C Gl24009 Protein 21.1  F/C Gl103807 Protein 21.1  
    F/C Gl13766 Protein 21.1  
    F/C Gl14926 Protein 21.1  
    F/C Gl16220 Protein 21.1  
    F/C Gl14745 Protein 21.1  
    F/C Gl15428 IFT complex B  
    VSP Gl33279 VSP  
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Table 1: ESV and PV candidate list  
ESV candidates (n=72) PV candidates (n=82) 
Cat. GeneID Product description Loc. Cat. GeneID Product description Loc. 
    VSP Gl13194 VSP AS8  
    HCM Gl15317 HCMP Group 1  
    HCM Gl24880 HCMP Group 2  
    HCM Gl103454 HCMP Group 1  
 
Table 1: ESV and PV candidate list. 72 ESV and 82 PV candidate lists. The subcellular localization of 16 (ESV) and 8 
(PV) candidates determined in this study are indicated. Additional information including GenBank accession 
numbers can be found in the supplementary table S2. Cat: category; GeneID: Gene accession number according to 
the G. lamblia genome database; Loc: localization determined in this study; er: endoplasmic reticulum; pe: 
perinuclear ER; ex: ER exit sites; es: encystation-specific vesicles; cy cytoplasm; vd: ventral disc; pv: peripheral 
vesicles; pm: plasma membrane. HGS: hypothetical protein Giardia-specific; HNS: hypothetical protein not Giardia-
specific; MET: metabolism; PRO: proteasome; NUC: nuclei; RT: ribosome translation; SUG: sugar metabolism; NUA: 
nucleic acid metabolism; MOT: motor proteins; TPO: transporter; ER: endoplasmic reticulum; MIS: miscellaneous; 
TRA: trafficking; P/K: phosphatases / kinases; F/C: flagella/cytoskeleton; VSP: variant-specific surface protein; HCM: 
high-cysteine membrane protein, pr: protein; asterisk: re-annotated.  
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Figure 3 shows a graphical representation of the parsed ESV proteins in 15 categories with 29 
hypothetical proteins remaining. Eleven of those (15.3%) have predicted homologs in other species, 
whereas 18 (25.0%) are considered Giardia-specific. The 82 PV proteins were parsed into 14 categories, 
with 32 candidates designated as hypothetical proteins and 26 thereof (31.7%) considered Giardia-
specific. Direct comparison of the ESV and PV datasets (figure 3) revealed a similar proportion of proteins 
with no functional prediction, i.e. hypothetical proteins (40.3% and 39.0%, respectively). Parsing of the 
data revealed clear differences in categories, with 3 and 2 groups appearing exclusively in the ESV and PV 
datasets, respectively (figure 3). Within the shared groups, the most striking differences were the 
overrepresentation of factors involved in protein translation (ESV: 11.1% versus PV: 2.4%) in the ESV 
dataset, or the enrichment of flagella/cytoskeleton proteins (ESV: 4.2% versus PVs: 20.7%) in the PV 
dataset.  
Figure 3: Categorization of the 72 ESV and 82 PV candidates. 17 categories based on predicted function were used. 
The percentage of candidates in each group is indicated at the end of the columns.  ESV candidates (green) and PV 
candidates (red) fall into 15 and 14 groups, respectively. ER: endoplasmic reticulum; VSPs: variant surface proteins; 
HCMPs: high cysteine membrane proteins. Detailed information on the candidates in each category can be found in 
the table S2.  
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Detection of known organelle proteins in ESV and PV datasets  
Fewer than 20 factors are known to associate to ESVs at any given point during ESV neogenesis 
and maturation [10, 16, 26, 29, 32, 35-39]. Only 3 localize exclusively to ESVs at 13h post induction (p.i.): 
CWP1 and the large fragment of the proteolytically processed CWP2 in the fluid phase fraction and 
CWP3 together with the small fragment of CWP2 in the condensed core [28]. CWP-derived tryptic 
peptides are detected very inefficiently in MS most likely due to the well-documented extensive intra- 
and intermolecular cross-linking by disulfide and isopeptide bonds [40, 41]. The proportion of DTT-
resistant high molecular weight complexes of CWP3-GFP can be estimated in the Western blot in figure 
1C (ESV). Nevertheless, peptides derived from the organelle marker CWP3-GFP or endogenous CWP3 
were detected exclusively in ESV-enriched samples by MS (average quantitative value of 2.7) albeit only 
at a stringency of 1 unique peptide and 50% protein probability. GFP-derived peptides were detected in 
all 3 ESV-enriched samples with an average quantitative value of 1.7.  
Of the 72 proteins in the ESV dataset, 4 are either known or predicted to associate to ESV organelles. In 
particular, we identified two COPII-coat components Sec13 (Gl137698) and Erp3 (Gl15204) (trafficking 
proteins, figure 3, table 1). The association of other COPII-components with ESVs, such as GlSar1 and 
GlSec31, during early development was observed previously [26, 29]. Additional ESV-associated factors 
are represented by 2 proteasome proteins (figure 3, table 1). Proteasome complexes are recruited to ESV 
membranes during early encystation, perhaps in connection with post-ER quality control and associated 
degradation processes [32]. It is important to note that with the exception of CWP1-3, all other 
previously described ESV-associated factors are also expressed in trophozoites. Since their expression is 
not strictly stage-specific and they are recruited to ESV organelles from other subcellular localizations 
during encystation, their absence in the ESV-specific dataset but detection in the data intersection 
instead is not surprising.  
 
The 15 PV proteins which have been identified in trophozoites and encysting cells thus far 
include SNAREs, components of the clathrin/AP-mediated trafficking machinery, Rab11, an acidic 
phosphatase and an encystation-specific protease termed ESCP [13, 16-18, 29, 42, 43]. Since most of 
these PV-associated proteins are involved in vesicle trafficking, they have secondary localizations, i.e. the 
cytoplasm, the plasma membrane, the ER or ESVs. Not surprisingly, we recovered the majority of these 
trafficking proteins in the data intersect. However, the Qa3-SNARE homolog syntaxin1 (Gl96994) [29, 43] 
was specifically included in the PV dataset. In addition to this membrane trafficking factor we recovered 
3 previously described PV-associated proteins including two VSPs (Gl33279, Gl13194) [44, 45] and, when 
lowering the stringency to 1 unique peptide, the encystation-specific cysteine protease ESCP (Gl14566) 
[13].  
 
Taken together, we detected 5 known ESV-associated proteins, including our organelle marker CWP3-
GFP, in the ESV dataset, whereas 4 known PV-associated factors were contained in the PV dataset. 
Because of their extensive cross-linking and post translational modifications CWP1 and CWP2, 
comprising the fluid component of the CWM in ESVs at 13 hours p.i., were detected only with relaxed 
stringency.  
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Figure 4: Subcellular localization of selected ESV and PV candidates.  
16 (ESV candidates) and 8 (PV candidates) HA-tagged variants were localized by 
immunofluorescence analysis in transgenic cells. A) Subcellular localization of 
16 ESV candidates in trophozoites at 13 hours p.i. B) Subcellular localization of 8 
PV candidates. Detailed information on the respective candidates can be found 
in table 1 and supplementary table S2. ER: endoplasmic reticulum; ESVs: 
encystation-specific vesicles; CYT: cytoplasm; VD: ventral disc; PVs: peripheral 
vesicles; PM; plasma membrane.  
Subcellular localization of candidate PV proteins  
As a first partial validation of the PV-derived dataset and to determine whether novel PV 
proteins are contained within the dataset, we expressed 8 proteins as C-terminally HA-tagged variants in 
G. lamblia (table 1, figure 4b). In addition to proteins involved in membrane traffic, we focused on 
additional predicted transmembrane or membrane interacting proteins. We localized 3 tagged 
candidates involved in SNARE-mediated membrane fusion: (i) a Qa3-SNARE (Gl96994) homologous to 
syntaxin 1a [29, 43] (ii) a putative Sec1 protein (Gl15104) which forms heterodimers with syntaxin 1a 
[46] and (iii) a putative alpha-SNAP (Gl16521). All 3 reporters localized predominantly to the cortical area 
of trophozoites, consistent with an association to PVs (figure 5A-C). Our localization data of the Giardia 
Qa3-SNARE are in agreement with previous studies localizing this protein to PVs [43].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
We localized two proteins with a predicted function in endocytic/endosomal transport: the adaptor 
protein (AP) large chain subunit BetaA (Gl15339) and a VPS46a homolog (Gl15472), a putative 
component of a giardial ESCRTIII complex. Localization of the tagged AP large chain subunit revealed a 
distribution consistent with the Giardia ER (figure 5D). This result is partially consistent with earlier 
studies detecting an AP1-subunit in PVs and the ER, and the AP2-subunit u2 in PVs and the plasma 
membrane [17, 18]. The tagged giardial VPS46a homolog was detected in the cytoplasm, and probably 
localizes also to the plasma membrane and/or to PVs (figure 5E).  
Subcellular localization studies on the vacuolar ATP synthase subunit (Gl8559, figure 5F) and the MDR-
like protein (Gl40224, figure 5G) showed perinuclear staining and distribution typical of the Giardia ER. 
One hypothetical protein (Gl4270, figure 5H) was detected in vesicle-like structures at the plasma 
membrane and in the cytoplasm. Whether these structures correspond indeed to PVs will require further 
investigation.  
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Figure 5: Subcellular localization of 8 
selected PV candidates.  
Representative localization of C-
terminally HA-tagged variants after 
constitutive expression in trophozoites 
(H) or 8-12 hours induced expression 
(A-G). A, B, C) Gl96994HA (Syntaxin 1a 
homolog), Gl15104HA (Sec1 
homolog), and Gl16521HA (putative 
alpha-SNAP) localize to PVs. D) 
Gl15339HA (beta adaptin) localizes to 
the ER. E) Gl15472HA (VPS46 
homolog) localizes to the cytoplasm 
and shows intense signal near the cell 
surface. F, G) Gl8559HA (v-type 
ATPase) and Gl40224HA (MDR-like 
protein) localize to the perinuclear 
region and the ER in trophozoites. H) 
Gl4270HA (hypothetical protein) 
localizes to vesicle-like structures at 
the plasma membrane and in the 
cytoplasm. Localization to PVs cannot 
be excluded. Antibodies: anti-HA high 
affinity from rat, Alexa488-conjugated 
goat anti-rat (green), alternatively rat 
anti-HA-FITC (green). pCWP1: 
inducible CWP1 promoter; pendo: 
endogenous promoter; int: stable 
integration into the genome; epi: 
episomal maintenance of the plasmid. 
Scale bar: 1.5 µm.  
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Subcellular localization of candidate ESV proteins  
To validate the ESV-organelle dataset, 16 proteins were chosen for ectopic expression as C-
terminally HA-tagged variants in G. lamblia (table 1, figure 4a) based on the following criteria: (a) 
Giardia-specific hypothetical proteins since they are unique to Giardia and might associate with ESVs; (b) 
proteins whose mRNAs were significantly upregulated during encystation [47], representing putative key 
factors in differentiation; and (c) proteins with predicted transmembrane domains and/or signal 
peptides, as they may be trafficked to ESVs. In addition, we wanted to localize proteins involved in (d) 
sugar metabolism or (e) sugar transport as these may represent key factors required for cyst wall glycan 
synthesis. Another category (f) was composed of predicted transporters which may be involved in direct 
import of substrates into ESV organelles from the cytoplasm. We also determined the subcellular 
localization of (g) a newly identified calcium-binding protein. Finally, we selected a signal recognition 
particle (h) to test for recruitment of complexes for co-translational insertion of proteins across the ER 
and ESV membranes, as suggested by the electron microscopy data (figure 8).  
Subcellular localization studies of 16 ESV candidate proteins revealed 11 candidates which had a 
distribution consistent with ER localization; 6 were detected exclusively in the ER while 5 also localized to 
ESVs. Four tagged candidates showed cytoplasmic localization and one candidate localized to the ventral 
disc.  
 
A) Novel ESV proteins 
Only two ER-resident proteins are known to reach ESVs without being secreted to the surface of 
the cell: Hsp70/BiP, which cycles between the ER and ESVs [32] and a subtilisin-like proprotein 
convertase termed gSPC [39]. Here we identify 3 additional hypothetical proteins that localize to the ER 
and ESVs during encystation: (i) At 13 h p.i., the 202 amino acid-long HA-tagged Gl14458 product was 
detected in the perinuclear ER, in ER-associated punctate structures reminiscent of ER exit sites, and 
overlapping with emerging ESVs in the cytoplasm (figure 6B). Transgenic cells expressing Gl14458-HA 
showed a significant delay or, in most cells, a block of CWP1 export from the ER and a reduction in the 
number of ESVs compared with wild type cells (figure 6A, B) or transgenic cells expressing unrelated HA-
tagged products (data not shown). (ii) ORF Gl32419 is stage-specifically upregulated [48] and codes for a 
564 amino acid protein of unknown function (table S2) whose HA-tagged variant localizes in the ER, 
including structures reminiscent of ER exit sites [27] as well as with maturing ESVs (figure 6C, D). In cells 
with mature ESVs containing condensed cores the protein localized to ER membranes, in particular to 
those adjacent to ESVs (figure 6C-E). (iii) The predicted Gl25205 product is a hypothetical Giardia-specific 
multipass membrane protein of 1246 amino acids with 14 hydrophobic domains. An epitope-tagged 
variant localized to the ER and in many cases also to morphologically normal ESVs at 13 hours p.i. (figure 
6F).  
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Figure 6: Subcellular localization of three ESV candidates: Gl14458HA, Gl32419HA, and Gl25205HA  
Representative localization of C-terminally HA-tagged variants after inducible (Gl14458, Gl32419) or constitutive 
expression (Gl25205) by confocal microscopy at 13h p.i.. Anti-CWP1 was used to detect ESV organelles. A) Wild 
type (WB) encysting trophozoite at 13h p.i.: CWP1 localized to “doughnut-shaped” ESVs which is typical for this 
time point [28]. No CWP1-signal in the perinuclear ER was visible. B) Gl14458HA at 13h p.i.: Gl14458HA was 
detected primarily in the perinuclear ER and overlaps with CWP1 in ESVs. Note the retention of CWP1 in the 
perinuclear ER and reduction of ESV numbers. In fact, the majority of induced cells in the population did not 
produce ESVs at all. C, D, E) Representative subcellular localizations of Gl32419-HA at 13h p.i. C) Partial signal 
overlap of Gl32419-HA (green) with CWP1 (red) in knob-like structures, reminiscent of ESV neogenesis at ER exit 
sites [27]. Alternatively, Gl32419-HA localized to the ER D) co-localizing with CWP1 primarily in the perinuclear ER 
and in ESVs suggesting delayed export of CWM to ESVs. E) In cells with canonical mature ESVs no signal overlap of 
Gl32419-HA and CWP1 was observed. F) HA-tagged Gl25205HA at 13h p.i. was detected in the ER and in ESVs with 
occasional signal overlap with CWP1. Antibodies: anti-HA high affinity from rat, Alexa488-conjugated goat anti-rat 
(green), and Texas red-conjugated anti-CWP1 (red). Nuclei were labeled with DAPI. pCWP1: inducible CWP1 
promoter; pendo: endogenous promoter; int: stable integration into the genome; epi: episomal maintenance of the 
plasmid, WB: wildtype. Scale bar: 1.5 µm.  
 
 
 
B) Factors involved in CW glycan synthesis 
ORF Gl15483 codes for a UDP-GlcNAc sugar transporter [49] with a reported localization at the 
perinuclear ER and at peripheral vesicles distinct from PVs [50]. This observation is only partially 
consistent with our localization of an HA-tagged variant in the ER but not to other organelles in encysting 
trophozoites at 13h p.i. (figure 7A, 7B). In dual labeling experiments, signal overlap of 15483-HA and 
CWP1 in the perinuclear ER and in areas corresponding to punctate peripheral ER regions or emerging 
ESVs was observed (figure 7A, arrows). When mature ESVs were present, the overlap of the two proteins 
was restricted mostly to the perinuclear ER (figure 7B). Notably, Gl15483-HA-expressing cells showed 
delay of CWP1 export from the ER and accumulation in the perinuclear ER at 13h p.i. (figure 7A, 7B).  
ORF Gl8382 codes for a putative UDP-GlcNAc-4’-epimerase (GALE) homolog in Giardia with an N-terminal 
signal sequence. Manual protein sequence analysis revealed that the giardial protein harbors all 
conserved motifs required for the enzyme’s function [51] (figure S3). An HA-tagged variant localized to 
the ER (figure 7C). These transgenic cells retained CWP1 in the ER at 13h p.i. and no mature ESVs were 
formed. The correlation, if any, between this phenotype and the predicted function of the protein, i.e. 
conversion of UDP-GlcNAc into the UDP-GalNAc monomer of the cyst wall glycan [52] in the ER lumen, 
remains to be determined.  
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Figure 7: Subcellular localization of the Giardia UDP-GlcNAc transporter (Gl15483) and the putative ER-GALE 
(Gl8382). Representative subcellular localization of C-terminally HA-tagged variants of UDP-GlcNAc transporter 
(Gl15483) and the putative UDP-GlcNAc-4’-epimerase (Gl8382) in encysting transgenic cells. A, B) At 13h p.i. : the 
HA-tagged transporter was detected in the ER. Co-localization with CWP1 was observed in the perinuclear ER and 
in areas corresponding to distinct ER regions or early ESVs (A, arrows). CWP1 is delayed in the perinuclear ER of 
Gl15483-HA-expressing cells where it overlaps with Gl15483-HA. In mature ESVs, no co-localization of the two 
proteins was observed. C) Localization of the putative UDP-GlcNAc-4’-epimerase (Gl8382-HA) at 13h p.i in the ER 
together with CWP1 whose export is delayed. Antibodies: anti-HA high affinity from rat, Alexa488-conjugated goat 
anti-rat (green), and Texas red-conjugated anti-CWP1 (red). Nuclei were labeled with DAPI. pCWP1: inducible CWP1 
promoter; int: stable integration into the genome; scale bar: 1.5 µm.  
 
 
C) Factors for co-translational protein insertion 
The panel of candidate ESV proteins contains a substantial number (8, 11.1%) of ribosomal or 
ribosome-associated proteins (figure 3, table 1) whereas the PV dataset only contained 2 of these 
potential contaminants. Interestingly, in transmission EM images we found that, in addition to 
decorating rough ER membranes, ribosomes distinctly associated with ESV membranes (figure 8A, inset 
arrows). Taken together with the identification of a component of the signal recognition particle, SRP54 
(Gl15156) in the ESV dataset, this suggests that ESV cargo proteins could be inserted co-translationally 
directly into the ESV lumen. Since transgenic cells expressing epitope-tagged ribosomal subunits were 
not viable, we tested this hypothesis indirectly by expression of an epitope-tagged SRP54 variant (table 
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1). The tagged product localized in a punctate, distributed pattern and signal overlap with CWP1 was 
detected predominantly in smaller ESVs (figure 8B). The possibility that proteins, presumably CWPs, are 
co-translationally inserted directly into ESVs is intriguing but requires additional experimental testing.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Stage-specific recruitment of ribosomes to ESV membranes  
A) Transmission electron microscopy image of ESVs in G. lamblia wild type encysting cells at 7 h p.i. (magnified on 
the right). Recruitment of ribosomes to ER membranes (tubular structures) and to early ESVs (round, electron-
dense structures) is observed. Ribosomes are visible as small, round and highly electron-dense structures arrayed 
along the cytoplasmic side of ESV and ER membranes. B) Immunofluorescence analysis of cells expressing a C-
terminally HA-tagged signal recognition particle component SRP54 (line pendo-15156HA-epi). The micrograph 
shows punctuate localization of SRP54-HA and partial overlap with CWP1 accumulation (arrows). Cytoplasmic and 
ER membrane associated SRP54-HA generates a high background signal, making a detection of the protein at ESV 
membranes difficult. Antibodies: anti-HA high affinity from rat, Alexa488-conjugated goat anti-rat (green), and 
Texas red-conjugated anti-CWP1 (red). Nuclei were labeled with DAPI. pCWP1: inducible CWP1 promoter; epi: 
episomal maintenance of expression vector; scale bar: 1.5 µm.  
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In summary our localization studies uncovered 5 ESV-associated proteins including 3 Giardia-specific 
proteins (Gl32419, Gl14458, Gl25205), the signal recognition particle subunit SRP54 (Gl15156), and an 
UDP-GlcNAc transporter (Gl15483). Six tagged candidates localized exclusively to the ER. Among these 
were a UDP-GlcNAc-4’-epimerase (GALE) eventually involved in synthesis of the CW glycan, four 
hypothetical proteins (Gl15956, Gl88581, Gl10221, Gl22136), and an amino acid transporter (Gl11299). 
Four tagged candidates showed cytoplasmic localization: two Giardia-specific hypothetical proteins 
(Gl7350, Gl9157), a calcium-binding protein (Gl7207), and a glycosyl transferase family 8 protein 
(Gl11595). Finally, a Giardia-specific protein of unknown function (Gl87926) was detected at the ventral 
disc. Taken together, this preliminary analysis suggests that i) abundant novel ESV cargo proteins are not 
present in mature ESVs, and ii) while large amounts of ER-derived contaminants can be eliminated by 
subtraction, many ER proteins remain in the dataset. The most likely explanation for this is the intimate 
physical contact and direct connections between the ER and ESVs as illustrated in figure 8A, which 
survive cell disruption and organelle preparation.  
Discussion 
ESV organelles are inducible Golgi-like membrane compartments for accumulation, processing, 
sorting, and export of the Giardia cyst wall material during differentiation of trophozoites into cysts. 
Their de novo genesis and maturation to secretion-competent organelles is only partially understood: 
Fewer than 20 ESV-associated factors (among them the 3 CWPs) have been identified or characterized 
[10, 16, 26, 29, 32, 35-39]. However, no defining ESV-specific, peripherally associated or membrane-
bound factor has been identified. Previous attempts to generate an ESV proteome using cell 
fractionation and density gradient centrifugation yielded datasets which revealed additional ESV factors 
but also contained very high levels of contaminating proteins [32] (Hehl, unpublished). Here, we tested a 
conceptually new approach to generate highly enriched organelle proteome datasets for ESVs and PVs 
resulting in identification of a candidate set of 72 ESV- and 82 PV-associated proteins.  
 
The ER and ESVs maintain a broad range of interactions  
Partial validation of the “ESV-specific” protein dataset (72 candidates) by subcellular localization 
studies of 16 selected ESV candidate proteins revealed 5 proteins which localized to ESVs, but also many 
ER proteins: 11 candidates had a distribution consistent with ER localization; 6 thereof were detected 
exclusively in the ER. This suggests that elements of ER organelles remain physically linked to and are co-
sorted with labeled ESVs, but not PVs.   
ESVs are closely associated with the ER during their neogenesis and nucleated from ERES in a COPII-
dependent process [26, 27]. Although light microscopy data suggests that ESVs become physically 
distinct from the ER after neogenesis [27, 28] previously published EM data [20, 42, 53] and data in the 
present study (figure 8A) clearly show membrane continuities between the organelle systems. The 
imaging data is supported by evidence for cycling of ER-resident proteins such as Hsp70/BiP between the 
two organelles [32]. An extensive network of tubular membrane connections mediating exchange of 
CWP1 between maturing ESVs makes a definition of the boundaries for ESVs even more challenging [26]: 
there is a possibility that this dynamic network is not restricted to ESV organelles but establishes direct 
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connections with the ER [28]. Further, the recruitment of proteasomes [32] and ribosomes to ER and ESV 
membranes, as shown also in this study, is an additional common feature of the two organelles. This 
suggests that basic trafficking-related processes such as co-translational import of secreted proteins, 
folding, retro-translocation, and associated degradation processes start at the ER level but may extend 
beyond ESV genesis.  
Consistent with the premise of subtractive elimination of ER proteins from organelle-specific factors, the 
MS data intersect was highly enriched in abundant ER-resident proteins, e.g.  PDI1-5, Hsp70/Bip and 
Hsp90/Grp94. On the other hand, many proteins in the ESV dataset showed a typical ER distribution, 
although 5 proteins also localized to ESVs. A likely explanation is that many tested candidates are present 
in ER subdomains closely associated or directly connected to ESVs. When encysting Giardia cells are 
subjected to cell disruption by sonication or other tested methods such as nitrogen cavitation (not 
shown), these ER domains remain physically linked to ESVs and are enriched accordingly in the sorting 
process.  
Despite elimination of ~90% of all hits in the dataset intersection, which was enriched for known ER 
proteins, the ESV dataset still contained a large number of proteins localizing to the ER. There are several 
possible explanations for this surprising finding, the most likely being the intimate association between 
the ER and ESVs as discussed above. The physical connections and membrane continuities may be 
resistant to our cell disruption protocols and may thus limit to extraction of ESVs from this subcellular 
context. In contrast, ER membranes and PV do not occupy the same cellular space: the ER network 
extends throughout the cytoplasm but not into the cortical layer just below the plasma membrane into 
which PVs are embedded [54]. Although the interface between the two organelle systems includes 
postulated direct contact points [8] the subcellular segregation of the two compartments appears to 
make separation by cell disruption easier.  
 
We performed a preliminary validation of the “ESV-specific” dataset by localizing 16 tagged 
factors. The results suggested that the dataset contained many ER proteins rather than novel ESV 
factors. Based on this we propose two non-mutually exclusive interpretations for the lack of novel ESV-
specific proteins in our datasets: i) The organelle enrichment strategy and post-sorting elimination of 
contaminants worked well for filtering out abundant generic ER proteins, but is less efficient in 
eliminating minor contaminants and/or proteins that remain attached to the fluorescently labeled 
organelles. ii) ESVs and the ER are highly distinct with respect to abundant luminal proteins such as 
CWPs, modifying factors, or chaperones. However, both organelles share most membrane or 
peripherally associated proteins. All available data on stage-specific gene expression during encystation 
suggests that only CWP genes are strictly stage-specifically regulated (i.e. completely “off” in 
trophozoites) whilst the remaining (<20) significantly modulated “encystation” genes are upregulated 
from a basal level in trophozoites during the first 7 hours p.i. [47]. Since CWPs as cargo proteins are 
certainly more abundant than ESV membrane or organelle-associated proteins, any novel 
representatives of the latter are difficult to identify within a still relatively high background of ER 
proteins. In fact, the apparent lack of abundant novel proteins in ESVs exacerbates the appearance of 
false-positive ER factors in the organelle-specific dataset.  
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A proposal for cargo-driven ESV neogenesis 
The emerging picture in Giardia encystation is that, aside from synthesis of the bulk cyst wall 
proteins, only relatively small adjustments of expression in some genes (e.g. enzymes for the synthesis of 
the cyst wall glycan) are required for encysting cells to produce mature ESVs [47, 55]. This also suggests 
that morphogenesis of ESV organelles could be driven by accumulation of cargo rather than by specific 
organelle-associated factors, analogous to the formation of dense core secretory granules (DCSG) in 
endocrine/neuroendocrine cells [56], or in ciliates [57]. In early electron microscopy studies, ESV 
formation was described as aggregation of electron-dense material in ER membrane-bounded 
compartments, followed by growth via direct addition of newly synthesized CWPs until large organelles 
are formed [21, 53, 58]. A more recent model posits that ESV formation is the result of self-organizing 
properties, mainly of CWP3, leading to formation of a dense core [28]. The ability of CWP1 and 2 to form 
highly cross-linked complexes [21, 41], and of CWP1 to bind directly to the GalNAc homopolymers [59], 
which constitutes 60% of the cyst wall material, provides the prerequisites for distributing the 
extracellular matrix material evenly on the surface of the parasite before initiating polymerization. The 
presence of basic and simple machinery for ESV formation is supported by the observation that the 
expression of CWP1 and CWP2 in human embryonic kidney cells is sufficient to induce accumulation in 
membrane compartments and secretion of the proteins [60]. This observation is in line with granule 
formation in non-granule forming cells upon expression of different dense core granule cargo proteins, 
including pro-vasopressin, chromogranin A or von Willebrand factor [61-63], suggesting that the cargo 
proteins themselves induce the formation of their own carriers through accumulation. Thus, ESV 
formation might be driven by progressive accumulation of CWPs by a “sorting by retention” mechanism, 
while ER-resident proteins such as Hsp70/BiP are removed via low-density vesicles or tubular 
connections between ER and ESVs as the organelles mature [32]. Taken together, the proteome data 
support a scenario for ESV formation and maturation which relies strongly on inherent properties of 
cargo proteins and likely only few and as yet unidentified additional components, rather than on a 
dedicated ESV-specific, organelle-associated machinery driving morphogenesis.  
Analysis of the remaining candidates in the data set might bring to light further proteins localizing to ESV 
organelles. However, none of these genes appear to be significantly upregulated during encystation [47]. 
Thus, unless significant translational control comes into play [36] we do not expect any additional highly 
abundant proteins to be discovered exclusively in ESVs. 
 
Taken together, identification of one or more low abundance protein(s) which could be used as defining 
factors for ESVs as post ER organelles within the only regulated secretory transport pathway in Giardia, 
remains a significant challenge.   
 
Ribosomal proteins are enriched in the ESV fraction 
A comparison of the 72 ESV-specific and 82 PV-specific candidates revealed a significant 
enrichment of translation/ribosome proteins in the former. Using transmission electron and 
immunofluorescence microscopy we found support for recruitment of ribosomes not only to the ER but 
also to ESV membranes during the differentiation process. However, additional functional verification is 
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required, in particular to test whether co-translational insertion of proteins directed to the regulated 
secretory pathway may occur directly into ESVs.  
In eukaryotic cells, ribosomes localize to the cytoplasm, the nuclear envelope, and the rough ER, giving 
the latter its typical appearance in transmission electron microscopy. While an association of ribosomes 
to Golgi membranes in eukaryotic cells containing a steady state Golgi organelle was not observed, 
giardial ribosomes can be visualized on ESV membranes. Co-translational insertion of secreted proteins 
directly across ESV membranes might be a consequence of the requirement for producing large 
quantities of CWP in the relatively short time when ESVs grow maximally. The process of CWP synthesis, 
translocation and folding clearly begins at the ER level from which CWPs are exported in a COPII-
dependent manner [27]). However, the amount of CWPs detected in the ER drops significantly after 
establishment of small immature ESVs (figure 5 in [27]). Direct co-translational import of CWPs via ESV 
membranes is one possible explanation for this observation. Directed translocation of proteins across 
ESV membranes towards the cytosol as part of a quality control system was inferred from the 
observation that proteasome complexes were recruited to the vicinity of developing ESV organelles [26]. 
Pore complexes such as Sec61, for which an alpha and a gamma subunit are annotated in the Giardia 
genome database, are required for co-translational insertion and are also strongly implicated in retro-
translocation to the cytoplasm [64]. In support of co-translational insertion of proteins across ESV 
membranes, a signal recognition particle component, 54 kDa protein (Gl15156), has been localized 
partially to ESVs (figure 8B). However, none of these factors are distributed in an organelle-specific 
manner and there is currently no possibility to design experiments allowing a dissection of the 
directionality of protein translocation across ESV or ER membranes.  
 
Is the cyst wall sugar monomer UDP-GalNAc synthesized in the ER? 
The Giardia cyst wall consists of 3 proteins (CWP1-3) and a β(1‐3)‐GalNAc homopolymer which 
makes up about 60% of the cyst wall [24, 25]. While the protein components are trafficked via ESV 
organelles to the surface of the cell, the place of synthesis, transport to the surface, as well as timing and 
manner of incorporation of the sugar components into the cyst wall remains largely unknown. The 
sparse literature on the subject suggests synthesis of the cyst wall monomer UDP-GalNAc from 
endogenous glucose by a series of stage-specifically regulated, enzymatic reactions [52]. A late step, i.e. 
conversion of UDP-GlcNAc into UDP-GalNAc, was proposed to be performed by a cytosolic UDP-GlcNAc-
4’-epimerase or so called GALE (Gl7982). While some experimental data showed that the enzyme 
converted UDP-GlcNAc into UDP-GalNAc during encystation, investigation of enzyme kinetics showed 
that the reverse reaction towards production of UDP-GlcNAc was clearly favored, raising significant 
doubts about a productive synthesis of UDP-GalNAc in the cytoplasm [65].  
 
In this study, two important proteins potentially involved in this process were identified in the ESV 
dataset: i) the only nucleotide sugar transporter (Gl15483) identified in the Giardia genome project [49] 
which specifically transports UDP-GlcNAc from the cytoplasm to the ER lumen [50], and ii) a putative 
UDP-GlcNAc-4’-epimerase (GALE). We detected epitope-tagged variants of the epimerase in the ER, and 
the transporter mainly showed distribution in the perinuclear ER and early ESVs, where its signal 
overlapped with that of CWP1. N-glycosylation of Giardia proteins is restricted to addition of GlcNAc1-2 to 
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asparagine [66]. Consistent with this, the parasite lacks genes required for synthesis of the typical 
eukaryotic core-oligosaccharide GlcNAc2Man9Glc3 and for further N-glycan processing in the ER and 
Golgi. While the UDP-GlcNAc-transporter Gl15483 in the ER membrane imports UDP-GlcNAc used for N-
glycosylation, the presence of an ER-localized UDP-GlcNAc-4’-epimerase converting UDP-GlcNAc into 
UDP-GalNAc indicates involvement of the putative GALE enzyme (Gl8382) in producing the UDP-GalNAc 
monomer for the cyst wall glycan in the ER.  
 
Opportunities and technical limitations of dual organelle sorting and in silico processing of mass 
spectrometry data   
In proteomic studies, the purity of the biological sample is of utmost importance for a successful 
analysis. One of the most crucial steps is subcellular fractionation. Despite considerable efforts to 
optimize protocols for purification of Giardia organelles, the levels of contaminating proteins from non-
target organelles and cellular structures remain high [32, 33]. The most frequently used subcellular 
fractionation techniques applied in organellar proteomics are density-based gradient centrifugation, 
affinity-based isolation, free flow electrophoresis, and recently also flow cytometry [67-70]. 
Fluorescence-based organelle sorting by flow cytometry is challenging because of the small size of 
organelles which usually results in reduced fluorescence intensity. In the case of Giardia organelles, 
labeling with a highly expressed luminal GFP-tagged organelle marker (CWP3-GFP) in ESVs or the 
endocytic uptake of a fluid-phase fluorescent dye by PV organelles created unique opportunities for 
intense organelle labeling. This was sufficient to clearly detect and enrich the organelles simultaneously 
by flow cytometry despite their small size and, most importantly, to achieve a 100% relative enrichment 
(i.e. 100% separation) of ESVs and PVs which was a precondition for the subsequent subtractive 
approach. Analysis of ESV and PV-enriched samples by shotgun mass spectrometry revealed high 
reproducibility between 3 independent experiments.  
 
The limited purity of organelle preparations and the high sensitivity of current mass spectrometers 
require additional measures to address the large quantities of false-positive hits. Researchers have 
developed different (in silico) strategies for the elimination of contaminating proteins from organellar 
datasets. A proteomic study on Giardia mitochondria-relic organelles (mitosomes) using gradient 
centrifugation took advantage of the organelle distribution into two neighboring fractions [33]. Using 
iTRAQ mass spectrometry the relative distribution of mitosomal marker proteins between the two 
fractions was evaluated, and novel putative proteins were identified based on their similar distribution 
ratio. Another study focusing on the proteome of Spironucleus hydrogenosomes utilized the distribution 
of the target organelle into two gradient fractions of distinct densities [71]. After mass spectrometry 
analysis, putative organelle-specific proteins were identified by their co-purification with organelle 
marker proteins. Both approaches significantly reduced the incidence of contaminants in the resulting 
large datasets, but the proportion of organelle-specific proteins remained low.  
 
In our case, simultaneous enrichment of ESV and PV organelles makes subtractive approaches to identify 
contaminating MS hits in silico possible. Using this approach we removed 1059 hits which were common 
to both organelle fractions, including a large proportion (86%) of ribosome/translation and ER-derived 
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contaminants which constitute a major challenge in organelle proteomic studies. Accordingly, among the 
72 ESV and 82 PV candidates only a single predicted ER protein was identified in each dataset. However, 
preliminary evaluation revealed a large proportion of hitherto unknown ER proteins. 
 
Two factors may contribute to the low discovery rate of organelle proteins: i) peripherally associated 
organelle proteins may be partially or completely lost during the purification and sorting process, ii) the 
subtractive approach to remove contaminating proteins likely also eliminates specific categories of 
organelle-associated proteins, i.e. those with secondary localizations or with large cytoplasmic pools. 
Examples are the small GTPases Rab1, Rab11, Arf1 and COPI components which also localize to the ER 
and other membranes. In addition, some peripherally associated factors are recruited to ESVs only 
during specific phases of the differentiation process, e.g. Rab1, COPI [26, 29], or members of the SNARE 
family [43].  
 
In summary, the success of a simultaneous sorting approach strongly depends on how cleanly the 
differentially labeled organelles can be prepared during cell disruption and how similar their cellular 
context is. The major limitation in our case is the close association of ESVs but not PVs with the ER 
subdomains. Since the cellular context of the two analyzed organelles differs greatly, subtractive analysis 
appears to be more efficient for PV candidates but still led to many false-positive candidates in the ESV 
dataset. Thus, subtractive analysis of datasets derived from simultaneously sorted organelles is a useful 
strategy to discover organelle-specific factors, but the degree of success depends strongly on the 
feasibility clean extraction of target organelles from their subcellular context.  
Materials and Methods 
Giardia cell culture and in vitro encystation 
Giardia lamblia WBC6 (ATCC catalog number 50803) trophozoites were grown under anaerobic 
conditions in 11 ml culture tubes (Nunc, cat. 156758) or triple flasks (Nunc, cat. 132867) containing TYI-S- 
33 medium supplemented with 10% fetal bovine serum and bovine bile according to standard protocols 
[41]. Parasites were harvested by chilling the tubes on ice for 30 minutes (for flasks: 1 hour in ice water) 
to detach adherent cells and collected by centrifugation (900 x g, 10 minutes, 4 °C). Encystation was 
induced using the two-step method as described previously [47] by cultivating the trophozoites in bile-
free medium for 44 hours and thereafter in medium (pH 7.85) containing porcine bile.  
 
Sample preparation for flow cytometry 
ESV-organelle staining: CWP3-GFP expressing cells [28] and WB wild type cells (control) were grown in 
triple flasks (800 ml) and kept in encystation conditions for 13 hours as described above. Cells were 
harvested and resuspended in 20 ml of encystation medium. To allow oxidative chromophore formation, 
the cell suspension was dispersed into a 6 well plate (Sigma, cat. Z707759) and exposed to air on ice over 
night. To complete GFP folding, the cells were harvested from the plate and incubated for 30 minutes in 
a water bath at 37 °C in anaerobic conditions.  
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PV-organelle labeling: wild type trophozoites were grown in triple flasks and harvested as described 
above. Cells were washed twice in 10 ml 1x PBS (900 x g, 10 minutes, 4 °C) and resuspended in 500 ul 
supplemented PBS (5 mM glucose, 5 mM cysteine, 0.1 mM ascorbic acid) containing 4 mg/ml dextran 
AlexaFluor-647 (Molecular Probes Inc., cat. D22914). Endocytic uptake of the fluorescent dye by PV 
organelles was achieved at 37 °C for 30 minutes, covered from light.  
All samples were washed twice in 10 ml 1x PBS (900 x g, 10 minutes, 4 °C) and resuspended in 5 ml 1x 
PBS. After addition of protease inhibitor cocktail (Calbiochem, cat. 539131) and PMSF (Sigma, cat. 
P7626), the cells were disrupted by four rounds of mild sonication (Branson Sonifier 250, Branson 
Ultrasonics Corporation, 4x 60 pulses, duty cycle 20%, output control 1.5) on ice. To remove remaining 
intact cells and cysts, the cell suspensions were passed through a 5 um filter (MILLEX-SV 5.00 um, 
Millipore, cat. SLSV25LS).  
 
Flow cytometry-based organelle sorting 
Flow cytometry-based sorting of organelles was performed on a BD FACS AriaIIITM cell sorter. For data 
acquisition and processing, the BD FACSDivaTM software (version 6.1.3) was used.  In order to achieve 
maximal speed the sort was performed with using a nozzle with a 70 micrometer orifice diameter at 4.83 
bar sheath pressure. GFP was excited by a 488 nm laser and emission was detected using a 525/45 band 
pass filter. AlexaFluor647 was excited by a 633 nm laser and emission was detected using a 670/40 band 
pass filter. Given the small organelle size, considerable proportion of observed events was stemming 
from particulate and electronic noise. All the fluorescent and light scatter parameters were estimated by 
the height of the voltage pulse generated by each event. The detection threshold was defined as a logical 
combination of green (GFP) and red (AF647) signal value using the "OR" functional operator. The 
organelle populations were defined by a parent gate (P3) based on FSC-H and SSC-H (figure 1). YFP 
control beads (SHEROTM Fluorescent Nanospheres, Spherotech Inc., cat. FP-0552-2) in the size range of 
the organelles (400 to 600 nm) were used to estimate the level of particulate and/or electronic noise 
with selected instrument settings. To select for GFP-positive and AF647-positive events out of the mixed 
organelle population, gates P1 and P2 were set in a bivariate dot-plot. An unlabeled cell suspension was 
used as negative control to define the gate positions. Prior to the sort, the two cell lysates were mixed in 
a ratio of about 1:4 to obtain similar numbers of target events, i.e. GFP-positive and AF647-positive 
events, in the mixture.  To attain maximal purity, a sort precision mode of 0/32/0 was chosen. The sort 
was performed with an average event rate of 25’000 to 30’000 per second, an average sort rate of 600 
events per second and a mean sort efficiency of 80%. Twenty million GFP-positive and AF647-positive 
events were collected in separate 5 ml polystyrene tubes (BD Biosciences, cat. 352052). For quality 
control of the sort, the collected material was analyzed by flow cytometry using the same settings as for 
the sort (figure 1).  
 
Protein precipitation 
Protein precipitation was performed using the PRM method [72]. Briefly, PRM reagent was added to the 
sample in a ratio of 1:4. The samples were vortexed and incubated at 25°C for 25 minutes. Proteins were 
pelleted at 3800 x g for 30 minutes and dissolved in 1 ml of ddH2O. After addition of 250 ul of PRM 
reagent, incubation and pelleting was repeated one more time. The final pellet was resuspended in 25 ul 
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of Laemmli buffer containing 0.5 % (v/v) β-mercaptoethanol, incubated for 5 minutes in boiling water, 
and stored over night at -20 °C.  
 
SDS-PAGE and immunoblot analysis  
SDS-PAGE on a 12% polyacrylamide gel and subsequent transfer to a nitrocellulose membrane (Protran, 
Whatman GmbH, cat. 10401396) was performed according to standard protocols. The following 
antibodies were used: Anti-GFP from mouse (JL-8, Clontech, cat. 632380; 1:2000) and a horseradish 
peroxidase-conjugated rabbit anti-mouse IgG (Sigma, cat. A9044, 1:8000). Signal detection was 
performed using Western Lightning Chemiluminescence Reagent (PerkinElmer Life Sciences, cat. 
NEL100001EA). Data collection was done in a Multimage Light Cabinet with AlphaEase FC software 
(Alpha Innotech, San Leonardo, CA, USA).  
 
Mass spectrometry analysis and protein identification 
Protein samples were boiled for 5 minutes and centrifuged for 1 minute at 16’100 x g  at room 
temperature to pellet insoluble material. The samples were separated by 1D-SDS-PAGE using precast 
12% Tris-Glycine gels (Invitrogen, cat. IM6000). 4 to 8 ul of supernatant were loaded, depending on the 
estimated amount of protein in the respective sample determined in a preceding test run. After staining 
with Roti Blue (CARL ROTH, cat. A152), each gel band was cut into 21 slices. In-gel digestion of proteins 
using trypsin and extraction of peptides was performed according to standard protocols. Samples were 
analyzed on a LTQ-Orbitrap XL mass spectrometer (Thermo Fischer Scientific, Bremen, Germany) coupled 
to an Eksigent-Nano-HPLC system (Eksigent Technologies, Dublin, CA, USA). A detailed description of 
sample preparation and mass spectrometry analysis can be found in the text S1.  
The raw-files from the mass spectrometer were converted into Mascot generic files (mgf) with Mascot 
Distiller software 2.4.2.0 (Matrix Science Ltd., London, UK). The peak lists were searched using Mascot 
Server 2.3 against the G. lamblia database (http://tinyurl.com/37z5zqp) with a concatenated decoy 
database supplemented with contaminants, The Arabidopsis Information Resource (TAIR9) protein 
database and the Swissprot database to increase the database’s size. The final database included 79141 
entries. The identification results were loaded into Scaffold 3.0 (Proteome Software, Portland, US) and 
filtered for a minimal mascot score of 20 for peptide probability, a protein probability greater than 80%, 
and a minimum of 2 unique peptides per protein.  
 
In silico removal and functional annotation clustering of the intersection dataset 
The final ESV and PV organelle-specific datasets were compiled by in silico identification and removal of 
the contaminating proteins. Briefly, the ESV-derived and PV-derived mass spectrometry (MS)-datasets 
from the three independent experiments were intersected separately. Proteins detected in both ESV and 
PV MS-datasets were considered as “contaminants” and removed, thus generating three independent 
subtractive lists enriched for putative ESV-specific hits and PV-specific hits, respectively. To enhance the 
stringency for detection of putative organelle-specific candidates, we accepted only ESV candidates that 
were detected in at least two more ESV MS-datasets than PV MS-datasets, and vice-versa. A detailed 
description of the procedure is attached in the supplementary figure S3. The contaminating proteins 
defined by the data intersection were evaluated and clustered into functional groups using the DAVID 
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bioinformatics tool (http://david.abcc.ncifcrf.gov/home.jsp) [34]. Since analysis in DAVID is restricted to 
3000 genes, clustering of the Giardia genome as a control was performed by the generation of 10 
independent lists each containing 3000 randomly selected Giardia genes.  
 
In silico analysis tools 
Analysis of primary structure and domain architecture of ESV and PV candidates (i.e., manual annotation) 
was performed using the following tools and databases: PSORTII (http://psort.hgc.jp/form2.html) for 
prediction of subcellular localization, TMHMM (http://www.cbs.dtu.dk/services/TMHMM/) for 
prediction of transmembrane helices, SMART (http://smart.embl-heidelberg.de/) for prediction of 
patterns and functional domains, pBLAST for protein homology detection (protein blast by NCBI,  
http://blast.ncbi.nlm.nih.gov/Blast.cgi), HHPred (http://toolkit.tuebingen.mpg.de/hhpred) for protein 
homology detection based on HMM-HMM comparison, and the Giardia genome database 
(http://giardiadb.org/giardiadb/) for changes in mRNA expression during the Giardia life cycle. For 
functional domains predicted by SMART we used an e-value of 10e-5 as cutoff, and for protein 
homologies predicted by pBLAST we accepted alignment scores above 80. Alignment scores between 50 
and 80 were accepted only when the pBLAST predictions were consistent with those of HHPred. The 
latter was used to make pBLAST more robust; only hits with a probability above 95% were accepted.  
Functional annotation clustering of the data intersect was performed using the DAVID bioinformatics 
tool (http://david.abcc.ncifcrf.gov/home.jsp) [34].  
 
Expression constructs and transfection 
For cloning of C-terminally HA-tagged proteins in Giardia, a vector PAC-CHA with additional restriction 
sites was designed on the basis of the previously described vector pPacV-Integ [26]. Additional restriction 
sites were inserted via oligonucleotide primers. A detailed vector map can be found in the figure S4. For 
each gene of interest two expression vectors were constructed, one in which expression of the gene of 
interest is driven by its own promoter (pendo), and another in which the gene of interest is under the 
control of the inducible cyst wall protein 1 promoter (pCWP1). GenBank accession numbers and a list of 
primers used for cloning can be found in tables S2 and S3, respectively. For transfection, 15 ug of plasmid 
DNA linearized with SwaI was electroporated (BIO RAD Gene Pulser, 350V, 960 mF, 800 Ohm). The 
expression vector is targeted to the Giardia lamblia triose phosphate isomerase (Gl-TPI) locus by 
homologous recombination [73] stable transfectants are selected with the antibiotic puromycin (Sigma, 
cat. 7699111) at a concentration of 77 uM for 5 days. For episomal maintenance, circular plasmid DNA 
was electroporated and selected with puromycine.  
 
Immune Fluorescence Assay  
Immunofluorescence analysis was performed as described previously [20]. The following antibodies were 
used in this work: Anti-HA high affinity from rat (Roche diagnostics AG, cat. 11867423001, 1:50), 
Alexa488-conjugated goat anti-rat (Invitrogen, cat. A11006, dilution 1:200), Texas Red-conjugated anti 
CWP1 (WaterborneTM Inc., cat. A300TR-R, dilution 1:50). For microscopy cells were embedded in 
Vectashield (Vector Labs, Inc., cat. H-1200) containing the DNA intercalating agent 4’-6-Diamidino-2-
phenylindole (DAPI) for staining of nuclear DNA. Immunofluorescence analysis was performed on the 
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standard fluorescence microscopes Leica DM IRBE with MetaVue software version 5.0r1, or Nikon Eclipse 
80i with Openlab Improvision software 5.5.2 for data collection. WCIF ImageJ was used for image 
processing. Alternatively, analysis was performed on a Leica SP2 AOBS confocal laser-scanning 
microscope (Leica Microsystems, Wetzlar, Germany) equipped with a glycerol objective (Leica, HCX PL 
APO CS 63x 1.3 Corr).  
 
Transmission electron microscopy 
Transmission electron microscopy and sample preparation was performed as described previously [29].  
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Supplementary material 
Table S1: Protein identification by mass spectrometry  
Raw data exported from proteome software (Scaffold version 3.0). Identification probabilities, 
quantification values, and number of unique peptides (files 1-3) are indicated for all detected proteins. 
For each of the 1281 proteins identified, the following information is provided: Product description 
(column B) and GeneID (column C) according to the G. lamblia genome database (GiardiaDB), molecular 
weight (column D), and the T-test scores (column E). For ESV-enriched fractions (E1-E3, columns F-H) and 
PV-enriched fractions (P1-P3, columns I-K) the protein probabilities (first worksheet), the quantitative 
values (second worksheet) and the number of unique peptides (third worksheet) are indicated.  
 
This table is too large to be incorporated into this document. Information is available on request and will 
be available online as soon as the manuscript is published.   
 
Table S2: ESV and PV candidate list with additional information 
For each of the 72 ESV and 82 PV candidates, the following information is provided: protein category 
(column B), GeneID (column C) and product description (column E) according to the G. lamblia genome 
database, NCBI reference number (column D), manual re-annotation (column F) and the prediction tools 
it is based on (column G), number of transmembrane domains (column H), signal peptide (column I), 
significant stage-specific up-regulation of transcription (column J),  localization of HA-tagged variants 
determined in this study (column K), and literature information (column L). TMD: Transmembrane 
domains; SP: Signal peptide; ER: Endoplasmic Reticulum; ESV: Encystation specific vesicles; PV: Peripheral 
vesicles; CYT: Cytosol asterisk:  prediction tools return different results.  
 
This table is too large to be incorporated into this document. Information is available on request and will 
be available online as soon as the manuscript is published.   
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Table S3: Oligonucleotide primer sequences 
Primers used for cloning of expression constructs. Sequences are in 5’ to 3’ orientation, restriction sites are marked in bold. pCWP1: inducible 
promoter of G. lamblia cyst wall protein 1; pendo: endogenous promoter, HA: hemagglutinin tag.  
 
Construct Forward primer (5’ to 3’ direction) Reverse primer (5’ to 3’ direction) 
pCWP1-15483HA 15483_s_NsiI CGATGCATAACGAGACTGTCCGTTTCCTTC 15483_as_HA_PacI 
CGTTAATTAATCACGCGTAGTCTGGGACATCGT
ATGGGTAATCTTGTTTTTTATTCTTACTGCG 
pCWP1-10221HA 10221_s_AvrII GCCCTAGGATGGAAAAATACCACGGGCTG 10221_as_SphI GAGCATGCTTCACTGTGTATGGCCGCGAC 
Pendo-10221HA p10221_s_XbaI CGTCTAGAGAGTATCTGCACCTCCAGTG 10221_as_SphI GAGCATGCTTCACTGTGTATGGCCGCGAC 
pCWP1-88581HA 88581_s_AvrII GCCCTAGGATGAAGATTTCCTTGCTCTGTTC 88581_as_SphI GAGCATGCGAGGAAGGGGAAAATGCAGAAC 
Pendo-88581HA p88581_s_XbaI CGTCTAGAGTTTAACCTAATGACCGTTATTG 88581_as_SphI GAGCATGCGAGGAAGGGGAAAATGCAGAAC 
pCWP1-22135HA 22136_s_AvrII GCCCTAGGATGACTGATACCGAGTCACAG 22136_as_SphI 
GAGCATGCGAAGCCACTGGCAATATTAATAAAA
AG 
Pendo-22135HA p22136_s_XbaI CGTCTAGACAGAATCCAAGATGCTGGTC 22136_as_SphI 
GAGCATGCGAAGCCACTGGCAATATTAATAAAA
AG 
pCWP1-11299HA 11299_s_AvrII GCCCTAGGATGCAAGTCGAAGACCCTGGTG 11299_as_SphI 
GAGCATGCTTTTTTATTGTACGGACAATTATCAA
C 
Pendo-11299HA p11299_s_XbaI CGTCTAGACTGTAGTGGAGTTGTCGGTC 11299_as_SphI 
GAGCATGCTTTTTTATTGTACGGACAATTATCAA
C 
pCWP1-11595HA 11595_Bcl_s CATGATCAATGACGACCGCGGCGTC 11595_SphI_as GAGCATGCATCCTTGCGTGTTCTAGCTC 
Pendo-11595HA p11595_XbaI_s CGTCTAGACTTGCCCAAGCAGCGGAC 11595_SphI_as GAGCATGCATCCTTGCGTGTTCTAGCTC 
pCWP1-32419HA 32419_AvrII_s GCCCTAGGATGAAGCACATAGGTCTCCAC 32419_SphI_as GAGCATGCGCGAAGAGAAAGGGGCTGC 
pendo-32419HA P32419_Xba_for GCTCTAGAGCGCATGCTAGGAATCGC 32419_SphI_as GAGCATGCGCGAAGAGAAAGGGGCTGC 
pCWP1-15956HA 15956_AvrII_s GCCCTAGGATGGTTCTTCAACTCCGCAG 15956_PacI_HA_as 
CGTTAATTAATCACGCGTAGTCTGGGACATCGT
ATGGGTACATTGACCACACCATGACAC 
Pendo-15956HA p15956_XbaI_s CGTCTAGACAGTTTGCCCAACACGCTTC 15956_PacI_HA_as 
CGTTAATTAATCACGCGTAGTCTGGGACATCGT
ATGGGTACATTGACCACACCATGACAC 
pCWP1-7207HA 7207_AvrII_s GCCCTAGGATGCAACAGCAGCAAGACCCAC 7207_SphI_as GAGCATGCTAAACGATATTGGAGAACACTCTC 
Pendo-7207HA 7207_SpeI_s GCACTAGTCAGATTCTGTGCTATTTGAATAAG 7207_SphI_as GAGCATGCTAAACGATATTGGAGAACACTCTC 
pCWP1-7350 7350_AvrII_s GCCCTAGGATGGTGAAAGTGGCCGAAG 7350_HA_PacI_as 
CGTTAATTAATCACGCGTAGTCTGGGACATCGT
ATGGGTAGGAAACACACAAAGCAGGAATTC 
Pendo-7350 7350_SpeI_s GCACTAGTCTCACGCGAACTGTAGCCTG 7350_HA_PacI_as 
CGTTAATTAATCACGCGTAGTCTGGGACATCGT
ATGGGTAGGAAACACACAAAGCAGGAATTC 
pCWP1-14458HA 14458_AvrII_s GCCCTAGGATGAGCAAACATCTGGCCATTG 14458_SphI_as GAGCATGCCTTGCAAAGGATCTTCCTCATAG 
Pendo-14458HA 14458_XbaI_s CGTCTAGACTTTGGCGGCTTTATGGCAG 14458_SphI_as GAGCATGCCTTGCAAAGGATCTTCCTCATAG 
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pCWP1-25205HA 25205_AvrII_s GCCCTAGGATGGCCGGAAATTACCCTGTC 25205_HA_PacI_as 
CGTTAATTAATCACGCGTAGTCTGGGACATCGT
ATGGGTAGATTTCCATTAGGCCATAATG 
Pendo-25205HA 25205_SpeI_s GCACTAGTGTACGTTCACACTCTTTACCAG 25205_HA_PacI_as 
CGTTAATTAATCACGCGTAGTCTGGGACATCGT
ATGGGTAGATTTCCATTAGGCCATAATG 
Pendo-15156HA p15156_XbaI_s CGTCTAGAGTACGCTTTTGGCGAGTCAGAG 15156_SphI_as GAGCATGCCTTTGACATCTTTGCCTTCTGAATC 
Pendo-10780HA p10780_XbaI_s CGTCTAGAGTTTCCGGAATAATGTTTGTCAG 10780_SphI_as GAGCATGCCTTCTGTCTGTACCTCTCTAC 
pCWP1-9157HA 9157_SpeI_s GCACTAGTATGAACAGCGGGGCTGACTCTG 9157_SphI_as GAGCATGCTGCGGATACTTCGTAGTTCCGTAG 
Pendo-9157HA p9157_XbaI_s CGTCTAGAGATCAGCGCGTCTAATGGCGTG 9157_SphI_as GAGCATGCTGCGGATACTTCGTAGTTCCGTAG 
pCWP1-87926HA 87926_AvrII_s GCCCTAGGATGTTTGCGGCAGACTCTCAAAAC 87926_SphI_as GAGCATGCCTCGCCCTTCTCCCTCAAG 
Pendo-87926HA p87926_AvrII_s GCCCTAGGGTCGTGAATGACGATGAGACTG 87926_SphI_as GAGCATGCCTCGCCCTTCTCCCTCAAG 
Pendo-8382HA 8382_SpeI_s GCACTAGTATGCTGTCTTTCTGGGTTTATC 8382_HA_PacI_as 
CGTTAATTAATCACGCGTAGTCTGGGACATCGT
ATGGGTACTTAAGAGCACACTTTATTAGGAAC 
Pendo-7982HA 7982_SpeI_s GCACTAGTATGCAGAACCACTCGTTCCTC 7982_HA_PacI_as 
CGTTAATTAATCACGCGTAGTCTGGGACATCGT
ATGGGTATAGACCAATCTCCTTGACATC 
pCWP1-96994HA 96994_AvrII_s ACCCTAGGATGACCGATTTTG ATGCACC 96994_Sph1_as GTGCATGCCTTTTTCACGGCACGGATG 
pCWP1-15104HA 15104_AvrII_s CACCTAGGGCCATTGAAACTTGAGGGAG 15104_Sph1_as GTGCATGCTGCTTTGAGGAACACCCCC 
pCWP1-16521HA 16521_AvrII_s CGCCTAGGATGAGTTATGCAAAGCAGGCG 16521_Sph1_as CTGCATGCCAACAACTCGCCGATAGCG 
pCWP1-15472HA 15472_AvrII_s GCCCTAGGATGGGGAAGATAGATCTTACC 15472_Sph1_as CGGCATGCCTCGACGCTCTGGGCCA 
pCWP1-15339HA 15339_AvrII_s CGCCTAGGATGGGCTCAACAACAAACATT 15339_HA_PacI_as 
GCTTAATTAATCACGCGTAGTCTGGGACATCGT
ATGGGTAATTTCTGTTCAGGCCAGTAAC 
Pendo-4270HA 4270_Xba1_s GCTCTAGATGGCACAGAGCGC GTCAAC 4270_HA_PacI_as 
GCTTAATTAACTACGCGTAGTCTGGGACATCGT
ATGGGTAGATCGGTAAATCCACAATATATGC 
pCWP1-8559HA 8559_NsiI_s CGATGCATATGTCGACAACATCCAGGAATC 8559_HA_PacI_as 
CGTTAATTAATCACGCGTAGTCTGGGACATCGT
ATGGGTACTGCTGCACGCAAATGTTCC 
pCWP1-40224HA 40224_AvrII_s GCCCTAGGATGAAGTCTGCGTTCAACCC 40224_Sph1_as GCGCATGCTAAGAACTTAGGTTGATACAGC 
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Figure S1: Workflow 
CWP3-GFP expressing cells at 13 hours p.i. (A) and wild type trophozoites after endocytic uptake of the 
fluid phase dye Dextran-AlexaFluor-647 (B) were disrupted by sonication and passed through a 5µm 
filter. The cleared microsome fractions were mixed (C) and organelles were simultaneously enriched by 
flow cytometry-assisted organelle sorting (FAOS) (D). Sample preparation and organelle sorting were 
performed in biological triplicates. Protein precipitates of organelle-enriched fractions were separated 
by 1D-SDS-PAGE and analyzed by mass spectrometry (MS) (E), resulting in 3 ESV and PV mass 
spectrometry datasets, each (F). Contaminating proteins were identified by intersecting the ESV and PV 
MS-datasets (G). A detailed description of the intersection can be found in figure S3. In silico data 
filtration, i.e., removal of the data intersection (H) revealed ESV-organelle (J) and PV-organelle (K) 
specific datasets.  
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Figure S2: Generation of the MS data intersection 
Mass spectrometry datasets of ESV-enriched (E1, E2, E3) and PV-enriched (P1, P2, P3) fractions of each 
replicate were intersected separately (top). The numbers stand for the proteins detected by mass 
spectrometry. Removal of the intersection revealed proteins exclusively detected in ESV-enriched 
fractions (middle, left) or PV-enriched fractions (middle, right). From these lists, only proteins occurring 
in at least two lists were accepted (bottom, blue). The proteins were further analyzed according to their 
distribution pattern in the six organelle-enriched fractions (B). B) Schematic representation of the 
protein distribution pattern in ESV- and PV-enriched fractions. ESV candidates (left): proteins of type X 
were detected exclusively and in at least two of three ESV fractions, proteins of type Y were detected in 
all ESV fractions and in one PV fraction, proteins of type Z were detected in only two ESV fractions and in 
one PV fraction. The same is true vice-versa for PV candidates (right). Type Z proteins were removed, 
resulting in 72 ESV and 82 PV candidate proteins. The respective protein numbers are indicated in 
brackets.  
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Figure S3: Conserved short chain dehydrogenases (SDH) motifs in Gl8382, Gl7982 and human GALE 
Protein sequences of G. lamblia Gl7982 (cytoplasmic GALE, [52], G. lamblia Gl8382 (putative ER-GALE), and the human GALE (hGALE) were 
analyzed manually. All conserved sequences required for hGALE function [51] are present in both Giardia GALEs and listed in the table. A 
conserved PG motif, which is required for the direction of the reaction, is only present in the Giardia ER-GALE. An N-terminal integral membrane 
domain in the ER-GALE shifts the conserved motif positions for about 40 amino acids towards the C-terminus, compared to the cytoplasmic GALE 
and hGALE.  
 
 
Gl8382 MLSFWVYLLLLFTTVLLARISRLASERKSARRSLLTGDSGLCVITGGGSGLGEALAHEYAALGHPLLLIGRKHENLERAKHALIEKFGEKASVTVLAADL 
Gl7982 -------------------------------MQNHSFLGKTVLITGGCGFIGSHFVEACHVLGMTVYVLDNLSSGKNVFKTTSDCSSSLVYTIGDIRDKA 
hGALE -------------------------------------MAEKVLVTGGAGYIGSHTVLELLEAGYLPVVIDNFHNAFRGGGSLPESLRRVQELTGRSVEFE 
 
Gl8382 EVESECIKVVEYLRDKSVFHLVNNAGVGQVSADISVSDARSIASINLTAPAVLSAGIHAGRYIFISSPQGLLPMPNRCVYAASKAGIHNLAESMRLDGMN 
Gl7982 IFSRLPQKIDFVIHLAAAVSVAESVTNPQKYMLTNVEGSRNVFQYAVDAKASAVLSASTAAYYGDCGKSAITEAFPYGGISPYAESKMEMERLGAEFQKT 
hGALE EMDILDQGALQRLFKKYSFMAVIHFAGLKAVGESVQKPLDYYRVNLTGTIQLLEIMKAHGVKNLVFSSSATVYGNPQYLPLDEAHPTGGCTNPYGKSKFF 
 
Gl8382 VTTAYPGWIATRLRMNARGNGLPNPQARTARSAEDVAKEIVSAALSGKRACCLDAKTRIVAILYSVWPEAAEFLIKCALK-------------------- 
Gl7982 SRCRFIFCRFFNVYGPRQDPSSPYTGVMSIFMDRCAARKPITIFGTGEQTRDFVFIKDLIVAAINLLGQLDKFPIGADAVQQNDPEEVQRSAYTGEGVYP 
hGALE IEEMIRDLCQADKTWNAVLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVAIGRREALNVFGNDYDTEDGTGVRDYIHVVDLAKGHIAALRKLKEQCG 
 
Gl8382 ---------------------------------------------------------------------------------------------------- 
Gl7982 TVFNIGSGISISVNELAELAKIVSGRHEVEIVHGEPRSGDILHSLSDCTRIRNATGWSASTTLRVGMSETWGWAAGEISYLSGDLVRVLENELKIDGVPV 
hGALE CRIYNLGTGTGYSVLQMVQAMEKASGKKIPYKVVARREGDVAACYANPSLAQEELGWTAALGLDRMCEDLWRWQKQNPSGFGTQA 
 
Gl8382 ---------------- 
Gl7982 AKSLCGKDADVKEIGL 
hGALE ---------------- 
 
 
Conserved motif Position Function Putative ER-GALE 
(Gl8382) 
Cytosolic GALE  
(Gl7982) 
Human GALE 
(hGALE) 
TGxxxGxG 12 to 19 Co-enzyme binding, maintenance of 
central β-sheet 
TGGGSGLG 
Position 45 - 52 
TGGCGFIG 
Position 14 - 21 
TGGAGYIG 
Position 8 - 15 
D 
frequently found 
60 Stabilization of adenine ring pocket, 
weak binding to coenzyme 
D 
Position 99 
D 
Position 64 
D 
Position 66 
NNAG (or Ala88) 
frequently found 
86-89 Stabilization of central β-sheet  NNAG 
Position 123 - 126 
A 
Position 79, probably 
A 
Position 89, probably 
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Conserved motif Position Function Putative ER-GALE 
(Gl8382) 
Cytosolic GALE  
(Gl7982) 
Human GALE 
(hGALE) 
N 
frequently found 
111 Active site NNAG 
Position 124, probably 
N 
Position 104, probably 
N 
Position 108, probably 
S-Y-K 138, 151, 155 Active site SAGIHAGRYIFISSPQ 
GLLPMPNRCVYAASK 
Position 154, 180, 184 
STAAYYGDCGKSAIT 
EAFPYGGISPYAESK 
Position 127, 152, 156 
SATVYGNPQYLPLDE 
AHPTGGCTNPYGKSK 
Position 132, 157, 161 
N 179 Connection of substrate binding loop 
and active site 
N 
Position 200 
N 
Position 181 
N 
Position 179 
PG  
least conserved 
183-184 Reaction direction, presumably 
involved in co-factor interactions 
PG 
Position 207 
Not present Not present 
T 
least conserved 
188 H-bonding to carboxamide of 
nicotinamide ring 
T 
Position 211 
T 
Position 193 
T 
Position 189 
C 307  C 
Position 277 
C 
Position 217, probably 
C 
Position 307 
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Figure S4: Vector map  
Schematic depiction of the vector used for candidate cloning. pCW1: putative promoter region of cyst 
wall protein 1 (GL50803_5638); ORF: open reading frame; HA: hemagglutinin tag; CWP 3’UTR: 3’ 
untranslated region of cyst wall protein 1 (GL50803_5638); RS1/2: recombination sites 1 
(GL50803_17200) and 2 (GL50803_93938); GDH 5’/3’ UTR: 5’ and 3’ untranslated regions of glutamate 
dehydrogenase (GL50803_21942); Puro Res.: puromycin N-acetyltransferase.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Text S1: Detailed description of mass spectrometry analysis  
Detailed description of SDS-PAGE, sample preparation, mass spectrometry analysis, database search and 
protein identification.  
 
SDS-PAGE and sample preparation for mass spectrometry 
After thawing, protein samples was boiled for 5 minutes and centrifuged for 1 minute at 16’100xg  at 
room temperature to pellet undissolved material. Samples were separated by 1D-SDS-PAGE using 
precast 12% Tris-Glycine gels (Invitrogen, IM6000). 4 a- 8 ul of supernatant were loaded, depending on 
the estimated amount of protein in the respective sample determined in a preceding test run. The gel 
was incubated in fixing solution (20% (v/v) methanol, 1% (v/v) 85% phosphoric acid, 79% water) for 15 
minutes and stained in Roti Blue (20% (v/v) methanol, 20% (v/v) Roti Blue concentrate, 60% water) over 
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night. After destaining the gel for 3 x 5 minutes in washing solution (25% (v/v) methanol, 75% water), 
each gel band was cut into 21 slices. Reduction of disulfide bridges was performed by covering the 
vacuum dried gel pieces with sufficient 10mM DTT in 25mM ammonium bicarbonate, pH 8, and 
incubation for 45 minutes at 60°C. For alkylation of cysteines DTT was removed, and 50mM 
iodacetamide in 25mM ammonium bicarbonate, pH8, was added for one hour at room temperature. Gel 
pieces were washed twice in 50% acetonitrile and airdried. In-gel digestion was performed in 25mM 
ammonium bicarbonate pH 8 containing 50 ng trypsin (Roche, 03708985001). After 5 minutes, gel pieces 
were overlaid with 25mM ammonium bicarbonate and incubated over night at 37°C. Peptides were 
extracted by addition of 50% acetonitrile / 5% trifluoroacetic acid to the gel pieces and subsequent 
removal of supernatant. The step was repeated twice. Peptides were dried and desalted using C18 
ZipTips (Millipore, ZTC18S960) and the following solutions: wetting solution (100% Ethanol), washing 
solution (3% acetonitrile; 0.1% trifluoroacetic acid) and elution solution (80% acetonitrile; 0.1% 
trifluoroacetic acid). After drying, peptides were resuspended in 3% acetonitrile and 0.2% formic acid 
and incubated for 15 minutes at room temperature.  
 
Mass spectrometry 
Mass Spectrometry analysis was performed at the Functional Genomics Center Zurich. Samples were 
analyzed on a LTQ-Orbitrap XL mass spectrometer (Thermo Fischer Scientific, Bremen, Germany) coupled 
to an Eksigent-Nano-HPLC system (Eksigent Technologies, Dublin, CA, USA). Solvent composition at the 
two channels was 0.2% formic acid, 1% acetonitrile for channel A and 0.2% formic acid, 80% acetonitrile 
for channel B. Peptides were resuspended in 3% acetonitrile and 0.2% formic acid and loaded on a self-
made tip column (75 µm × 70 mm) packed with reverse phase C18 material (AQ, 3 μm 200 Å, Bischoff 
GmbH, Leonberg, Germany) and eluted with a flow rate of 200 nl per min by a gradient from 3 to 10% of 
B in 5 min, 48% B in 55 min, 97% B in 60 min.  Full-scan MS spectra (300−2000 m/z) were acquired with a 
resolution of 60 000 at 400 m/z after accumulation to a target value of 500 000. 
Collision induced dissociation (CID) MS/MS spectra were recorded in data dependent manner in the ion 
trap from the six most intense signals above a threshold of 500, using a normalized collision energy of 
35% and an activation time of 30 ms. Charge state screening was enabled and singly charge states were 
rejected. Precursor masses selected twice for MS/MS were excluded for further selection for 120s. The 
exclusion window was set to 20 ppm, while the size of the exclusion list was set to a maximum of 500 
entries. Samples were acquired using internal lock mass calibration set on m/z 429.088735 and 
445.120025. 
 
Database search and protein identification 
The raw-files from the mass spectrometer were converted into Mascot generic files (mgf) with Mascot 
Distiller software 2.4.2.0 (Matrix Science Ltd.,London, UK). The peak lists were searched using Mascot 
Server 2.3 against the Giardia lamblia database (http://tinyurl.com/37z5zqp) with a concatenated decoy 
database supplemented with contaminants and The Arabidopsis Information Resource (TAIR9) protein 
database and the Swissprot database (to increase the database’s size). The final database included 79141 
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entries. The parameters for precursor tolerance and fragment ion tolerance were set to ± 5 ppm and 
± 0.8 Da, respectively. The identification results were loaded into Scaffold 3.0 (Proteome Software, 
Portland, US) and filtered for a minimal mascot score of 20 for peptide probability, a protein probability 
greater than 80% and a minimum of 2 unique peptides per protein.  
 
 
Text S2A: DAVID functional annotation clustering of data intersection  
Functional annotation clustering of the data intersection using the DAVID bioinformatics tool 
(http://david.abcc.ncifcrf.gov/home.jsp). For each cluster, the enrichment score is given at the top, and 
functional groups (left) and protein counts (right) within the respective cluster are listed. The 1059 
putative contaminants of the data intersection are categorized into 56 annotation clusters.  
 
This table is too large to be incorporated into this document. Information is available on request and will 
be available online as soon as the manuscript is published.   
 
 
Text S2B: DAVID functional annotation clustering of the G. lamblia genome 
Functional annotation clustering of the G. lamblia genome using the DAVID bioinformatics tool 
(http://david.abcc.ncifcrf.gov/home.jsp). For each cluster, the enrichment score is given at the top, and 
functional groups (left) and protein counts (right) within the respective cluster are listed. Clustering of all 
predicted proteins in the G. lamblia genome (5150 validated genes) using 10 random gene lists 
containing 3’000 genes each.  
 
This table is too large to be incorporated into this document. Information is available on request and will 
be available online as soon as the manuscript is published.   
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2. The Cre/loxP system in Giardia lamblia: genomic manipulations in a tetraploid 
protozoan  
This study represents a smaller part of my PhD work which I started in the third year. The project idea, 
designs and experimental strategies were developed by me and my direct supervisor Prof. Adrian B. 
Hehl, who supported me in all steps during this project.  
 
All experimental work was performed by me, except for some of the final analysis steps which were 
performed by Dr. Carmen Faso (figure 4C and figure 5 middle and bottom panels). Manuscript draft 
writing and figure assembly was performed by me with the support of Dr. Carmen Faso. The manuscript 
is currently prepared for submission.  
 
The combined results of this study and the main study of my PhD (Proteomics of secretory and endocytic 
organelles in Giardia lamblia) gave rise to two follow-up projects performed by Dr. Carmen Faso and 
Jacqueline Ebneter in our laboratory.  
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Abstract 
The bacteriophage P1-derived Cre/loxP system is a fascinating and valuable tool that has revolutionized 
genetic and cell biological research by making diverse genetic manipulations possible in a wide variety of 
organisms. The Cre recombinase efficiently mediates recombination between specific 34 bp-sized loxP 
sites, resulting in excision, insertion, inversion or translocation of loxP-flanked (floxed) DNA sequences. 
We implemented the Cre/loxP system in Giardia lamblia - an evolutionary diverged protozoan whose 
tetraploid genome organization severely limits the application of reverse genetic approaches to study 
molecular and cellular processes. We demonstrate that conditional expression of functional Cre 
recombinase can be used to recycle selectable markers in order to genetically fix insertions/deletions in 
G. lamblia chromosomes. Providing the means for more complex and versatile genetic manipulations, 
the Cre/loxP technique has the potential to significantly impact the investigation of gene and protein 
function in G. lamblia.  
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Introduction 
 Giardia lamblia is a fascinating and unique protozoan model to investigate minimal cellular 
mechanisms and explore eukaryotic diversity. This intestinal parasite is an early-diverged eukaryote that 
has undergone substantial reductive evolution to an even simpler organization than the predicted last 
common eukaryotic ancestor (1). Giardia has simplified molecular machineries for most cellular 
processes and metabolic pathways, and canonical eukaryotic organelles such as mitochondria, 
peroxisomes, and the Golgi have been minimized or even lost (2-4).  
 
The Giardia life cycle comprises a motile trophozoite stage which multiplies by binary fission in the gut of 
animal and human hosts and an environmentally resistant and infections cyst stage which is shed with 
the feces. As a member of the Diplomonad phylum, Giardia trophozoites have two diploid nuclei which 
are both transcriptionally active, making the cell effectively tetraploid (5, 6). While the binuclear state 
raises interesting questions about the emergence and functionality of each nucleus, Giardia’s tetraploid 
status restricts the application of genetic and cell biological approaches to investigate this intestinal 
parasite. This situation is further complicated by several additional factors:  
i) targeted insertion of linear DNA molecules by double cross-over is efficient in the WB isolate of G. 
lamblia which is the standard laboratory strain (7). However, chromosomal insertion of linear DNA 
occurs only in one of the two nuclei after transfection although both nuclei are able to harbor inserts (8);  
ii) the repertoire of suitable drug-resistance markers (7, 9-11) for the selection of transgenic parasite 
cells is limited;  
iii) most cells in culture are in G2 of the cell cycle, and it is unclear how this affects the efficiency of 
recombination events within a target nucleus. Accordingly, multiple transfections of transgenic Giardia 
lines are not routinely feasible. Nevertheless, co-transfected circular plasmids which contain multiple 
genes of interest and a single resistance marker can be selected as non-integrated episomes leading to 
co-expression of up to three heterologous proteins in the majority of transgenic parasites (12). However, 
the study of gene function remains limited: complex genetic manipulations requiring multiple 
chromosomal alterations such as gene knockouts have not been reported so far.   
 
 Given the challenge of manipulating a tetraploid genome, current strategies to deplete protein 
levels for functional analyses in G. lamblia primarily target mRNA production, stability, and accessibility 
to the translation machinery. The recently uncovered RNA interference machinery (13, 14) provides a 
useful but limited tool to investigate gene or protein function. Gene silencing by expression of antisense 
sequences (15, 16) or long-dsRNA using expression vectors (17, 18) has been reported. However, the 
outcome appears to depend largely on a series of factors such as the choice of expression vector, target 
RNA and length of the antisense-construct, thus resulting in highly variable knock down efficiencies (16, 
18). Reduction of target protein levels using hammerhead ribozymes or translation blocking morpholinos 
likewise result in considerable variation of downregulation of expression (19-21) or are not feasible at all 
because of the unusual mode of translation initiation in Giardia (22).  
 
In this report, we addressed the challenge of manipulating Giardia’s tetraploid genome to facilitate gene 
function analyses and cell biology studies in this fascinating protozoan by implementing the well-
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characterized Cre/loxP system (23).  Cre (causes recombination) is a 343 amino acid bacteriophage P1-
encoded enzyme that mediates DNA recombination at specific target sites termed loxP (locus of crossing 
over (x) in P1) (23). LoxP sites consist of 34 bp DNA sequences containing an 8 bp asymmetrical core 
flanked by two 13 bp inverted repeats (24). Depending on the relative orientation of two identical loxP 
sites with respect to one another, Cre mediates excision, insertion, inversion, or translocation of loxP-
flanked (“floxed”) DNA sequences (25). Within the last 30 years the Cre/loxP technology has been 
harnessed as a powerful research tool to tightly regulate the location and timing of genetic 
manipulations and it has been successfully applied to a wide variety of organisms including other 
protozoan parasites such as Toxoplasma gondii, Trypanosoma brucei and Plasmodium falciparum (26-
28).  
 
To test the feasibility of applying the Cre/loxP system to Giardia, we first determined if Cre is functionally 
expressed in this protozoan by testing Cre-dependent reconstitution of a green fluorescent protein 
variant (GFP)-encoding open reading frame (ORF) (29) interrupted by an mCherry-encoding expression 
cassette flanked by loxP sites (floxed). We could show that, following nuclear-targeted Cre-recombinase 
expression, the floxed mCherry cassette is correctly excised in transgenic parasites, resulting in GFP 
fluorescence. We then demonstrated that the Cre/loxP system can be successfully implemented for the 
removal of a floxed puromycin drug-resistance cassette in a chromosomally inserted expression vector, 
thus allowing for the “recycling” of the resistance marker in subsequent rounds of transfection of 
transgenic parent cell line.  
 
Taken together, the data presented in this report provide proof-of-concept for a considerably broader 
range of genomic manipulations in G. lamblia using the Cre/loxP system and demonstrate that gene 
knock outs are technically feasible in this tetraploid protozoan.  
Results 
Conditionally expressed Cre recombinase excises a floxed mCherry expression cassette and 
reconstitutes a split GFP ORF in G. lamblia  
To determine if Cre is functionally expressed in Giardia, we developed a reporter system based 
on Cre-dependent reconstitution of a green fluorescent protein (GFP)-encoding open reading frame 
(ORF) interrupted by a floxed mCherry-encoding expression cassette (GFPN-mCherryfl-GFPC, figure 1A).  
First, we generated a G. lamblia cell line stably transfected with the GFPN-mcherryfl-GFPC construct 
(figure 1A). Stable integration of the linearized construct into the intergenic region flanking the triose 
phosphate isomerase (TPI) gene (30) by double cross-over was confirmed by PCR and sequencing (not 
shown). We performed flow cytometry-based single cell sorting and collected red fluorescent transgenic 
cells in 96 well plates. Single cell-derived colonies were established in ~30% of all wells, indicating that 
roughly every third G. lamblia cell survived the procedure. Analysis of the single cell-derived colonies by 
live cell imaging (figure 2A) revealed that mCherry-expressing cells were viable. Flow cytometry 
demonstrated a 2.4-fold higher relative average fluorescence intensity and clear distinction of the 
transgenic parasite population compared with wild type control cells (figure 2B).  
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Figure 1: Schematic illustration of the Cre/loxP reporter system. (A) Cells are stably transfected with construct 
GFPN-mcherryfl-GFPC. In the absence of Cre recombinase, the construct encodes for a constitutively-expressed 
full-length ER-targeted mCherry. Black lines represent the site of genomic integration for construct GFPN-
mcherryfl-GFPC. pBiP: putative promoter sequence of GlHsp70/BiP; SP: secretory signal peptide coding sequence 
from GlHsp70/BiP; GFPN, GFPC: N- and C-terminal moieties of the GFP ORF; 3’: 3’UTR of GlCWP1; black arrow: loxP 
site; grey arrows: Oligonucleotides used for construct cloning (table S1). (B) The Cre-recombinase is encoded on a 
separate expression vector NEO-Cre. CWP1: cyst wall protein 1 (Gl5638); 3’ (green): 3’UTR of CWP1; pCWP1: 
putative CWP1 promoter region, NLS: nuclear localization signal; Cre-rec: Cre-recombinase; grey arrows: 
Oligonucleotides used for construct cloning (table S1). (C) Transient transfection of GFPN-mcherryfl-GFPC 
expressing cells with NEO-Cre followed by induction of Cre expression results in loss of the floxed mcherry 
expression cassette and reconstitution of a full length, constitutively-expressed, ER-targeted GFP ORF. Following 
excision, a single loxP site remains. Black lines represent the site of genomic integration for construct GFPN-
mcherryfl-GFPC. 
 
We introduced Cre into a cell line expressing a mCherry reporter by transfection of a circular, 
and therefore episomally-maintained, plasmid vector for conditional expression of nuclear-targeted Cre 
recombinase (construct NEO-Cre, figure 1B). Following G418-based selection of transgenic cells carrying 
the NEO-Cre- episome, we induced transient Cre expression by activating the cyst wall protein promoter 
for 1.5 h in encystation medium and placing the cells in standard culture medium again.  After 
propagation for 16 h to allow Cre-mediated reconstruction of the interrupted GFP ORF (figure 1C) we 
subjected the population to single cell sorting to generate clonal lines for analysis. PCR-based analysis of 
genomic DNA (gDNA) extracted from clonal lines demonstrated successful reconstruction of the GFP ORF 
in 6 of 10 selected recombinant cell lines (figure 2C). In addition, Cre-mediated functional reconstitution 
of the GFP ORF was verified for three single cell-derived colonies by immunofluorescence microscopy 
(figure 2D) and Western blot analysis (figure 2E) detecting GFP. Taken together, our data demonstrate 
that Cre recombinase expressed in G. lamblia is functional and can be used for specific excision of 
engineered floxed DNA fragments from chromosomes.  
Further PCR and DNA sequencing analyses of the GFP-positive, single cell-derived lines revealed that, 
although the GFP ORF had been reconstituted, the floxed mCherry cassette was still present (not shown). 
A possible explanation for this is that the floxed mCherry cassette was maintained in these cells in both 
integrated and circular form due to the presence of the Cre recombinase. This would have led to the 
establishment of an equilibrium between insertion and excision of the cassette (25, 31), maintained until 
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Figure 2: Cre mediated excision reconstitutes GFP expression. (A) The GFPN-mcherry-GFPC reporter line 
expressing mCherry prior to Cre-mediated removal of the floxed mcherry expression cassette. Live cell imaging 
by confocal microscopy shows red fluorescent trophozoites. Scale bars: 20 µm (left) and 2 µm (right). (B) Flow 
cytometry analysis reveals a 2.4-fold higher relative average fluorescence intensity for the mcherry reporter 
line (red, X-AMean = 2.94) compared to wild type trophozoites (grey, X-AMean = 1.21). X-AMean: arithmetic 
mean of the relative fluorescence intensity; X-Stdev: standard deviation of X-AMean. (C) Analysis of single cell-
derived colonies obtained from the GFPN-mcherryfl-GFPC reporter line after Cre-induction and single cell 
sorting. Primer pair 1746 and 1506 was used to check for the retention of the floxed mcherry cassette 
(expected product size ~ 1900bp) or the successful reconstruction of the GFP ORF (expected product size 
~780bp). 6 colonies out of 10 show a PCR product for reconstruction of the GFP ORF. N: negative control gDNA 
from wild type cells. P: positive control GFPN-mcherryfl-GFPC-encoding plasmid; M: size reference marker. (D) 
The reporter line after Cre-mediated removal of the floxed mCherry cassette. Wide field immunofluorescence 
microscopy depicting GFP-expressing cells. Scale bars: 20 µm (left) and 10 µm (right). (E) Western blot analysis 
confirms the presence of the GFP reporter (32 kDa) in three selected single cell-derived colonies that positive 
by PCR for GFP reconstitution (lines GG C3, D3, D5). The reporter is not detected in a GFPN-mcherryfl-GFPC 
(GmG) line that was negative by PCR for GFP reconstitution (GmG A10) nor in wild type control cells (WB). 
GmG: GFPN-mcherryfl-GFPC; GG: GFPN-loxP-GFPC; M: protein ladder.  
the episomal vector containing the cre gene is eventually lost in the absence of a positive selection. 
Given the stringent gating applied to the single cell sorting procedure the presence of cell lines 
originating from more than one cell was highly unlikely (figure S1).  
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Figure 3: Schematic illustration of the puromycin recycling strategy. (A) Cells stably transfected 
with construct Purofl-BiP-GFP encode for the reporter protein BiP-GFP downstream of a floxed 
puromycin resistance cassette. Black lines represent the site of genomic integration for 
construct Purofl-BiP-GFP. Puro: puromycin N-acetyltranferase; GDH: glutamate dehydrogenase 
(GL50803_21942); pGDH: GDH promoter; 3’ (orange): 3’ UTR of GDH; BiP: GlHsp70/BiP 
(GL80503_17121); pBiP: Hsp70/BiP promoter sequence; asterisk: KDEL encoding sequence; 
black arrow: loxP site; grey arrows: oligonucleotides used for PCR amplification of fragments 
(table S1). (B) The Cre-recombinase is encoded on a separate construct named NEO-Cre. CWP1: 
cyst wall protein 1 (GL50803_5638); 3’ (green): 3’UTR of CWP1; pCWP1: CWP1 promoter region, 
NLS: nuclear localization signal; Cre-rec: Cre-recombinase; grey arrows: oligonucleotides used 
for PCR amplification of fragments (table S1). (C) Loss of the floxed puromycin resistance 
cassette and maintenance of the BiP-GFP reporter after transient Cre expression in cell lines 
with integrated Purofl-BiP-GFP. Following excision, a single loxP site remains upstream of the 
BiP-GFP cassette. Black lines represent the site of genomic integration for construct Purofl-BiP-
GFP.  
Chromosomal excision of a drug resistance marker in a transgenic cell line using the Cre/loxP system  
In order to determine if the Cre/loxP system can be implemented for the removal of a drug-
resistance marker from the genome of stably transfected G. lamblia, we developed a reporter construct 
coding for a BiP-GFP expression cassette and a floxed puromycin resistance cassette (Purofl-BiP-GFP, 
figure 3A). The GFP reporter is under the control of the constitutive Bip promoter and targeted to the 
endoplasmic reticulum. We generated a G. lamblia cell line stably transfected with construct Purofl-BiP-
GFP (figure 3A); we confirmed stable integration into the intergenic region flanking the TPI gene by PCR 
and DNA sequencing. Expression of the BiP-GFP reporter was verified by fluorescence microscopy 
analysis (not shown). Since the expression level of the GFP reporter was variable within the cells of a 
population, we performed single cell sorting to select for the strongest BiP-GFP expressing clonal lines 
(figure S2).  
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Figure 4: Analysis of transgenic clonal lines obtained from a Purofl-BiP-GFP parent strain after Cre-induction 
und single cell sorting. (A) Primers used for PCR analysis to check for the excision of Puro (first panel), the 
presence of Puro (second panel), the position of Puro upstream of the BiP-GFP expression cassette (third 
panel), and the presence of Cre (fourth panel). The expected product size for each PCR reaction is indicated. 
(B) PCR analysis performed at 4 weeks post induction of Cre. All ten clonal cell lines analyzed show the PCR 
product for excised Puro (fist panel), presence of Puro (second panel), position of Puro upstream of BiP-GFP 
(third panel) and presence of Cre (fourth panel). (C) PCR analysis performed at 7 weeks post induction of Cre. 
All three clonal lines analyzed (A1, A6, C12) show the PCR product for excised Puro (first panel) and for the 
presence of Puro (second panel). None of the three strains analyzed shows a PCR product for Puro upstream 
of the BiP-GFP cassette (third panel) or for the presence of Cre (fourth panel).  
As previously described, we introduced Cre into clonal Purofl-BiP-GFP cell lines by transfecting the 
episome NEO-Cre (figure 3B) and selecting transgenic cells for resistance to G418. Transient expression 
of Cre was induced by a pulse of 1.5 hours in induction medium after which cells were cultured again in 
standard growth medium. Preliminary analysis of the Cre-pulsed population by PCR and DNA sequencing 
demonstrated successful excision of the floxed puromycin resistance cassette from the genome (not 
shown). The cells were grown for 21 days in the absence of G418 selection to promote loss of the NEO-
Cre episome. To obtain clonal BiP-GFP expressing cell lines with an excised puromycin cassette (figure 
3C), we used single cell sorting (figure S3). PCR analysis of gDNA extracted from 10 single cell-derived 
clonal lines performed 4 weeks post induction of Cre demonstrated successful excision of Purofl from the 
chromosomal DNA in all lines (figure 4, middle, top panel). However, further analyses demonstrated that 
all clonal cell lines still contained the puromycin resistance-encoding sequence (figure 4, middle, second 
panel) which, to a certain extent, was located upstream of the BiP-GFP expression cassette (figure 4, 
middle, third panel). The Cre-encoding sequence was also amplified in all cells (figure 4, middle, fourth 
panel), indicating that the episomal NEO-Cre vector was still present - even after 4 weeks of cell culture 
without selection. This result was in line with the data presented in the previous section, where we 
demonstrated episomal maintenance of the floxed mCherry cassette following Cre-mediated equilibrium 
even in the absence of positive selection for the NEO-Cre vector (25, 31).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PART IV     MANUSCRIPTS 
82 
Three clonal cell lines, A1, A6 and C12, were selected for further analysis and cultured in 
standard growth medium without antibiotic selection for 3 additional weeks. A repetition of the PCR-
based analysis of gDNA extracted from each line revealed a different picture. Successful excision of the 
floxed puromycin expression cassette (figure 4, right, first panel) as well as the persistence of the 
puromycin-encoding region (figure 4, right, second panel) was confirmed in all 3 lines. However, the 
puromycin-encoding region was not linked to the BiP-GFP expression cassette anymore (figure 4, right, 
third panel) and no Cre-encoding sequence was amplified (figure 4, right, fourth panel), indicating that, 
after several weeks of growth in non-selective culture medium, the NEO-Cre plasmid had been lost.  
Interestingly, the excised, floxed puromycin cassette appeared to be maintained as a non-integrated 
DNA element, most likely in the form of a small circularized DNA molecule (as excised by the Cre 
enzyme), despite the absence of any engineered origin of replication. We tested whether this non-
integrated element was able to confer resistance to puromycin by culturing lines A1, A6 and C12 in 
standard growth medium supplemented with 40 µg/ml puromycin, the concentration routinely used for 
selection of resistant cells in culture. After 3 days in selective medium, no viable cells were detected, 
whereas cell confluence was reached in non-selective medium (data not shown). This suggests that 
persistence of the circularized, episomally maintained puromycin cassette does not confer resistance to 
the antibiotic.  
Taken together, our data demonstrate that the Cre/loxP system can be applied to remove a 
floxed puromycin resistance gene after integration into the G. lamblia genome and re-establish 
sensitivity to puromycin. The Cre-recombinase mediates equilibrium between excision and insertion of 
the floxed DNA sequence. The equilibrium, however, is driven towards excision and stagnates upon loss 
of the Cre-encoding plasmid after 4-7 weeks rendering cells sensitive to puromycin again.  
 
Recycling of the transfected puromycin resistance allows the generation of dual reporter G. lamblia 
cell lines 
 We next tested whether we could re-utilize the puromycin selection marker in a subsequent 
transfection after excision of the previously stably integrated puromycin resistance cassette. To do this, 
we used clonal cell line A1 which constitutively expressed BiP-GFP as a parent cell line for transfection 
with constructs encoding either a mitosome reporter (GL50803_17161; construct PTom40HA) (32) or an 
ER exit site component (GL50803_9376; construct PSec23HA) (12), both tagged at the C’ terminus with 
an HA epitope. Expression of both reporter genes is driven by their respective promoter sequences (12). 
Both vectors carry a constitutively-expressed puromycin resistance cassette for selection of antibiotic 
resistant transgenic parasites. Line A1 was transfected according to established protocols and transgenic 
cells were selected using 40 µg/ml puromycin added to standard growth medium. Resistant cells were 
detected after ~5 days and were harvested at confluence for analysis by immunofluorescence 
microscopy. While the parent A1 line expressed only BiP-GFP (figure 5, top), the puromycin-resistant 
transgenic lines expressed in addition HA-tagged GlSec23 (figure 5, middle) or GlTom40 (figure 5, 
bottom). Both reporters localized at the appropriate subcellular structures, the ER exit sites or 
mitosomes, in the majority of cells (12, 33). This demonstrates that we could indeed re-utilize the 
puromycin resistance gene to generate novel dual reporter G. lamblia lines in a transgenic parent cell 
line expressing an ER marker (BiP-GFP) in combination with either a COPII subunit (GlSec23) or a 
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Figure 5: The puromycin 
resistance cassette can be re-used 
for further transfection rounds.  
Immunofluo-rescent antibody 
labelling and wide-field 
microscopy analysis of parent line 
A1 (upper panels) and secon-
darily transfected line A1 with 
either construct PSec23HA 
(middle panels) or PTom40HA 
(bottom panels). While parent A1 
cells present only BiP-GFP 
labelling of the ER (in red), trans-
fectants with both constructs 
present additional HA labelling (in 
green) localized either to ER exit 
sites (middle panels) or to 
mitosomes (lower panels). 
Nuclear DNA was labelled with 
DAPI and is shown in the merged 
images. Insets: DIC images. Scale 
bars: 2 µm.  
 
mitosome component (GlTom40). The experiment also shows for the first time that antibiotic sensitive, 
transgenic parent cell lines can be used for further genetic manipulation and expression of additional 
reporter proteins without negative effects.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Taken together, our data demonstrate how, following removal of a floxed puromycin resistance cassette 
with a short pulse of Cre recombinase expression, we successfully “recycled” the puromycin resistance 
cassette for subsequent episomal secondary transfections and establishment of dually transfected 
Giardia cell lines.  
Discussion 
 G. lamblia’s tetraploid status has severely hampered the application of reverse genetic 
approaches to study molecular and cellular processes in this parasitic protozoan. Currently, suitable 
strategies for the study of gene function in Giardia are restricted to gene overexpression using 
transfection of plasmid vectors (7, 9, 10), and mRNA-dependent knockdown by targeting mRNA 
production, stability, or accessibility of the translation machinery. Several knock down approaches have 
been reported, including the expression of antisense-sequences (15, 16) or long-dsRNA sequences (17, 
18), and the transfection with hammerhead ribozymes (19, 20) or morpholinos (21). However, 
inconsistent levels of down-regulation of expression have frequently been observed (16, 18-21). Since 
morpholinos are designed to bind their target mRNA in the region between the 5’cap and 25 nucleotides 
downstream of the translation start codon, the application of this tool in G. lamblia is challenging due to 
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the  unusually short 5’ untranslated regions (5’UTR) (34). Furthermore, targeting specificity is a challenge 
when dealing with gene families which may present very high levels of sequence similarity. This makes 
ribozyme and morpholino sequence design difficult and may confound phenotypic analysis. In addition, 
since morpholinos cannot be replicated, any phenotype resulting from their presence is not genetically 
sustainable. This implies that any ensuing analysis has to be performed within a very short time from 
morpholino delivery. Taken together, current strategies for loss-of-function studies in G. lamblia present 
several disadvantages and, in the best case, provide information only on the biological impact of reduced 
protein levels. This may not be sufficient to address questions concerning the exact role and function of 
abundant proteins.  
 
 To address the challenge of manipulating a tetraploid genome by physically targeting DNA 
sequences rather than depleting mRNA levels and/or functionality, we implemented the phage-derived 
Cre/loxP system (23) in G. lamblia. We demonstrated that Cre is functionally expressed in this protozoan 
species and that the Cre/loxP-based strategy can be successfully employed to remove a floxed 
puromycin resistance cassette from the G. lamblia genome. This allowed for “recycling” of a selectable 
puromycin resistance marker for a further transfection round of the same cell line.  
The implications for the effective removal and re-utilization of a genomically-integrated puromycin 
antibiotic resistance cassette are of crucial importance to Giardia researchers for at least four reasons:  
 
i) Given the limited number of antibiotic selection markers applicable to transgenic Giardia cultures (11), 
our Cre-based strategy permits repeated use of a single drug-resistance cassette. This opens up exciting 
opportunities for serial manipulations of the Giardia genome using a single selection marker. In this 
work, we demonstrated the feasibility of this approach by repeatedly transfecting transgenic parent lines 
using a single resistance marker. 
 
ii) Previous reports have shown how the maintenance of a constitutively-expressed puromycin resistance 
cassette causes off-target effects which include a partial de-regulation of G. lamblia differentiation (35). 
Therefore, Cre-mediated removal of the antibiotic resistance cassette allows for a less confounding 
evaluation of any transgene-related phenotype.  
 
iii) Taking this a step further, we can envisage the application of the Cre/loxP system and its variants (25) 
to the serial removal of any target gene, thus paving the way towards bona fide gene knock-out studies 
in G. lamblia, which are currently not feasible.  
 
iv) The generally high degree of sequence divergence in Giardia makes utilization of heterologous 
antibodies in cell biology research, even against proteins which are otherwise highly conserved across 
species (36), highly impractical. Here we provide an alternative to generating homologous antibodies in 
the form of transgenic, antibiotic sensitive parent cell lines which constitutively express organelle 
markers and can be super-transfected. 
 
 The main limitation when applying the Cre/loxP method to genomic manipulations in G. lamblia 
concerns stringent regulation of Cre recombinase expression once it is induced. We found that, in the 
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absence of positive neomycin-based selection, the Cre-encoding plasmid (NEO-Cre) was still present 
after more than 4 weeks in cultured cell populations. Although the Cre-encoding ORF was engineered 
downstream of a tightly-regulated inducible promoter, the persistence of even very few Cre molecules 
may decrease the overall efficiency of excision over (re-)integration by maintaining equilibrium between 
the two phenomena (25, 31).   
To address this challenge, Cre-recombinase could be electroporated as an enzyme directly into cells, 
similarly to restriction enzymes in the restriction mediated enzyme integration (REMI) technique (37). 
This would allow for a more rapid loss of recombinase activity as a result of protein turn-over and 
dilution during cell division. However, this may also result in an overall reduction in the efficiency of 
excision and would almost certainly require single cell sorting procedures to establish homogenous 
excised cell lines.  
Alternatively, Cre recombinase activity itself could be subject to regulation. Recently, Andenmatten and 
colleagues developed the DiCre system in T. gondii as an alternative strategy for induction of Cre activity 
(38). This method is based on the conditional expression of Cre as two separate subunits which are fused 
to either the FK506 Binding Protein (FKBP) or the rapamycin binding domain of mTOR (FRB), respectively 
(38). Rapamycin-dependent complexing of the FKBP-FRB moieties (39) results in dimerization of the two 
Cre-subunits and full Cre recombinase activity.  
 
In summary, by establishing the Cre/loxP system in Giardia and by demonstrating that this novel tool can 
be used to serially manipulate the parasite’s genome, we have reached a new milestone in genome and 
cell biological research of this tetraploid protozoan. We are convinced that the application of the 
Cre/loxP technique provides a powerful and novel means for more complex and versatile genetic 
manipulations in G. lamblia, and we predict that this method will significantly impact investigation of 
gene and protein function in this evolutionary diverged parasitic protozoan.  
 Methods 
Giardia cell culture and in vitro encystation 
Giardia lamblia WBC6 (ATCC catalog number 50803) trophozoites were grown under anaerobic 
conditions in 11 ml culture tubes (Nunc, cat. 156758) containing TYI-S- 33 medium supplemented with 
10% foetal bovine serum and bovine bile according to standard protocols (29). Parasites were harvested 
by chilling the tubes on ice for 30 minutes to detach adhering cells and collected by centrifugation (900 x 
g, 10 minutes, 4 °C).  
Encystation was induced using the two-step method as described previously (40) by cultivating the 
trophozoites in bile-free medium for 44 hours and thereafter in medium (pH 7.85) containing porcine 
bile.  
 
Cloning of expression vectors  
Construct GFPN-mcherryfl-GFPC: We designed an expression vector encoding the N-terminal half of GFP 
(GFPN, 270 bp) and the C-terminal half of GFP (GFPC, 447 bp) as described previously (41) and positioned 
a floxed mCherry-encoding expression cassette (mcherryfl) in the opposite orientation in between 
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(figure 1A). The two loxP sites were positioned in the same orientation to permit Cre-mediated excision 
of mcherryfl to reconnect GFPN and GFPC, which reconstitutes a full-length ORF for GFP (figure 1C). The 
G. lamblia Hsp70/BiP (GL50803_17121) putative promoter sequence including the N-terminal 116 bp 
region of the ORF, encoding also the secretory signal peptide, was placed upstream of ORFs GFPC and 
mcherryfl to achieve constitutive and high level expression of ER-targeted fluorescent reporter proteins. 
The cassette was ligated into the previously described vector pPacV-Integ using XbaI and PacI restriction 
sites (30). Oligonucleotides used for engineering of constructs are indicated in figure 1A and listed in 
table S1.  
 
Construct Purofl-BiP-GFP:  We used the previously described pPacV-Integ vector (30) and inserted two 
loxP sites in the same orientation on either side of the puromycin resistance (Puro) cassette. 
Downstream of the floxed Puro cassette, we placed an expression cassette for a Hsp70/BiP 
(GL50803_17121) promoter-driven C-terminal GFP fusion to the Hsp70/BiP (GL50803_17121) coding 
sequence. The GFP moiety was further modified at the 3’ end by including a 12bp Lys-Asp-Glu-Leu coding 
sequence to insert an ER-retrieval signal. This resulted in a constitutively-expressed BiP-GFP fusion 
predicted to be subject to ER retrieval. Oligonucleotides used for construct engineering are indicated in 
figure 3A and listed in table S1.  
 
Construct NEO-Cre: The Cre-recombinase encoding sequence (GenBank accession number NC_005856.1) 
was amplified from plasmid p116, a gift from Dr. Kurt Tobler (Institute of Veterinary Virology, University 
of Zurich, Switzerland). The Cre ORF was modified at the 5’ end by including a 18bp Lys-Lys-Lys-Arg-Lys-
Val coding sequence to insert a nuclear localization signal (42). To permit inducible expression of the Cre-
recombinase, the promoter sequence of G. lamblia cyst wall protein 1 (GL50803_5638) was positioned 
upstream of the Cre encoding region. The construct was ligated into the previously described RAN-neo 
vector using XbaI and PacI restriction sites (10, 29).  
 
Constructs PSec23HA and PTom40HA: Constructs PSec23HA encodes a C-terminally HA-epitope tagged 
variant of the ER exit site marker GlSec23 (Gl50803_9376) which is positioned downstream of its 
endogenous promoter sequence and carries a constitutively-expressed puromycin expression cassette. 
The construct was designed as described previously (12). Construct PTom40HA encodes a C-terminally 
HA-epitope tagged variant of the protein translocation channel (GL50803_17161), a component of the G. 
lamblia translocase of the outer membrane (TOM) complex localized in the outer mitosomal membrane 
(32). The Tom40 encoding sequence and its promoter region were amplified using oligonucleotides 1295 
and 1309 (listed in table S1) and the construct was inserted into the previously described vector pPacV-
Integ using XbaI and PacI restriction sites (30).  
 
Plasmid transfection 
pPacV-Integ based plasmids prepared from E.coli were linearized using Swa1 restriction endonuclease 
(16), and 15 µg of digested DNA was electroporated (BIO RAD Gene Pulser, 350V, 960 mF, 800 Ohm)  
into 3 x 10e6 freshly harvested trophozoites. Linearized plasmids were targeted to the G. lamblia triose 
phosphate isomerase (GlTPI) locus and integration occurred by homologous recombination under 
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selective pressure of the antibiotic puromycin (Invitrogen, cat. ant-pr-1) at a concentration of 40 µg/ml. 
Following selection of resistant clones, transgenic cell lines were maintained and analyzed without 
antibiotic. Stable transfection was confirmed by PCR on extracted genomic DNA (gDNA) resulting in 
~2000 bp amplicons spanning the predicted GI-TPI integration site for pPacV-Integ-derived constructs 
using the primer pair 1440 and 1441 (12). gDNA quality was assessed by PCR performed in parallel using 
primers 1460 and 1461, resulting in a 999 bp product which corresponds to the GL50803_9157 gene with 
its promoter sequence. Oligonucleotide sequences are listed in supplementary table S1.  
For episomal maintenance of the NEO-Cre plasmid, trophozoites were transfected with circular 
expression vectors which do not integrate into the genome of the WB isolate and grown under selective 
pressure with neomycin (Sigma, cat. G8168) at a concentration of 140 µg/ml.  
 
Oxidative GFP chromophore formation and single cell sorting  
5 x 10e7 mCherry or GFP-expressing trophozoites cells were harvested as described, resuspended in 1.5 
ml standard growth medium and transferred to 24 well plates (Sigma, cat. Z707791). Following 
incubation on ice for 16 h, oxygenated cells were harvested and protein folding was completed by 
incubation for 30 minutes at 37°C. The samples were washed once (900 x g) in PBS supplemented with 5 
mM glucose (Fluka, cat. 49139), 5 mM L-cysteine (Sigma, cat. C6852), and 0.1 mM ascorbic acid (Fluka, 
cat. 95209) at pH 7.1. The cell pellet was resuspended in 200 ul of supplemented PBS.  
Single cell sorting was performed on a BD FACSAriaIIITM cell sorter. For data acquisition and processing, 
BD FACSDivaTM software (version 6.3.1) was used. The sort was performed using a nozzle with a 100 
micrometer orifice diameter at 20 psi sheath pressure. GFP and mCherry were excited by a 488 nm and a 
561 nm laser, respectively, and emission was detected using 510/30 and 616/23 band pass filters. The 
cell populations were defined by a parent gate P1 based on FSC-A and SSC-A. An additional gate P2 
based on FSC-A and FSC-H was set to select for single events. GFP and mCherry positive cells were 
defined by gate P3 in the respective fluorescence channels. Wild type trophozoites were used as 
negative control. The cells were sorted into 96 well plates (Sigma, cat. Z707902) containing Giardia 
standard growth medium. Sorted cells were grown in anaerobic conditions in the presence of reducing 
agents (BD GasPakTM, cat. 260683). After 5 days, single cell derived clonal populations were transferred 
to 11 ml culture tubes (Nunc, cat. 156758) for further culturing and analysis.  
 
Transient activation of Cre-recombinase expression:  
After single cell sorting, strains Purofl-BiP-GFP and GFPN-mcherryfl-GFPC were transfected with the 
episomally maintained NEO-Cre vector. Transient activation of Cre-recombinase expression under the 
control of the tightly regulated, encystation-specific cyst wall protein 1 (CWP1) promoter was achieved 
by  incubating trophozoites in encystation medium for 1.5 h (40) before returning them to standard 
culture conditions. This interval is sufficient to generate a brief pulse of Cre-recombinase expression but 
not long enough for trophozoites to commit to encystation (40).  
 
Immunolabelling assay  
Chemical fixation and preparation for fluorescence microscopy was performed as described (3). Briefly, 
cells were washed with cold PBS after harvesting and fixed with 3% formaldehyde in PBS for 40 min at 
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20°C, followed by 5 minutes incubation with 0.1 M glycine in PBS. Cells were permeabilized with 0.2% 
Triton X-100 in PBS for 20 min at room temperature and blocked overnight in 2% BSA in PBS. Incubations 
of all antibodies were done in 2% BSA/0.2% Triton X-100 in PBS for 1 h at 4°C. The following antibodies 
were used in this work: FITC-conjugated anti-HA epitope (Roche Diagnostics GmbH, Manheim, Germany; 
dilution 1:50), Alexa594-conjugated anti-mouse (Molecular Probes, USA; dilution 1:300) and anti-GFP 
monoclonal (Clontech; dilution 1:300). Post incubation washes were done with 1% BSA/0.1% triton X-100 
in PBS. Labeled cells were embedded for microscopy with Vectashield (Vector Laboratories, Inc., 
Burlingame, CA, USA) containing the DNA intercalating agent 4'-6-Diamidino-2-phenylindole (DAPI) for 
detection of nuclear DNA.  
 
Microscopy and flow cytometry-based analysis 
Fluorescence analysis was performed either on a wide-field fluorescence microscope (Leica DMI 6000B) 
with LAS AF software (version 3.1.0) for data collection, or on a Leica SP2 AOBS confocal laser-scanning 
microscope (Leica Microsystems, Wetzlar, Germany) equipped with a glycerol objective (Leica, HCX PL 
APO CS, 63x, 1.3 Corr) and Leica Confocal software (version 2.61) for data collection. WCIF ImageJ 
(version 1.37c) was used for image processing.  
Flow cytometry-based analysis was performed on a BC GalliosTM flow cytometer with Gallios Software for 
data acquisition. GFP and mCherry were excited by a 488 nm and an external 561 nm laser, and emission 
was detected by 525/40 and a 620/30 band pass filters, respectively. Kaluza software (version 1.2) was 
used for data processing.  
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Supplementary material 
Figure S1: Single cell sorting of line GFPN-mcherry-GFPC after induction of Cre. Line GFPN-mcherry-GFPC was 
subjected to single cell sorting after induction of Cre (A). Wild type cells were used as a negative control (B). The 
cell population is defined by parent gate P1 (red, FSC-A/SSC-A scatter plot). Gate P2 (green, FSC-A/FSC-H scatter 
plot) selects for single events. GFP-positive cells were selected by gate P3 (blue, SSC-A/AlexaFluor 488 scatter plot).  
 
 
 
 
 
 
 
 
 
 
 
Figure S2: Single cell sorting of line Purofl-BiP-GFP before induction of Cre. Line Purofl-BiP-GFP was subjected to 
single cell sorting before induction of Cre (A). Wild type cells were used as negative control (B). The cell population 
is defined by parent gate P1 (red, FSC-A/SSC-A scatter plot). Gate P2 (green, FSC-A/FSC-H scatter plot) selects for 
single events. GFP-positive cells were selected by gate P3 (blue, SSC-A/AlexaFluor 488 scatter plot).   
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Figure S3: Single cell sorting of line Purofl-BiP-GFP after induction of Cre. Line Purofl-BiP-GFP was subjected to 
single cell sorting after induction of Cre (A). Wild type cells were used as negative control (B). The cell population is 
defined by parent gate P1 (red, FSC-A/SSC-A scatter plot). Gate P2 (green, FSC-A/FSC-H scatter plot) selects for 
single events. GFP-positive cells were selected by gate P3 (blue, SSC-A/AlexaFluor 488 scatter plot). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S1: Oligonucleotides used for construct engineering. The table includes oligonucleotide numbers (column 1), 
names (column 2), purpose (column 3), and sequence in 5’ to 3’ orientation (column 4). Restriction sites are 
indicated in bold face characters. Schematics for constructs and primer annealing positions are indicated in figures 
1 to 4.  
Primer 
number 
Primer name Used for Primer sequence (5’ to 3’ direction) 
936 CWP3p_Nhe_s Amplification of pCWP3-CWP3 (for 
construct CWP3-mcherryfl-GFP) 
GAGCTAGCGAGATAGGAGAATACTACCTG 
1142 Puro_seq_fw Check position of Puro upstream of 
BiP-GFP 
GACCACCAGGGCAAGGGTC 
1239 17121NSirev Amplification of pBiP-BiP (for construct 
Purofl-BiP-GFP) 
GGATGCATTTCTGCATAGTCGTACTCAGG 
1240 Sbf1GFPfw Amplification of GFP (for construct 
Purofl-BiP-GFP) 
ACCCTGCAGGCCCATAAAGGAGAAGAACT
TTTCAC 
1241 GFP_KDELpacrev Amplification of GFP (for construct 
Purofl-BiP-GFP) 
CGTTAATTAATTAGAGTTCATCTTTTTTGTA
TAGTTCATCCATGCCA 
1295 Tom40_HA_pac_rev Amplification of pendo-Tom40HA (for 
construct PTom40HA) 
CGTTAATTAATTACGCGTAGTCTGGGACAT
CGTATGGGTA CTTGTGATTGCTCGAA 
 
1309 Tom40_promo_s_xbaI Amplification of pendo-Tom40HA (for 
construct PTom40HA) 
CGTCTAGAGCCGCAGCCTCCACGATC 
1440 Integ.test for Confirmation of stable transfection CAAGATACTACACTCGTTGTTAATGTG 
1441 Integ.test rev Confirmation of stable transfection GGGCTTGTACTCGGTGCCCAT 
1460 p9157_XbaI_s Quality control of genomic DNA CGTCTAGAGATCAGCGCGTCTAATGGCGT
G 
1461 9157_SphI_as Quality control of genomic DNA GAGCATGCTGCGGATACTTCGTAGTTCCGT
AG 
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Primer 
number 
Primer name Used for Primer sequence (5’ to 3’ direction) 
1476 GFPN_SbfI_s Amplification of GFP N-terminal part GACCTGCAGGATGCATAAAGGAGAAGAAC
TTTTCAC 
1477 GFPN_loxP_as Amplification of GFP N-terminal part ATAACTTCGTATAATGTATGCTATACGAAG
TTATCTCAGGCATGGCGCTCTTG 
1506 GFP_PacI_as_longer Amplification of GFP C-terminal part CCTTAATTAACTATTTGTATAGTTCATCCAT
GCCATG 
1533 Cre_NLS_NsiI_s Amplification of Cre, check for 
presence of Cre 
GAATGCATATGAAGAAGAAGCGCAAGGTG
TCCAATTTACTGACCGTAC 
1534 Cre_PacI_as Amplification of Cre, check for 
presence of Cre 
CGTTAATTAACTAATCGCCATCTTCCAGCA
G 
1544 17127fwquant  CACTCTAACGTGCTGACAGT 
1556 GFPC_loxP_NsiI_s Amplification of GFP C-terminal part CGATGCATATAACTTCGTATAGCATACATT
ATACGAAGTTATTAGGATACGTGCAGGAG
AGGAC 
1585 GDH5UTR_NsiI_s Amplification of the puromycin 
resistance cassette from a previously 
used plasmid (Stefanic et al., 2009), 
check for presence of Puro 
CGATGCATGAAGCGCTGACCACAAATAAC 
1586 GDH3UTR_XbaI_loxP_a
s 
Amplification of the puromycin 
resistance cassette from a previously 
used plasmid (Stefanic et al., 2009) 
CGTCTAGAATAACTTCGTATAATGTATGCT
ATACGAAGTTATGAATTCGAGCTCGGTACC
AG 
1590 p17121_XbaI_s Amplification of pBiP-BiP (for construct 
Purofl-BiP-GFP)  
CGTCTAGAGACGGTCGTCCCTATCGTAATG 
1602 3'UTR_XbaI_SphI_as Amplification of mcherry CGTCTAGAGCATGCCGTTTGTTTACTCACTC
GTG 
1604 pBiP_NsiI_s Amplification of pBiP-LS CGATGCATGTCGTCCCTATCGTAATGCAG 
1605 BiP_LS_Afl2_as Amplification of pBiP-LS GTCTTAAGGTTGGGGATGATCTCCACTTG 
1606 mcherry_Afl2_s Amplification of mcherry GTCTTAAGATGGTGAGCAAGGGCGAGGA
G 
1655 Puro_seq_as Check for presence of Puro GTGAGGAAGAGTTCTTGCAG 
1722 RS1_s Check for excision of Puro CTGCAGTTGCATTCGCTACAATGCTG 
1760 BiP-LS_AvrII_as Check for excision of Puro, check 
position of Puro upstream of BiP-GFP 
GCCCTAGGGTTGGGGATGATCTCCACTTG 
1799 CWP3_loxP_SphI_as Amplification of pCWP3-CWP3 (for 
construct CWP3-mcherryfl-GFP) 
GAGCATGCTAATAACTTCGTATAATGTATG
CTATACGAAGTTATTCTGTAGTAGGGCGGC
TGTATC 
1800 mcherry_SphI_s Amplification of mcherry (for construct 
CWP3-mcherryfl-GFP) 
GAGCATGCGTGAGCAAGGGCGAGGAGGA
TAAC 
1801 CWP-3'UTR_NruI_as Amplification of mcherry (for construct 
CWP3-mcherryfl-GFP) 
CGTCGCGATGTAAATGCATGAACTGTTCAA
AGAGCCGTTTGTTTACTCACTCGTGGCTAC 
1802 GFP_loxP_NruI_s Amplification of GFP (for construct 
CWP3-mcherryfl-GFP) 
CGTCGCGAATAACTTCGTATAGCATACATT
ATACGAAGTTATTACATAAAGGAGAAGAA
CTTTTCACTG 
1803 GFP_PacI_as Amplification of GFP (for construct 
CWP3-mcherryfl-GFP) 
CGTTAATTAACTATTTGTATAGTTCATCCAT
GCCATG 
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PART V DISCUSSION AND PERSPECTIVES 
1. Discussion 
1.1. General 
Encystation-specific vesicles (ESVs) are key organelles in the G. lamblia life cycle. The stage-specifically 
induced secretory organelles are responsible for accumulation, maturation, sorting and regulated 
secretion of the Giardia cyst wall material (CWM). The CWM (protein and carbohydrate) is secreted 
across the plasma membrane and deposited on the parasites surface where it forms a protective 
composite biopolymer that confers resistance to harsh environmental conditions. Being a critical 
component for Giardia’s survival before infection of the next host, ESVs and associated proteins 
constitute potential drug targets. However, only little information about their structure, composition, 
neogenesis and functionality is available so far.  
Due to Giardia’s extensive ER 1 previous cell fractionation attempts to identify organelle-specific proteins 
have been hampered by the consistent contamination of mass spectrometry datasets with ER-derived 
proteins 2, 3. To improve the specificity of the method, i.e. to increase the identification of organelle-
specific hits, we attempted a conceptually new approach: Using flow cytometry we simultaneously 
sorted fluorescently labeled ESVs and a second set of organelles, the peripheral vesicles (PVs), using a 
mixed microsome fraction as starting material. Since simultaneous enrichment entails the same 
contaminating protein background in both fractions, we removed this large majority of hits from the 
mass spectrometry datasets by an in silico filtration procedure (Wampfler and Hehl, under review).  
 
Our global aims were to i) develop this novel approach and obtain an ESV proteome dataset enriched in 
organelle-specific factors,  ii) identify new ESV-associated proteins which might help us to iii) gain novel 
insight into the genesis, composition and functionality of these unusual secretory organelles.   
 
Using a novel, combined approach we identified and removed a tremendous number of proteins (1059, 
i.e. ~90% of the combined datasets) which were common to both, ESV and PV organelle fractions. 
Analysis of the eliminated hits revealed a massive proportion of contaminating proteins, the majority 
being chaperones and factors from the ribosome/translation machinery. Based on previous attempts 2, 3, 
this result was expected and in line with our idea to increase the specificity of ESV and PV organelle 
datasets by subtraction of overlapping hits.  
By removing these contaminants, we obtained a set of 72 ESV organelle and 82 PV organelle candidates. 
Surprisingly, partial validation of the ESV-organelle dataset by subcellular localization of 16 tagged 
candidates revealed many ER-derived proteins rather than novel ESV-specific factors: 11 proteins (69%) 
showed distribution consistent with ER, and 5 thereof (31%) were also detected in ESVs. Of the five 
proteins localizing to both, the ER and ESVs, none was exported to the surface of the cell during the 
deposition of the cyst wall. In contrast, partial validation of the PV-organelle dataset by subcellular 
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localization studies of 8 candidates uncovered 3 (38%) clearly PV-associated proteins and two (25%) 
additional PV proteins which also have secondary localization.  
 
The main conclusions we draw from this project were that i) our novel combined strategy is a powerful 
instrument to discover organelle-specific factors but seems to strongly depend on clean separation of 
target organelles from their subcellular context during mechanical fractionation of the cells; ii) A strong 
physical connection between ESVs and the ER exists, whereas PVs seem to maintain a more discrete 
compartment identity and have a distinct set of organelle-specific proteins; iii) In line with previous 
transcriptomic analysis of encysting trophozoites 4, CWP1-3 are most likely the only highly abundant and 
stage-specifically expressed cyst wall proteins secreted via ESVs; and iv) ESV neogenesis and maturation 
appears to be driven primarily by inherent properties of the cargo proteins themselves with the 
assistance of few co-factors, if any. Our conclusions are discussed in more detail hereinafter.  
 
1.2. Organelle identities: The critical factor for the success of the dual sorting approach   
The most crucial steps in organelle proteomics are cell disruption and generation of a mixed microsome 
fraction (a compromise between efficient liberation of organelles from the cellular context and limitation 
of damage to the membrane bounded organelle), followed by the purification or strong enrichment of 
the target organelle by a subcellular fractionation procedure. Frequently used techniques are affinity-
based isolation, density gradient centrifugation, free flow electrophoresis, and more recently also flow-
cytometry 5-8. However, despite considerable efforts to optimize purification protocols, proteins of 
subcellular origin distinct from the target organelle are persistent contaminants in proteomic datasets 2, 
3. In order to overcome these limitations, various in-silico strategies have been developed that allow the 
elimination of many false-positive hits from organelle proteomic datasets 3, 9.  
 
In our study, positively sorted droplets formed by the nozzle in the flow cytometer contain one 
fluorescently labeled organelle. However, the organelle is basically suspended in a liquid containing a 
vast array of cell debris including resealed membrane microsomes, membrane sheets, and other small 
debris as well as soluble proteins. Simultaneous sorting of two differentially labeled organelles from this 
same mixed microsome fraction allowed us to identify these contaminating proteins by mass 
spectrometry analysis and subtract them from the organelle datasets (Wampfler and Hehl, under 
review).  
In line with this idea, the vast majority of proteins was detected in both organelle-enriched samples and 
was enriched in factors associated with ribosomes and the protein translation machinery and highly 
abundant ER chaperones. However, the subsequent partial validation of the two organelle datasets by 
subcellular localization of candidates using fluorescence microscopy revealed an unexpected result: 
whereas several new PV-associated proteins could be confirmed, most of the candidate ESV proteins 
localized to the ER.   
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This result is most likely explained by the different subcellular contexts of the two organelles. PV 
organelles localize to the cortical layer just below the plasma membrane into which the ER network does 
not extend 10, which presumably makes separation from their subcellular context more efficient during 
cell disruption. In contrast, the physical separation of ESVs from their subcellular context might be 
severely hampered by their close connection with the ER, resulting in co-purification of ER-derived 
membrane fragments and associated proteins during ESV-organelle sorting. The close association of the 
ER and ESVs begins when ESVs are synthesized de novo at ER exit sites and obtain a massive amount of 
cargo from the ER 11, 12. The two organelles exchange proteins in a COPI and COPII dependent manner 2, 11 
and are probably even connected via an extensive network of tubular membranes 11. Electron 
microscopy data clearly demonstrate that membrane continuities between the ER and even mature ESVs 
exist (Wampfler and Hehl, under review, 13-15). Consistent with this, proteasomes and ribosomes are not 
only found at ER- but also at ESV membranes (Wampfler and Hehl, under review, 2).  
 
Our data demonstrate that the simultaneous organelle sorting approach is a useful approach for the 
discovery of novel organelle-specific proteins but strongly depends on the subcellular context of the 
target organelles. In addition, our data provide additional evidence for a strong physical connection 
between the ER and ESVs.  
 
1.3. CWP1-3 comprise the only major, stage-specifically expressed cyst wall components  
A specific, organelle-defining protein localizing exclusively to ESV at 13 hours post induction (p.i.) of 
encystation presupposes that its expression in trophozoites is basically zero but induced during 
encystation. Thus far, only the three cyst wall proteins (CWP1-3) fulfill these criteria.  
A microarray study on the transcriptional regulation of gene expression in encysting Giardia trophozoites 
revealed that not more than 18 genes are significantly up-regulated during the early phase of 
encystation, i.e. the first 7 hours 4. The small gene set includes factors known to play a role in 
encystation, such as CWP1-3, a transcription factor termed Myb1-like protein 4, and several enzymes 
required for the synthesis of the unique cyst wall glycan 16, 17. Another study investigated the 
transcriptional response during the entire Giardia life cycle using serial analysis of gene expression 
(SAGE) 18. A group of 42 genes was found to be upregulated during the entire process of encystation, i.e. 
>24h after induction. The two studies differed significantly in the mode of induction of encystation and 
other parameters but nevertheless identified 8 genes in common, including the CWPs and factors 
required for the cyst wall sugar synthesis. The small number of transcriptionally regulated genes 
reported by these studies suggests that with the exception of massively regulated CWPs, only relatively 
small adjustments in mRNA expression are required for encystation.  
Comparison of the 72 candidate ESV organelle proteins identified in this proteomics study with the 
upregulated genes revealed only one candidate in common: the synaptic glycoprotein 2. We detected 
this protein of unknown function in the ER at 13 hours p.i. (Wampfler and Hehl, under review).  
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Although some encystation-specific factors are clearly regulated on the level of mRNA abundance, post-
transcriptional regulation of gene expression seems to play an important role as well 19. An example is an 
EGF-like cyst protein 1 (EGFCP1) which is trafficked, together with CWPs, via ESVs to the surface of the 
cell 20. Surprisingly, the EGFCP1 transcript level significantly decreases during encystation, whilst the 
protein level increases, suggesting changes in translation rate, protein half-life or protein turnover. In 
addition to this one example, a recent large-scale proteomic study uncovered several hundred proteins 
that are differentially expressed during encystation, with the major changes occurring at early time 
points 19. Compared to the trophozoite stage, 362 proteins were more abundant at 4 hours post 
induction (analysis not shown). Between 4 and 8 hours p.i., 85 proteins were differentially regulated. The 
lowest change was observed between 8 and 12 hours p.i. with only 7 upregulated proteins. Although this 
was a study attempting to identify the whole proteome of encysting cells, a comparison of the 72 
candidate ESV proteins with these post-transcriptionally upregulated genes revealed 10 candidates in 
common, including 3 hypothetical proteins, a ribosomal protein, the dynein heavy chain, a putative 
importin alpha subunit, a nucleotide-triphosphate hydrolase (NTPase), an Hsp70-binding protein, a 
phosphatase, and a calcium-binding protein. We further investigated the calcium-binding protein and 
found it with a cytosolic distribution at 13 hours p.i. in fluorescence microscopy experiments (Wampfler 
and Hehl, under review).  
 
Based on our finding that none of the remaining candidate ESV proteins were transcriptionally induced 
during encystation 4, 18 we did not expect to find any stage-specifically expressed proteins localizing 
exclusively to ESVs among them. However, we cannot exclude the existence of low abundance, stage-
specifically regulated ESV-proteins that are not contained in our proteomic dataset, since their detection 
by shot gun mass spectrometry remains challenging. Some of the remaining candidates in our ESV 
dataset were upregulated on a post-transcriptional level during encystation 19 but are also expressed at 
significant levels in trophozoites 21. Their analysis might bring to light additional proteins that are 
recruited to ESVs during encystation from primary localizations (e.g. the ER) in proliferating trophozoites.  
Altogether, our data provide strong indications that CWP1-3 are indeed the only highly abundant and 
completely stage-specifically expressed cyst wall components secreted via ESVs during encystation. Our 
results agree with previous data suggesting the formation of a minimal extracellular matrix in G. lamblia.  
 
1.4. A proposal for cargo-driven ESV neogenesis  
The lack of novel, ESV-specific protein candidates detected in this study suggests that ESV 
morphogenesis might be driven by a simple mechanism such as accumulation of cargo rather than by 
organelle-specific machinery, similar to the formation of dense-core secretory granules (DCSG) in 
eukaryotic cells.  
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DCSG comprise a key component in regulated exocytosis and are found in a wide variety of specialized 
eukaryotic cells. They are investigated in greatest detail in mammalian endocrine or exocrine cells where 
they act as intermediate storage compartments containing densely packed hormones or proteases and, 
in response to specific stimuli, fuse with the plasma membrane to release their contents 22, 23. DCSG 
share, by definition, a core of electron dense material that appears dark in electron micrographs and 
granule maturation is often associated with proteolytic processing of cargo, for example cleavage of pro-
insulin to insulin 23, 24.  
Initially, two models have been proposed for the formation of DCSGs: The sorting-by-entry model, which 
is based on specific cargo selection by a membrane receptor 25-27, and the sorting-by-retention model, 
which describes the formation of immature granules containing both, granule-specific and unspecific 
cargo, while unspecific cargo is progressively removed from the granule via vesicle mediated trafficking 
27.  
The investigation of DCSG in organisms other than mammals has led to a steadily increasing number of 
secretory granules that do not conform to any of the two models, and there has been a lot of debate on 
where in the cell the granule cargo is actually sorted 23. The diversity of secretory granules seems to be 
much more complex than originally thought. Nevertheless, protein sorting into most DCSG investigated 
to date appears to be associated with three features (figure 10) 23: There are (i) membrane traversing or 
membrane-associated tethers, which in some cases recruit coat proteins on their cytoplasmic side, (ii) 
tether-associated cargo which is either captured directly or bound via linker proteins, and (iii) cargo 
components that have an inherent tendency to multimerize or aggregate and form condensed cores.  
 
Figure 10: Model of protein sorting into DCSGs 
23
. 
DCSG proteins can be divided into three groups: 
There are (i) thethers (red) that traverse or 
associate with the membrane, (ii) cargo proteins 
that associate with the membrane tethers, and 
(iii) cargo proteins that aggregate and form a 
dense core (blue). The core can be composed of 
several proteins. The yellow boxes indicate the 
different protein domains that have been 
involved in cargo sorting, and the white boxes 
indicate examples of cargo proteins.  
 
 
CWP1-3 comprise the basic features required for ESV formation. (i) ESV formation at ERES has been 
shown to require the COPII-coat machinery 11, 12. Because CWPs are soluble proteins, this suggests the 
presence of a membrane-spanning receptor which recruits COPII-coat proteins at the cytoplasmic side 
and selects CWPs in the ER lumen. A putative sorting signal for this receptor comprises the N-terminal 
region of CWP1, which was shown to be required to induce ESV formation in Giardia 28. Alternatively, but 
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less likely, CWPs might act as membrane-tethers themselves by insertion of alpha-helical domains into 
the lipid bilayer or interact with modified membrane lipids, respectively. A dual role of proteins acting as 
both membrane tether and granule cargo is frequently observed 29-31 and would, in the case of CWPs, 
explain why no membrane receptor has been identified to date. (ii) CWP1 and the long processed 
domain of CWP2 are ESV cargo proteins that aggregate but are completely excluded from the dense 
core. These proteins build covalent complexes via rapid disulfide-crosslinking and isopeptide bonds 28, 32-
34, but remain in a fluid phase during ESV maturation and formation of a dense core 35. (iii) CWP3 has an 
inherent tendency to aggregate and to form a condensed core in maturing organelles together with the 
small cleaved domain of CWP2 35. Consequently, CWPs share basic hallmarks with most DCSG cargo from 
ciliates or animal cells 23.  
 
The current data suggest the requirement of only simple (highly reduced) machinery driving ESV 
morphogenesis and maturation during the first 13 hours of encystation. According to the most basic 
scenario, CWPs induce formation of COPII transport intermediates by their inherent property to 
aggregate. In line with this, several microscopy studies suggest but could not definitively prove that ESVs 
are formed by progressive aggregation of electron-dense material in membrane-bounded compartments 
until large organelles were formed 13, 32, 36. More recent studies show nucleation of ESVs in close 
proximity to ER exit sites 12.  
The basic requirements for ESV morphogenesis by simple cargo aggregation are fulfilled; CWP3 was 
shown to form a condensed core 35, whereas CWP1 and CWP2 are known to undergo fast cross-linking 
via disulfide and isopeptide bonds 28, 32-34. That inherent properties to aggregate might play a major role 
in ESV formation was suggested by data from several independent studies. Reiner and colleagues 
showed that the presence of dithiotreitol (DTT), which reduces disulfide bonds, leads to abandonment of 
ESV formation in trophozoites triggered for encystation and even disappearance of ESVs in already 
encysting trophozoites 33. The reducing effect was reversible, since ESVs reappeared within minutes after 
removal of DTT. A more recent study did not confirm the disappearance of ESVs upon DTT treatment but 
showed that cross-linking of CWPs directly correlates with the morphology of the organelles: the authors 
observed a change in ESV compartment morphology from spherical to elongated, which was almost 
completely reversed after DTT was washed out 2. Further, Davids and colleagues demonstrated the 
reduction of ESVs formation upon treatment with cystamine, an inhibitor of isopeptide-forming 
transglutaminases 34.  
 
These data demonstrate that cross-linking of CWPs indeed is a key step in ESV morphogenesis and 
probably maintenance, and eventually is even sufficient to drive the entire process. In support of this 
scenario, co-expression of CWP1 and CWP2 in human embryonic kidney cells was shown to be sufficient 
to induce the formation membrane-enclosed vesicles which traffic the proteins to the cell surface 
(Abdul-Wahid 2004). This phenomenon is frequently observed upon ectopic over-expression of DCSG 
PART V     DISCUSSION AND PERSPECTIVES 
100 
Figure 11: Synthesis of the Giardia cyst wall sugar homopolymer 
16
. The precursor UDP-GlcNAc 
(left) is synthesized from endogenous glucose by a series of cytoplasmic enzymes. The precursor 
is converted into the cyst wall sugar monomer UDP-GalNAc (middle) by an as yet unidentified 
UDP-GlcNAc-4’-epimerase (GALE). The cyst wall sugar monomer is polymerized to the cyst wall 
sugar β-(1,3)-GalNAc polymer (right) by an as yet unidentified enzyme termed cyst wall synthase 
42
. UDP: Uridine diphosphate; GlcNAc: N-acetyl-glucosamine; GalNAc: N-acetyl-galactosamine.  
cargo proteins, such as pro-vasopressin, chromogranin A, or von Willebrand factor in non-granule 
forming cells and strongly suggests that the cargo proteins themselves induce the formation of their 
proper carriers 37-39.  
 
1.5. Where does the cyst wall sugar component join the game?  
Considering its environmental resistance, the Giardia cyst wall is a biopolymer with a surprisingly simple 
composition consisting of three proteins (CWP1-3) and a β(1‐3)‐GalNAc homopolymer 40, 41. The sugar 
component constitutes about 60% of the cyst wall mass and is synthesized from UDP-GalNAc monomers 
by an as yet unidentified cyst wall synthase 42. While the CWPs are trafficked via ESV organelles to the 
surface of the cell, it is still unclear where and when the sugar component is synthesized, how it reaches 
the cell surface and how it is finally incorporated into the cyst wall. 
It was proposed that UDP-GalNAc is synthesized from glucose in the cytosol by a series of enzymes that 
are upregulated during encystation (figure 11) 16. The final step in synthesis of the monomer involves an 
UDP-GlcNAc-4’-epimerase (GALE) that converts a precursor, UDP-GlcNAc, to UDP-GalNAc 43. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Although experimental data showed that the enzyme converts UDP-GlcNAc into UDP-GalNAc, the theory 
has a critical weak point because kinetic analysis revealed that the reverse reaction is clearly favored 44. 
This raises significant doubts on the productive synthesis of the cyst wall monomer UDP-GalNAc by the 
proposed enzyme. Moreover, the synthesis of the cyst wall sugar in the cytosol would imply a 
transporter either in any organellar membrane (ER, ESVs, PVs) or the plasma membrane so that the 
sugar component reaches the cell surface – but an UDP-GalNAc transporter has not been identified in 
Giardia 45, and neither has a β(1‐3)‐GalNAc polymer transporter.  
The lack of a lectin that specifically binds the unique β(1‐3)‐GalNAc polymer makes the investigation of 
the cyst wall sugar component challenging. A recent study demonstrated that CWP1 binds the GalNAc 
polymer of the Giardia cyst wall and used recombinant CWP1 to detect the sugar polymer 46. Based on 
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these data, the authors suggested that the GalNAc polymer is made in vesicles distinct from ESVs and 
secreted early to the surface of encysting Giardia 46. Although the idea of using CWP1 as a probe for 
detection of the sugar polymer is clever, the lack of control experiments and the presence of 
endogenous CWP1 in addition to epitope-tagged markers makes the interpretation of these data 
problematic.  
Another study used the Dolichos biflorus agglutinin (DBA) to detect the GalNAc polymer 47. Although the 
seed lectin has a much higher specificity for α-linked GalNAc, it can be generally considered as GalNAc-
specific 48. Although the data was of limited quality and not conclusive, Midlej and colleagues suggested 
that vesicles distinct from ESVs mediate transport of carbohydrate and perhaps also the GalNAc 
component to the surface of encysting cells 47.  
 
In our study, two proteins in the ESV dataset attracted our attention since they might be involved in cyst 
wall sugar synthesis and transport: Giardia’s only nucleotide sugar transporter 49 which specifically 
transports cytosolic UDP-GlcNAc into the ER 45, and a putative UDP-GlcNAc-4’-epimerase which might 
convert UDP-GlcNAc into UDP-GalNAc (Wampfler and Hehl, under review). We detected the epimerase 
in the ER, whereas the transporter localized mainly to the perinuclear ER as well as to ESVs.  
While there is strong support for import of UDP-GlcNAc into the ER for N-glycosylation, the presence of 
the epimerase producing UDP-GalNAc in the ER is intriguing; N-glycosylation in Giardia is restricted to 
addition of GlcNAc1-2 to asparagine 
50, hence a role of the epimerase in glycosylation is out of the 
question. One interpretation of our data is the involvement of the epimerase in UDP-GalNAc production 
for later cyst wall synthesis. This entails that the sugar component is either trafficked via separate 
vesicles to the surface of the cell, as suggested earlier 47, or reaches the surface via ESVs together with 
the CWPs.  
 
1.6. Dense core secretory granules and the formation of extracellular matrices in protozoa  
Dense-core secretory granules (DCSG) are found in many distantly related species and play important 
roles in diverse processes. The best characterized granules are those from animal endocrine or 
neuroendocrine cells, such as insulin-storage granules in pancreatic β-cells, or granules storing 
chromogranin A in chromaffin cells of the adrenal glands 23. Besides DCSG of metazoa, the best 
investigated are those from ciliates, particularly the ones found in Tetrahymena termophila and 
Paramecium tetraurelia 53, 54. Ciliate DCSG are often called toxicysts and release molecules that are used 
for hunting, as for example in catching and killing prey, or as defense mechanism against predators 55. 
The social amoeba Dictyostelium discoideum secretes material via DCSG to form a resistant spore wall in 
order to survive extreme environmental conditions 56-58. Even the phylogenetically most basic eukaryotic 
lineages possess DCSG. Similar to Giardia, Entamoeba 59-61 as well as apicomplexans such as Eimeria and 
Toxoplasma in their sexual stage 62 secrete components via DCSG to build environmentally resistant cysts 
or oocysts, respectively, which play a key role in surviving outside of the host. Invasive stages of Eimeria 
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and Toxoplasma synthesize three different secretory granules termed micronemes, rhoptries, and dense 
granules, and secrete their contents sequentially during and after host cell invasion 63-66.  
Three examples of secretory granule biogenesis and the formation of protective extracellular matrices in 
protozoa are discussed in more detail below: the oocyst wall formation in E. maxima, encapsulation of  
T. termophila, and encystation of E. invadens.  
 
Oocyst wall formation in Eimeria maxima  
Similar to Giardia, coccidian parasites such as Eimeria and Toxoplasma rely on the synthesis of a robust 
oocyst wall for their fecal-oral transmission from host to host. E. maxima stores the material for oocyst 
wall formation in three specific organelles which are developed during the parasite’s sexual, 
macrogamete stage: the veil forming bodies (VFB) and the wall forming bodies type 1 (WFB1) and type 2 
(WFB2) 67, 68. The oocyst wall is formed upon sequential release of the contents of these organelles and 
was described in detail by Ferguson et al. 69.  
VFB secrete their contents already in an early macrogamete stage, giving rise to a loose veil around the 
oocyst. WFB1s and WFB2s are synthesized only during macrogamete maturation (figure 12). WFB1s are 
large spherical compartments and contain electron-dense material 62. They emerge during macrogamete 
maturation and locate to the peripheral cytoplasm, but the origin of the organelles or how their contents 
are trafficked, respectively, was never determined 62. WFB2s are less electron-dense and develop as 
dilations of the rough ER. In early stages of macrogamete maturation they have amorphous content 
which later develops into a characteristic, electron-dense and doughnut-shaped structure 62. The WFB2s 
remain enclosed in the rough ER during macrogamete maturation. In the mature macrogamete both, the 
WFB1s and WFB2s, locate to the periphery of the cell (figure 12, g). Whether the WFB2s emerge directly 
from the rough ER or if their content is transported via the Golgi to the peripherally located organelles 
was never determined 69. The oocyst wall material is secreted sequentially when the mature 
macrogamete is fertilized by a microgamete and develops into a zygote. Fusion of the cytoplasmic 
WFB1s with the cell surface, and apparent polymerization of the material, results in the formation of an 
outer, electron-dense oocyst wall. At the same time, the WFB2s lose their doughnut-shaped structure 
and disappear simultaneously with the emergence of an inner oocyst wall (figure 12, j and l).  
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Figure 12: Different stages of oocyst wall 
formation in Eimeria maxima 
69
. (g) 
Mature macrogamete with stained wall 
forming bodies (WFBs) containing the 
material for later oocyst wall formation. 
The WFB1s (red) are stained with Evans 
Blue, whereas the WFB2s (green) are 
stained with an antibody against the WFB2 cargo protein Gam56. Gam56 shows the typical doughnut-formed 
distribution in WFB2s observed in the mature macrogamete stage. Both WFBs locate to the cell periphery at this 
time point. (j, l) Fully formed oocysts walls. The outer layer is stained with Evans Blue (red), whereas the inner layer 
is stained by either anti-Gam56 (j, green) or anti-Gam230 (l, green) antibodies. Some residual cytoplasmic staining 
by anti-Gam56 (j) is visible.  
 
The Eimeria oocyst wall formation has striking parallels with the encystation process in Giardia. Both 
parasites store their wall material in granules and sequentially secrete it to the surface to build first an 
outer and subsequently an inner layer of the wall. Another similarity is the formation of biophysically 
distinct compartments within granules, visible by the doughnut-shaped distribution of CWP1 and CWP2 
surrounding a condensed core in ESVs and the Gam56 and Gam82 proteins in the Eimeria WFB2s. 
Analogous to Giardia CWP2, the Eimeria WFB cargo proteins Gam56 and Gam82 are proteolytically 
processed before they are integrated into the oocyst wall 62. However, the parasites show an interesting 
difference in secretion of their wall components: While Eimeria mediates sequential secretion by spatial 
separation of the material in different granule types (VFB, WFB1, WFB2), Giardia solves this issue by the 
formation of two biophysically distinct fractions in a single organelle type (ESVs).  
 
Encapsulation of Tetrahymena termophila 
The ciliate Tetrahymena termophila secretes material in a similar way in order to build a sturdy capsule 
around the cell. Since the capsule does not enclose the entire cell an environmental protective function 
is unlikely, and it was therefore suggested that the capsule is used for nutrient trapping or defense 
against predators 55. The capsule material is stored in more than 100 dense-core granules termed 
mucocysts (figure 13, A-C). Detailed microscopy studies initially proposed the emergence of the granules 
from ER-derived membranes 70. In the light of current information, it is generally assumed, however, that 
mucocysts are formed at the TGN 71, probably because animal DCSG, as the most characterized ones to 
date, are formed at the TGN23, 72.  
The six most abundant T. termophila mucocyst proteins identified belong to a family named GRL 
(GRanule Lattice) proteins 71, 73, 74. In addition to the GRL proteins a second, poorly understood class of 13 
luminal proteins was identified, including GRTp1 (GRanule Tip protein 1) which preferentially localizes 
near the granule tip 75. Similar to CWPs in Giardia, the T. termophila GRL proteins are initially assembled 
in the ER where they form hetero-oligomers. Deletion of each individual GRL protein results in the ER 
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retention of the remaining GRL proteins 74. This indicates that, similar to Giardia, aggregation of GRL 
cargo proteins seems to play a key role during their export from the ER. In further analogy with ESVs, 
mucocyst maturation is characterized by proteolytic processing and selective condensation of the GRL 
proteins into a crystalline core 76, 77. During the maturation process, mucocysts are distributed in the 
cytosol (figure 13A). In later stages, the mature granules are docked to the plasma membrane (figure 13, 
B and C).  
 
 
Figure 13: Encapsulation of Tetrahymena termophila. A, B) For encapsulation, T. termophila synthesizes more than 
100 granules, termed mucocysts, that contain material for the capsule. Mucocysts are visualized by indirect 
immunofluorescence of the granule cargo protein GRT1 (granule tip protein 1) which is concentrated at the tip of 
each granule. The six GRT proteins which are part of the condensed granule core are not visualized 
53
. Immature 
granules are distributed in the cytosol of the ciliate (A), whereas mature granules are docked to the plasma 
membrane (B). C) Immunofluorescence staining of the mucocyst cargo protein p80 visualizes mucocyst granules 
arrayed as meridians covering the entire surface of the organism apart from the mouth structure 
78
. D) Exocytosis 
of a mucocyst shows fusion of the mucocyst membranes with the plasma membrane and expansion and expulsion 
of the mucocyst contents 
78
. E) Light micrograph of an encapsulated T. termophila cell 
73
.  
 
 
Mucocyst fusion with the membrane can be triggered by a rise in cytosolic calcium and results in 
synchronous cargo release within seconds (figure 13D) 78. During exocytosis, the crystalline structured 
GRL proteins in the dense core undergo a roughly 7-fold expansion 76, resulting in the rapid 
encapsulation of the parasite (Figure 13E). The expansion of the so called “spring-loaded” GRL proteins is 
controlled through their binding to calcium 76. The calcium sensitivity of the GRL1 protein remarkably 
increases after proteolytic processing, and the processed form of GRL1 has been shown to undergo a 
conformational change upon calcium binding 79. In contrast to the GRL proteins, the GRT proteins seem 
not required for mucocyst cargo assembly or secretion of the capsule material, thus a post-exocytic 
function was suggested for this second family of cargo proteins 79.  
 
T. termophila encapsulation shows many parallels to Giardia encystation. However, a difference lies in 
the de-condensation of the dense core components. Whereas the Tetrahymena GRL proteins are 
“spring-loaded” and undergo fast de-condensation within seconds after exocytosis, secretion of the 
Giardia CWP3 core takes several hours, suggesting a slow de-condensation process prior to exocytosis 35.  
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Encystation in Entamoeba invadens  
Entamoeba histolytica is the cause for amebic dysentery and liver abscesses in humans. Analog to 
Giardia, host transmission of E. histolytica occurs via the fecal-oral route of the infectious stage, the cyst. 
Since in vitro triggering of encystation in E. histolytica is highly inefficient, its reptile-infecting relative  
E. invadens has become the reference model for Entamoeba encystation 80.  
The E. invadens cyst wall is comprised of a β-(1,4)-GlcNAc homopolymer (chitin) 81 and a small set of 
chitin-binding proteins termed Jacobs, Jessies and chitinases 59, 60. The encystation process involves 
sequential secretion of the cyst wall sugar and protein components via separate vesicles. The encystation 
process was visualized and described in detail by Chatterjee et al., and based also on additional data 
from important previous works 59, 60, the authors suggested a “wattle and daub” model for cyst wall 
formation (figure 14).  
Early during encystation, two types of vesicles of unknown origin containing Jacob lectins and chitin arise 
in the cytoplasm. Gradual secretion of their content to the cell surface results in the formation of an as 
yet immature cyst wall which is still permeable to small molecules (figure 14, wattle stage). Due to the 
cyst wall permeability at this stage, Chatterjee et al. suggested that chitin and the chitin-binding Jacob 
proteins build the scaffold or wattle of the cyst wall. Jacobs, which are glycoproteins themselves, are 
linked to the plasma membrane by constitutively expressed surface lectins 59.  
In a later stage, an additional set of vesicles containing the Jessie lectins is synthesized. Secretion of 
Jessie lectins and integration into the wall is accompanied by the reduced permeability of the cyst wall to 
small molecules, suggesting that Jessie lectins play a role in sealing the cyst wall (figure 14, daub stage). 
Chatterjee et al. assumed that Jessies are linked to the cyst wall via their chitin binding domain and seal 
the membrane by their tendency to self-aggregate 61. However, the authors did not rule out other 
mechanisms, such as disulfide-crosslinking, which might affect cyst wall permeability. The role of 
chitinases, which are secreted early during encystation, is largely unknown.  
 
 
 
Figure 14: The wattle and daub model for encystation in Entamoeba 
invadens 
46
. The model predicts accumulation of the E. invadens cyst wall 
in three stages. 1) Foundation stage: the Jacob lectins (red), which are 
themselves glycoproteins, are secreted to the surface and linked to the 
plasma membrane by constitutively expressed integral membrane lectins 
(blue). 2) Wattle stage: chitin (green) and chitinases (orange) are 
deposited on the surface. Jacob lectins cross-link the chitin fibrils via 
several chitin-binding domains. 3) Daub stage: the cyst wall gets 
impermeable by the integration of Jessie lectins (violet). Jessie lectins are 
linked to the cyst wall by their chitin-binding domain. Sealing probably 
occurs due to their tendency to self-aggregate.  
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The encystation processes in Entamoeba and Giardia have several striking parallels. The cyst wall of both 
parasites is made up of a carbohydrate homopolymer, which is the β-(1,4)-GlcNAc polymer chitin in 
Entamoeba and a β-(1,3)-GalNAc polymer uniquely found in Giardia 40, 41, 81. The limited data available 
generated without a specific marker for the cyst wall glycan suggest that the cyst wall sugar component 
in Giardia is secreted by vesicles distinct from ESVs 47, which would be analogous to the secretion of 
chitin in Entamoeba. Further similarities are found for the Entamoeba and Giardia CWPs themselves. 
Some or all CWPs have lectin activity and bind to the cyst wall sugar component and have tendency to 
self-aggregate 35, 46, 61. In addition, some of the proteins are proteolytically processed during encystation 
35, 60, 82.  
 
The existence of DCSG in many different species reflects the need for rapid and regulated secretion 
under certain conditions for survival. Animal DCSG share many fundamental hallmarks with DCSG from 
ciliates or other protozoa, such as granule maturation by proteolytic processing, formation of a dense 
core, and calcium-triggered, regulated exocytosis mediated by SNARE proteins and Rab GTPases 22.  
Their widespread distribution among species including the most ancient eukaryotes and their common 
hallmarks suggests that DCSG evolved from an early eukaryotic ancestor. However, molecular studies on 
DCSG of distantly related species strongly argue that DCSG in different lineages were invented several 
times independently and are the product of convergent evolution 22. Elde and colleagues demonstrated 
that key DCSG proteins, such as luminal cargo proteins, processing proteases, and integral membrane 
proteins involved in granule docking and exocytic fusion, are clearly related in the ciliates Paramecium 
and Tetrahymena, but do not show homology to their animal counterparts. The same is true for DCSG-
associated Rab and SNARE proteins which mediate granule docking and fusion of ciliate or animal DCSG 
22. The missing relatedness of granule-associated Rab GTPases and SNARE proteins between animals and 
ciliates is particularly informative because these proteins are usually highly conserved between even 
distantly related species. Consistent with this, Rab and SNARE proteins associated with the Golgi of 
ciliates have Golgi-associated orthologs in animals 22.  
Convergent evolution of DCSG in diverse species may be the result of selective pressure on the regulated 
secretory pathway and adaptation of the organisms to different environmental conditions. Consistent 
with this idea, DCSG of different species are involved in a wide variety of processes and secrete diverse 
cargo, allowing individual species to perfectly adapt to their specific biological niches.  
 
1.7. Three scenarios for cargo-driven ESV neogenesis 
During the past 20 years, considerable effort was undertaken to discover a defining, ESV-specific 
organelle marker. Despite substantial effort on all levels, including extensive genome searches 14, 52, 
transcriptome studies 4, 18, and proteomic analysis of ESV organelles and even the entire Giardia 
proteome at different life cycle stages 2, 19, 83, no defining organelle-marker was identified. Based on 
these data and our unsuccessful attempt at detecting unique ESV-specific proteins (Wampfler and Hehl, 
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under review), we suggest three non-mutually exclusive scenarios for morphogenesis and maturation of 
ESV organelles with CWPs as the main driving factors. The models are schematically illustrated in figure 
15, and their main difference lies in the initial cargo sorting step:  
 
Model 1:  An unknown integral membrane receptor captures CWP1 and recruits the COPII coat 
to the ER  
Model 2:  An unknown integral membrane receptor captures the nascent cyst wall UDP-GalNAc 
homopolymer and recruits the COPII coat to the ER 
Model 3:  CWPs directly interact with the ER membrane, either by insertion of an alpha-helical 
domain into the lipid bilayer or via interaction with modified lipids.  
 
Model 1 
In model 1 (figure 15, top), we suggest the participation of an integral membrane receptor that captures 
ESV cargo. The probably strongest indication for the presence of such a receptor for CWPs is the fact that 
soluble, secreted proteins in most cases depend on cargo receptors for recruitment of cytoplasmic 
membrane coat complexes for export from the ER.  
The dependence of ESV formation on COPII coats was mainly experimentally demonstrated in two 
studies. Stefanic and colleagues created a G. lamblia cell line expressing a dominant negative mutant 
variant of the COPII coat recruitment GTPase Sar1 11. These transgenic cells formed only few ESVs with 
aberrant morphology, if any, strongly suggesting that export of CWM from the ER and thus ESV 
formation depends on the COPII coat machinery. Later, Faso and colleagues nicely visualized the 
neogenesis of ESVs at ER exit sites in Giardia 12.  Whether a predicted integral membrane receptor 
captures CWPs was not determined. However, the finding that the N-terminal domain of CWP1 is 
required for ER export and protein targeting to ESVs implies a putative sorting domain within CWP1 28.  
Covalent and non-covalent intermolecular interactions between CWPs provide unique opportunities for 
co-transport and sorting of CWPs into ESVs 28, 32-34. CWPs form intermolecular complexes which are 
captured and retained by a specific membrane receptor, and newly synthesized CWPs are progressively 
cross-linked and retained in growing ESVs in a “sorting by retention” mechanism. CWP3 and the short 
proteolytic fragment of CWP2 form a solid core based on their inherent property to aggregate, and 
perhaps with the help of additional as yet unknown factors 35.  
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Model 2 
Analogous to model 1, model 2 (figure 15, middle) involves an integral membrane receptor recruiting the 
COPII coat machinery on the cytoplasmic side. Instead of capturing CWPs directly, the model posits that 
the cargo receptor is a lectin that selectively binds a nascent cyst wall GalNAc homopolymer.  
Our organelle proteome study suggests that the UDP-GalNAc monomer might be converted from UDP-
GlcNAc in the ER (Wampfler and Hehl, under review). Thus, formation of the GalNAc homopolymer could 
be initiated in the ER, where it is captured by a receptor with specific lectin activity. The carbohydrate in 
turn captures soluble CWPs 46, packaging all major components for export.  
The Giardia cyst wall synthase is deemed the responsible enzyme for polymerization of UDP-GalNAc 
monomers into the β(1‐3)‐GalNAc polymer 42. Although the enzyme’s activity has been detected in a 
particle fraction isolated by isodensity fractionation from encysting Giardia, its identity as well as its 
localization within compartments was never determined. Of interest, the authors considered a 
localization of the enzyme in ESVs, since activity of the synthase was detected in fractions that also 
labeled positively with monoclonal antibodies against CWP1. However, ESV-mediated export of the 
synthase could also mean that the enzyme gets a ride to the cell surface and does not automatically 
imply its activity at this stage.  
Our model 2 is in agreement with the export of the cyst wall carbohydrate from the ER which was 
suggested by Midley and colleagues 47, but contrasts in the sense that secretion of the carbohydrate 
occurs via ESVs and not in independent vesicles 47.  
 
Model 3 
Model 3 (figure 15, bottom) posits that CWPs directly interact with the membrane by the insertion of an 
amphiphatic alpha-helix into the lipid bilayer. Interactions of this kind are observed frequently for DCSG 
cargo proteins 23. Another possibility comprises the interaction of CWPs with specific membrane lipid 
domains 72.  
A direct interaction of CWPs with the membrane would explain why no cargo receptor has been 
identified to date. However, the lack of a receptor in model 3 raises the question how the COPII coat is 
recruited to the budding transport intermediate. Only recently, several different mechanisms for export 
of bulk cargo from the ER were unraveled 84-87. As an example, Siddiqi et al. identified two unusual 
budding complexes transporting large lipoprotein particles with diameters up to 250 nm from the ER to 
the Golgi in rat hepatocytes and intestinal cells 84-86. Although the complexes involve one or more COPII 
proteins, they contain protein markers distinct from the canonical COPII coat machinery. Even more 
interesting, Thor and colleagues showed that rapid, COPII-dependent bulk flow from the ER in ovary 
hamster cells is induced even in the absence of specific export signals 88.  
Alternatively, we have to consider the involvement of lipid rafts. These have been shown to facilitate 
coat assembly at the TGN when secretory granules were formed 72. Lastly, we should consider that COPII 
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coat recruitment to budding ESVs in Giardia might follow an unconventional manner, and does not 
absolutely require the involvement of a receptor.  
 
Physical links between ESVs and the ER  
Based on data from our study, ESVs maintain a strong and persistent contact with the ER. We predict 
that the two organelles remain connected for a long time, probably even until cargo processing and 
partitioning is finished at ~12-14 hours p.i., before sorting occurs 35. During this period, distinct ER-
resident proteins, such as Hsp70-BiP, a high cysteine non-variant cyst protein (HCNCp), several EGF-like 
cyst protein family members (EGFCP 1-6), and the novel candidates identified in our study, appear to 
have access to ESVs (Wampfler and Hehl, under review, 2, 20, 89). Because the majority of these proteins 
are not secreted to the surface, they must be cycled back to the ER at a certain time. This might occur via 
low density, COPI coated vesicles. Such a “granule clean up” is frequently observed when DCSG bud off 
from the TGN in mammalian cells, giving rise to the originally postulated “sorting by retention” model 27. 
In analogy, export of the Giardia chaperone Hsp70/BiP, which has a KDEL retention signal, and its 
subsequent retrograde transport to the ER most likely in a ERD2- and COPI-dependent manner was 
experimentally demonstrated 2. Alternatively, removal of the proteins from ESVs could also occur via 
tubular membrane links between ESVs and the ER 11. These tubular connections may also be involved in 
exchanging fluid phase cargo between ESVs and were suggested to synchronize maturation of the 
organelles.  
 
Cargo maturation 
During ESV maturation, CWP2 is proteolytically processed (starting at ~8h p.i.) and partitioned in two 
fractions; whereas the long N-terminal part remains in a fluid state together with CWP1, the small C-
terminal fragment of the protein undergoes condensation with CWP3 and localizes to the dense core of 
ESVs 35. There is an ongoing debate about the protease responsible for CWP2 processing, with three 
postulated candidates 90-93.   
A lasting connection between ESVs and the ER until cargo processing and granule maturation is 
completed suggests that the protease, which cleaves CWP2, localizes to the ER or to budding ESVs. This 
has only been shown for one of the suggested candidates, a subtilisin-like proprotein convertase (SPC), 
which localizes mainly to the perinuclear ER in trophozoites and to ESVs in encysting cells 93.  
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Figure 15: Three proposed 
models for ESV morphogenesis 
in G. lamblia.  Model 1: An 
integral membrane receptor 
captures CWPs (example: 
CWP1) and recruits the COPII 
coat at the cytoplasmic side. 
The coat mediates membrane 
bending at an early stage and is 
lost when ESVs mature. CWP2 
enters the granule by disulfide 
crosslinking with CWP1, and 
CWP3 undergoes condensation 
with the small proteolytic 
fragment of CWP2.  
Model 2: An integral mem-
brane receptor captures the 
nascent GalNAc carbohydrate 
polymer and recruits the COPII 
coat at the cytoplasmic side. 
After initial membrane bending 
for granule formation the coat 
is disassembled. The GalNAc 
polymers recruit CWPs by 
binding to their lectin domains. 
CWP3 aggregates together 
with the small proteolytic 
fragment of CWP2 in a 
condensed core.  
Model 3: CWPs (example: 
CWP1) directly interact with 
the membrane, either by 
insertion of an alpha-helical 
domain (3A) or by interaction 
with lipid-raft like domains 
(3B). CWP2 enters the granule 
by disulfide cross-linking with 
CWP1, and CWP3 undergoes 
condensation with the small 
proteolytic fragment of CWP2. 
The COPII coat is recruited to 
early ESVs by alternative 
mechanisms.  
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During our studies we got strong indication that formation of ESVs is primarily driven by cargo proteins 
themselves and does not involve organelle-specific factors. Based on these data we suggested three 
conceivable models for ESV neogenesis and maturation with CWP1-3 as key factors.  
 
Despite considerable progress in recent years and the availability of several working models, the 
molecular underpinning of ESV neogenesis and regulation are still incompletely understood: A number of 
important questions await experimental investigation: How is cargo sorting into ESVs mediated? How is 
selective condensation achieved? At which stage are ESVs independent from the ER? Where and how is 
the glycan component integrated into the cyst wall?  
 
A this point it becomes clear that addressing these questions requires new approaches, for example 
knock-out of the key players CWP1-3. However, the parasite’s tetraploid organization 94, 95 and the 
availability of only two suitable resistance markers for selection of transgenic cells 96-99 makes genetic 
manipulations which are routine in other systems, such as gene knock outs, unfeasible. Alternative 
approaches to reduce protein levels such as expression of antisense sequences 11, 100-103, long double-
stranded RNA 104, 105, or transfection with translation-blocking morpholinos 106 resulted in variable and 
inconsistent knock down levels 11, 105-107. In order to overcome some of these limitations we established 
the E. coli phage P1-derived Cre/loxP system in G. lamblia (Wampfler and Hehl, manuscript in 
preparation). In addition, we provide a detailed protocol how this newly established system can be used 
to realize gene knock outs in the tetraploid parasite.  
 
1.8. The Cre/loxP system in G. lamblia 
The Cre-recombinase is an E. coli phage P1-encoded enzyme that mediates recombination of short DNA 
sequences termed loxP sites, helping the phage to maintain its circular DNA as a single unit copy in the 
host cell and thus ensuring proper segregation to daughter cells 108, 109. Since its characterization 30 years 
ago 108, 110, this simple and efficient two-component system has become a powerful tool in genome 
research and is applied to tightly control genome manipulations in diverse organisms, including 
protozoan parasites such as T. gondii, T. brucei, and P. falciparum 111-113.  
Investigation of gene and protein function in Giardia is currently restricted to (over)expression of 
(modified) target genes or the reduction of protein levels by interfering with mRNA synthesis, stability, 
or accessibility to the translation machinery 11, 104, 106, 114. However, knock-down approaches reported so 
far, including the transfection with morpholinos and hammer head ribozymes as well as the expression 
of antisense sequences or double-stranded RNA, commonly result in inconsistent levels of protein 
depletion 11, 105-107, 114.  
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To address the challenge of manipulating Giardia’s tetraploid genome in a more effective manner, we 
implemented the Cre/loxP system in this binuclear protozoan parasite (Wampfler and Hehl, manuscript 
in preparation).  
In order to test if the Cre-recombinase is expressed and functional in G. lamblia, we designed a Cre/loxP-
based reporter system consisting of a split GFP ORF interrupted by a floxed mcherry expression cassette 
(Wampfler and Hehl, manuscript in preparation). We showed that, upon activation of Cre, the floxed 
mcherry expression cassette is excised from the Giardia genome, resulting in reconstruction of a full 
length GFP ORF and expression of the GFP-reporter. We then used the new tool to excise a stably 
inserted, floxed puromycin resistance from the Giardia genome and demonstrated that the same 
selectable resistance marker can be recycled and used for a second round of transfection in the same cell 
line.  
 
The major limitation of the Cre/loxP system in Giardia comprised the long maintenance of the Cre-
encoding plasmid in the cultured cells even in the absence of positive selection pressure. The 
interpretation of our data suggests that once activated, the recombinase established equilibrium 
between excision and insertion of the floxed puromycin resistance cassette, surprisingly despite the 
presence of a tightly regulated inducible promoter controlling Cre-expression. The equilibrium, which is 
driven towards excision, stagnated only upon loss of the Cre-encoding episome in cultured cell 
populations after more than 4 weeks.  
 
Our results demonstrated that conditional expression of the Cre-recombinase by the positioning of an 
inducible promoter sequence upstream of the Cre-coding region is not controlled tight enough. In 
theory, only 4 Cre molecules per cell are required for recombination of two loxP sites and hence an 
establishment of equilibrium between excision and insertion 115. Of interest, Andenmatten and 
colleagues 116 developed an alternative strategy in T. gondii that permits regulation of the Cre-
recombinase on a protein level (figure 16). The DiCre system is based on the conditional expression of 
the Cre-recombinase as two separate, N-terminal and C-terminal, subunits which are either fused to the 
FK506-binding protein (FKBP) or the rapamycin binding domain of mTOR (FRB). Addition of rapamycin, 
an anti-fungal antibiotic, causes the formation of a stable FKBP-rapamycin-FRB complex 117, resulting in 
dimerization of the two Cre-subunits and thus activation of the recombinase.  
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A crucial finding was that the Cre-recombinase tolerates certain nucleotide variations in its target 
sequences, but recombines only homotopic pairs of these variant sites 115 (figure 17). The combined 
application of several alternative target sites, such as lox511 118, lox2272 119, or m2120, permits the 
realization of complex manipulations of the genome.  
 
 
Figure 17: Alternative Cre targeting sites. The 
wildtype loxP site consists of an 8 bp asymmetrical 
core (spacer) flanked by two 13 bp inverted repeats 
110
. Alternative targeting sites contain nucleotide 
variations in the spacer sequence (lox511, lox5171, 
lox2272, and m2) or in the inverted repeats (lox71, 
lox66) and are tolerated by the Cre-recombinase 
115
.  
 
 
When used as inverted repeat variants, these alternative target sites might provide a straight-forward 
strategy to overcome the challenge of Cre-mediated equilibrium in Giardia. Inverted repeat-variants, 
termed LE (left element) and RE (right element) mutants, contain nucleotide variations in their left or 
right inverted repeat, respectively (figure 17, bottom). Cre-mediated recombination is effectively 
performed between LE and RE mutant sites, but results in the generation of two different target sites 
that cannot be recombined a second time (figure 18). Inverted repeat-variants were mainly used to 
generate stable DNA insertions 115.  
Figure 16: The DiCre system 
116
. Left: The N-terminal 
subunit of Cre is fused to FKBP12 (green), and the C-
terminal subunit of Cre is fused to FRB (violet). The 
addition of rapamycin leads to the formation of a 
FKBP-rapamycin-FRB ternary complex and 
dimerization of the Cre subunits, reconstituting its 
enzymatic activity. FKBP: FK506 binding protein, 
FRB: Rapamycin-binding domain of mTOR 
(mammalian target of rapamycin).  
 
PART V     DISCUSSION AND PERSPECTIVES 
114 
 
Figure 18: Use of loxP inverted repeat variants to achieve stable DNA insertion 
115
. A) Cre-mediated recombination 
between two wildtype loxP target sites can be performed repeatedly, resulting in equilibrium between excision and 
insertion of the floxed DNA sequence. B) Inverted repeat variants containing single bp substitutions in either the 
left inverted repeat (left element, LE) or the right inverted repeat (right element, RE). Cre-mediated recombination 
of LE and RE mutant sites results in the generation of two different, inert target sites which are not recombined 
efficiently with each other. GOI: gene of interest; SM: selectable marker, RE: right element (right inverted repeat); 
LE: left element (left inverted repeat).  
 
 
Application of inverted repeat-variants in Giardia by positioning LE and RE target sites on either side of a 
puromycin resistance cassette would permit fast and permanent removal of the resistance marker from 
the Giardia genome, hence considerably accelerate the system when applied for serial genome 
manipulations.  
 
The Cre/loxP technique in G. lamblia provides novel means for more complex and versatile genetic 
manipulations, and it will facilitate future investigation of gene and protein function in this parasite. In 
conjunction with alternative Cre-recombinase target sites, this genetic tool has the potential to 
overcome some of the major barriers in G. lamblia research, such as the parasite’s tetraploid genome 
and the limited repertoire of selectable markers, and brings us a step closer towards the first gene 
knockout in this evolutionary diverged protozoan.  
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2. Perspectives  
During our studies we got strong indications that morphogenesis of ESVs is primarily driven by cargo 
proteins without involving organelle-specific factors. Based on these data we proposed three models for 
ESV neogenesis and maturation. However, many open questions remain, some of which can only be 
addressed by gene knock outs of the key players CWP1-3. With the implementation of the Cre/loxP 
system in G. lamblia we developed the required technology and toolbox to generate gene knock outs in 
this tetraploid parasite. Hereinafter we describe how a CWP1 knock out, as an example, could be 
realized in G. lamblia.  
 
2.1. CWP1 gene knock out in Giardia lamblia 
To perform a gene knock out in the tetraploid Giardia 94, 95, four rounds of homologous recombination 
are required to remove all gene copies. So far, the availability of only two resistance markers, puromycin 
and neomycin 96-99, did not allow this. Here we propose the repeated use of a floxed puromycin 
resistance cassette which is excised from the genomic insertion site by Cre-recombinase after each 
round of homologous recombination (Wampfler and Hehl, manuscript in preparation). A schematic 
description of the strategy is provided in figure 19. For a proof of concept we chose one of the CWPs 
because the protein is likely completely dispensable in trophozoites and no conditional knock out 
strategy is therefore required.  
 
Specifically, we would design four plasmids, each containing a floxed puromycin resistance cassette 
flanked by different recombination sites (RS1 – RS4) that target the construct to the CWP1 gene locus. In 
a first round of recombination, one copy of CWP1 is exchanged by a floxed puromycin resistance 
cassette for selection of transgenic cells, while three copies of the CWP1 gene remain in the genome 
(figure 19, A1). The Cre-recombinase, under control of the inducible CWP1-promoter, is then transfected 
into the cells via an episomally maintained plasmid using neomycin selection. Transient activation of the 
recombinase by activating the CWP1 promoter controlling its transcription (Wampfler and Hehl, 
manuscript in preparation) results in Cre-mediated excision of the floxed puromycin resistance (figure 
19, A3). The Cre-encoding plasmid is lost over time due to termination of antibiotic pressure by 
neomycin. To obtain clonal cell lines that successfully removed the plasmid, flow cytometry-based single 
cell sorting can be performed.  
 
In the following rounds of homologous recombination, one has to ensure that the construct is targeted 
to a remaining intact copy of the CWP1 target gene and does not recombine with the “empty” gene 
locus where previous crossover reactions took place. This is achieved by using different recombination 
sites in each round, i.e. flanking upstream and downstream sequences in the target gene region but at 
different distances (figure 19, B and C). Each recombination reaction therefore removes not only the 
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target gene but also all sequences upstream and downstream of the target gene region within the 
recombination sites. Consequently, the number of possible recombination sites in each round decreases, 
“forcing” the plasmid to replace another intact CWP1 gene copy.  
 
Each Cre-mediated excision of a floxed puromycin resistance leaves one loxP site behind in the genome. 
For each new recombination round, a plasmid with two additional loxP sites flanking the puromycin 
resistance is inserted into the cell. Since the Cre-recombinase does not differentiate between identical 
target sites, more than two loxP site would result in uncontrolled insertion, excision, or transformation 
events. In order to ensure the proper removal of floxed puromycin in each round, alternative loxP sites 
must be used. The Cre-recombinase recognizes these alternative target sites but mediates 
recombination specifically only between homotopic ones 115. For example, one could use loxP and the 
alternative sites lox5171, lox2272 and m2 118-120.  
 
Cre-mediated excision of floxed DNA sequences is not a uni-directional reaction but instead an 
equilibrium between excision and insertion 115. As long as Cre is present, a subpopulation of the cells will 
maintain the floxed puromycin resistance in the genome (Wampfler and Hehl, manuscript in 
preparation). Consequently, one has to wait after each knock out round until the episomally maintained 
plasmid encoding Cre has been lost. An alternative approach is the transfection of cells with the Cre-
recombinase protein, analogous to the restriction enzyme mediated integration (REMI) technique 121. 
The advantage is that proteins taken up by the cells are not replicated and are thus rapidly diluted when 
cells divide. However, in the absence of any selection pressure this advantage most probably goes to the 
expense of decreased transfection rate and recombination efficiency. Alternatively, the Cre recombinase 
activity itself could be regulated, using the recently developed DiCre system in T. gondii 116.   
PART V     DISCUSSION AND PERSPECTIVES 
117 
Figure 19: Scheme for the generation of 
a CWP1 knock out in Giardia. A) G. 
lamblia genome containing 4 copies of 
the CWP1 target gene, including 
upstream and downstream sequences 
with recombination sites RS1, RS2, RS3, 
and RS4 (A1). A plasmid encoding for a 
floxed puromycin resistance flanked by 
RS1 is transfected into the cells using 
puromycin-based selection (A1). The first 
crossover reaction replaces both, a 
CWP1 gene as well as the RS2, RS3 and 
RS4 sequences with the floxed 
puromycin resistance (A1, A2). An 
episomally maintained plasmid encoding 
for the Cre-recombinase is transfected 
into the cells based on neomycin 
selection (not shown). Cre is activated by 
a pulse / empty chase approach and 
excises the puromycin resistance from 
the genome, leaving behind one loxP site 
(A3). B) For the second round of 
recombination, only three copies of the 
CWP1 gene, RS2, RS3, and RS4 
recombination sites are left in the 
genome (B1). The plasmid encoding for 
the lox5171-flanked puromycin 
resistance and RS2 sites is transfected 
into the cells based on puromycin 
selection (B1). The second crossover 
reaction replaces both, a CWP1 gene 
copy as well as the RS3 and RS4 
recombination sites with the floxed 
puromycin resistance (B1, B2). Transfection of the Cre-encoding plasmid and activation of the enzyme leads to 
excision of the second CWP1 gene copy, leaving a lox5171 site behind (B3). For the third round of homologous 
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recombination, only two copies of CWP1 and two RS3 and RS4 recombination sites are left (B3). C) A third and 
fourth round of homologous recombination is performed by plasmids encoding for the puromycin resistance which 
is flanked by alternative loxP sites (lox2272 and m2) and RS3 and RS4 recombination sites, respectively (C1). The 
final product is a G. lamblia CWP1 knock out containing four alternative loxP sites where the CWP1 gene copies 
were removed (C2). Alternatively, the fourth round is performed without loxP-sites flanking the puromycin 
resistance, resulting in a G. lamblia CWP1 knock out with a stably integrated puromycin resistance cassette (not 
shown). However, to be able to perform functional analysis of CWP1 in a knock out strain, epitope-tagged wild-type 
or modified copies of the gene will have to be reinserted by yet another round of transfection.  
 
2.2. Alternative applications of the Cre/loxP system in G. lamblia 
Once established in G. lamblia, the Cre/loxP system provides a versatile tool to address diverse 
questions. The tool could be used as a sensitive detection system for rare events, for example to 
investigate if G. lamblia takes up DNA from the environment or is subject to horizontal gene transfer 
from microorganisms which inhabit the same ecological niche. An alternative approach focuses on the 
sexual behavior of Giardia which is a major point of discussion. The parasite has long been considered 
strictly asexual, but the presence of meiotic genes 122, 123 and increasing evidence from population 
genetic studies 124, 125 suggest that sexual recombination in fact occurs. However, this has not been 
shown in vitro so far.  
 
To address these issues, we suggest designing two constructs which, if present in the same cell, lead to 
the establishment of a puromycin resistance (figure 20, A-C). Hereinafter we describe our approaches in 
more detail.  
 
All suggested approaches are based on two constructs:  
1. A first plasmid contains the ORF of the puromycin resistance cassette. In order to avoid 
expression of the pac gene at this stage, the start codon including promoter sequence is 
separated from the coding sequence by an intervening floxed neomycin resistance (figure 20A). 
Using neomycin-based selection the construct is stably integrated into the G. lamblia genome, 
giving rise to the Giardia strain termed “Start-Neofl-Puro”.  
2. A second plasmid termed “Neo-pCWP1-Cre” encodes the Cre-recombinase with an upstream 
positioned inducible CWP1-promoter, and a neomycin resistance cassette (figure 20B).  
 
As long as the two constructs are maintained in separate cells, the pac gene conferring puromycin 
resistance is not transcribed due to separation of the start codon and promoter sequence. However, as 
soon as the constructs are present in the same cell, activation of the Cre-recombinase by a pulse/empty 
chase approach (Wampfler and Hehl, manuscript in preparation) results in Cre-mediated excision of the 
floxed neomycin cassette (figure 20C). This places the puromycin start codon and the promoter 
sequence upstream of the puromycin ORF, resulting in puromycin-resistant parasites.  
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The establishment of an antibiotic resistance in the Giardia “Start-Neofl-Puro” strain upon acquisition of 
the “Neo-pCWP1-Cre” coding sequence allows in all approaches the positive selection of Giardia cells 
that a) took up the “Neo-pCWP1-Cre” DNA from the environment or the culture medium, respectively 
(figure 20 D-J), b) obtained DNA from co-cultured “Neo-pCWP1-Cre” plasmid expressing E.coli cells by 
horizontal gene transfer (not shown), and c) mediated sexual recombination with co-cultured Giardia 
cells that stably integrated the “Neo-pCWP1-Cre” sequence (figure 20 K-P). If occurring at all in vitro, 
these events are likely exceedingly rare, but because of the resulting resistance there is a good chance  
that they will be picked up by this sensitive system.  
 
Figure 20: Cre/loxP system based approaches in G. lamblia. A-C) Constructs designed for the approaches. The first 
construct “Start-Neofl-Puro” (A) contains the ORF for a puromycin resistance cassette separated from its start 
codon and promoter sequence. The interrupting sequence is a floxed neomycin resistance cassette. The second 
construct “Neo-pCWP1-Cre” (B) contains the Cre-recombinase with an upstream pCWP1 promoter for inducible 
expression and a neomycin resistance cassette. If the two constructs (A and B) are maintained in the same cell, 
activation of the Cre-recombinase leads to excision of the floxed neomycin cassette and at the same time 
positioning of the puromycin start codon and promoter sequence right uptream of the puromycin ORF.  
D-J) DNA uptake experiment. G. lamblia cells with stably integrated “Start-Neofl-Puro” (D) are grown with the 
“Neo-pCWP1-Cre” plasmid (E) in the culture medium. After some time of cultivation (F) some of the Giardia cells 
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might have taken up the DNA from the medium (G). Activation of the Cre-recombinase (H) results in the 
development of a puromycin resistance in these cells (J) which are selected by the addition of puromycin.  
K-P) Sexual recombination experiment. Giardia cells with stably integrated “Start-Neofl-Puro” (K) and Giardia cells 
with stably integrated “Neo-pCWP1-Cre” (L) are cultivated together for a distinct time (M). If sexual recombination 
in vitro occurs, DNA is exchanged between few individual cells, resulting in few cells containing both constructs (N). 
Activation of the Cre-recombinase (O) results in the development of a puromycin resistance in these cells (P) which 
can be selected by the addition of puromycin.  
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